8701013-00|22 30|delirium|MESH:D003693
8701013-02|101 107|ulcers|MESH:D014456
8701013-03|99 107|delirium|MESH:D003693
8701013-04|57 65|delirium|MESH:D003693
439781-00|21 32|hypotension|MESH:D007022
22836123-00|11 35|scleroderma renal crisis|MESH:D007674
22836123-01|0 24|Scleroderma renal crisis|MESH:D007674
22836123-01|26 29|SRC|MESH:D007674
22836123-01|57 75|systemic sclerosis|MESH:D012595
22836123-01|77 80|SSc|MESH:D012595
22836123-02|82 85|SRC|MESH:D007674
22836123-03|40 66|thrombotic microangiopathy|MESH:D057049
22836123-03|113 116|SSc|MESH:D012595
22836123-04|42 45|SRC|MESH:D007674
22836123-05|89 92|SSc|MESH:D012595
23433219-00|51 60|psychosis|MESH:D011605
23433219-01|113 122|psychosis|MESH:D011605
23433219-02|77 86|psychosis|MESH:D011605
23433219-04|175 184|psychosis|MESH:D011605
23433219-04|202 223|psychiatric disorders|MESH:D001523
23433219-06|70 88|psychotic symptoms|MESH:D011605
23433219-06|135 153|psychotic symptoms|MESH:D011605
23433219-07|16 35|depressive disorder|MESH:D003866
23433219-07|67 83|bipolar disorder|MESH:D001714
23433219-07|117 148|antisocial personality disorder|MESH:D000987
23433219-07|280 289|psychosis|MESH:D011605
23433219-08|0 25|Major depressive disorder|MESH:D003865
23433219-08|57 88|antisocial personality disorder|MESH:D000987
23433219-08|165 174|psychosis|MESH:D011605
23433219-09|37 46|psychosis|MESH:D011605
23433219-10|33 51|affective disorder|MESH:D019964
23433219-10|53 75|antisocial personality|MESH:D000987
23433219-11|86 104|psychotic symptoms|MESH:D011605
23535177-00|78 97|Parkinson's disease|MESH:D010300
23535177-00|110 120|dyskinetic|MESH:D004409
23535177-01|61 80|Parkinson's disease|MESH:D010300
23535177-01|82 84|PD|MESH:D010300
23535177-01|107 118|dyskinesias|MESH:D004409
23535177-01|120 124|LIDs|MESH:D004409
23535177-03|90 94|LIDs|MESH:D004409
23535177-05|52 56|LIDs|MESH:D004409
23535177-06|150 154|LIDs|MESH:D004409
23535177-08|260 290|abnormal involuntary movements|MESH:D004409
23666265-00|87 95|cystitis|MESH:D003556
23666265-01|133 141|cystitis|MESH:D003556
23666265-04|12 16|pain|MESH:D010146
23666265-08|62 66|pain|MESH:D010146
23666265-11|85 90|edema|MESH:D004487
23666265-13|28 36|cystitis|MESH:D003556
23846525-00|6 15|hepatitis|MESH:D056486
23846525-01|13 27|hepatotoxicity|MESH:D056486
23846525-01|55 64|hepatitis|MESH:D056486
23846525-02|48 57|hepatitis|MESH:D056486
23846525-04|23 37|hepatotoxicity|MESH:D056486
23846525-05|93 107|hepatic injury|MESH:D056486
23864035-00|85 101|multiple myeloma|MESH:D009101
23864035-01|92 108|multiple myeloma|MESH:D009101
23864035-01|110 112|MM|MESH:D009101
23864035-02|212 214|MM|MESH:D009101
23864035-08|36 57|peripheral neuropathy|MESH:D010523
23864035-11|48 50|MM|MESH:D009101
23871786-00|43 50|anxiety|MESH:D001008
23871786-02|72 79|anxiety|MESH:D001008
23871786-07|55 62|anxiety|MESH:D001008
23871786-09|57 64|anxiety|MESH:D001008
23871786-10|105 112|anxiety|MESH:D001008
23872883-00|66 80|cardiotoxicity|MESH:D066126
23872883-01|0 23|Cardiovascular diseases|MESH:D002318
23872883-01|25 29|CVDs|MESH:D002318
23872883-02|129 143|cardiotoxicity|MESH:D066126
23892921-00|116 132|multiple myeloma|MESH:D009101
23892921-00|216 223|Myeloma|MESH:D009101
23892921-01|82 98|multiple myeloma|MESH:D009101
23892921-01|100 104|RRMM|MESH:D009101
23892921-02|15 19|RRMM|MESH:D009101
23892921-09|52 68|myelosuppression|MESH:D001855
23892921-10|0 21|Peripheral neuropathy|MESH:D010523
23892921-10|65 85|deep vein thrombosis|MESH:D020246
23892921-15|52 56|RRMM|MESH:D009101
23949582-02|63 83|hemorrhagic cystitis|MESH:D006470
23949582-02|63 83|hemorrhagic cystitis|MESH:D003556
23949582-08|34 46|genotoxicity|MESH:D030342
23952588-00|48 58|dyskinesia|MESH:D004409
23952588-00|93 112|Parkinson's disease|MESH:D010300
23952588-01|39 58|Parkinson's disease|MESH:D010300
23952588-01|60 62|PD|MESH:D010300
23952588-01|115 125|dyskinesia|MESH:D004409
23952588-02|61 71|dyskinesia|MESH:D004409
23952588-02|114 116|PD|MESH:D010300
23952588-03|68 70|PD|MESH:D010300
23952588-05|18 28|dyskinesia|MESH:D004409
23952588-09|0 10|Dyskinesia|MESH:D004409
23952588-11|36 46|dyskinesia|MESH:D004409
23952588-12|14 24|dyskinesia|MESH:D004409
23952588-12|259 269|dyskinesia|MESH:D004409
23952588-13|36 46|dyskinesia|MESH:D004409
23952588-14|48 58|dyskinesia|MESH:D004409
24040781-00|59 70|proteinuria|MESH:D011507
24040781-00|96 98|AL|MESH:D000686
24040781-00|99 110|amyloidosis|MESH:D000686
24040781-01|0 11|Proteinuria|MESH:D011507
24040781-02|183 191|fibrosis|MESH:D005355
24040781-02|204 211|atrophy|MESH:D001284
24040781-02|237 251|glomerulopathy|MESH:D007674
24040781-03|51 62|amyloidosis|MESH:D000686
24040781-03|178 189|proteinuria|MESH:D011507
24067251-00|35 48|kidney injury|MESH:D007674
24067251-04|57 76|acute kidney injury|MESH:D058186
24067251-04|78 104|kidney tubular dysfunction|MESH:D007674
24067251-04|109 125|Fanconi syndrome|MESH:D005198
24067251-05|80 94|kidney disease|MESH:D007674
24067251-05|130 156|kidney tubular dysfunction|MESH:D007674
24067251-05|198 220|glomerular dysfunction|MESH:D007674
24067251-05|238 254|Fanconi syndrome|MESH:D005198
24067251-07|121 137|Fanconi syndrome|MESH:D005198
24068571-00|13 35|postoperative delirium|MESH:D011183
24068571-01|9 31|Postoperative delirium|MESH:D011183
24068571-02|59 81|postoperative delirium|MESH:D011183
24068571-05|64 72|delirium|MESH:D003693
24068571-05|106 131|neurological dysfunctions|MESH:D009422
24068571-06|39 48|confusion|MESH:D003221
24068571-07|6 28|postoperative delirium|MESH:D011183
24068571-08|116 138|postoperative delirium|MESH:D011183
24068571-09|87 95|delirium|MESH:D003693
24068571-10|32 54|postoperative delirium|MESH:D011183
24072398-00|9 19|neurotoxic|MESH:D020258
24072398-00|67 77|depressive|MESH:D003866
24072398-01|133 152|depressive symptoms|MESH:D003866
24072398-02|94 104|depressive|MESH:D003866
24072398-03|26 36|depressive|MESH:D003866
24072398-06|5 15|depressive|MESH:D003866
24072398-07|46 56|depression|MESH:D003866
24072398-08|99 109|depressive|MESH:D003866
24088636-00|18 34|optic neuropathy|MESH:D009901
24088636-03|34 48|loss of vision|MESH:D014786
24088636-04|136 175|extensively drug-resistant tuberculosis|MESH:D054908
24088636-04|177 183|XDR-TB|MESH:D054908
24088636-04|227 241|loss of vision|MESH:D014786
24088636-05|59 75|optic disc edema|MESH:C531767
24088636-06|19 41|toxic optic neuropathy|MESH:D009901
24088636-07|0 23|Deterioration of vision|MESH:D015354
24091473-00|74 90|cardiac toxicity|MESH:D066126
24091473-01|154 162|toxicity|MESH:D064420
24091473-02|56 79|cardiovascular collapse|MESH:D002318
24091473-03|97 120|ventricular tachycardia|MESH:D017180
24091473-03|122 134|fibrillation|MESH:D001281
24100055-00|29 53|thrombocytopenia type II|MESH:D013921
24100055-01|12 28|Thrombocytopenia|MESH:D013921
24100055-01|46 69|end-stage liver disease|MESH:D058625
24100055-01|108 127|portal hypertension|MESH:D006975
24100055-01|162 173|endotoxemia|MESH:D019446
24100055-02|46 70|thrombocytopenia type II|MESH:D013921
24100055-02|72 83|HIT type II|MESH:D013921
24100055-02|99 115|thrombocytopenia|MESH:D013921
24100055-03|68 84|thrombocytopenia|MESH:D013921
24100055-03|154 165|HIT type II|MESH:D013921
24100055-04|183 219|end-stage or malignant liver disease|MESH:D058625
24100055-04|183 219|end-stage or malignant liver disease|MESH:D017114
24100055-05|86 97|HIT type II|MESH:D013921
24100055-06|52 68|thrombocytopenia|MESH:D013921
24100055-06|130 153|End-Stage Liver Disease|MESH:D058625
24100055-06|164 179|liver cirrhosis|MESH:D008103
24100055-08|10 16|HIT II|MESH:D013921
24100055-08|72 83|HIT type II|MESH:D013921
24100055-09|30 33|HIT|MESH:D013921
24100055-09|51 76|end-stage hepatic failure|MESH:D058625
24100055-10|25 36|HIT type II|MESH:D013921
24100257-00|0 18|Takotsubo syndrome|MESH:D054549
24100257-00|23 49|apical ballooning syndrome|MESH:D054549
24100257-01|0 18|Takotsubo syndrome|MESH:D054549
24100257-01|20 22|TS|MESH:D054549
24100257-01|39 60|broken heart syndrome|MESH:D054549
24100257-01|198 221|acute coronary syndrome|MESH:D054058
24100257-02|62 83|mitral valve prolapse|MESH:D008945
24100257-02|88 97|migraines|MESH:D008881
24100257-02|147 157|chest pain|MESH:D002637
24100257-03|168 170|TS|MESH:D054549
24100257-04|114 123|migraines|MESH:D008881
24100257-05|108 125|migraine headache|MESH:D008881
24100257-07|46 64|status migrainosus|MESH:D008881
24100257-08|55 80|coronary artery vasospasm|MESH:D003329
24100257-08|151 153|TS|MESH:D054549
24114426-00|0 10|Depression|MESH:D003866
24114426-00|12 25|impulsiveness|MESH:D010554
24126708-00|87 106|Parkinson's disease|MESH:D010300
24126708-01|55 74|Parkinson's disease|MESH:D010300
24126708-01|164 174|dyskinesia|MESH:D004409
24126708-01|179 200|visual hallucinations|MESH:D006212
24126708-04|29 59|idiopathic Parkinson's disease|MESH:D010300
24126708-06|65 75|dyskinesia|MESH:D004409
24126708-06|161 182|visual hallucinations|MESH:D006212
24132704-12|65 77|hyperlipemia|MESH:D006949
24132704-13|86 98|hyperlipemia|MESH:D006949
24158386-00|58 74|Hodgkin lymphoma|MESH:D006689
24158386-01|0 16|Hodgkin lymphoma|MESH:D006689
24158386-01|18 20|HL|MESH:D006689
24158386-01|53 63|malignancy|MESH:D009369
24158386-03|101 109|toxicity|MESH:D064420
24158386-04|43 45|HL|MESH:D006689
24158386-04|63 71|toxicity|MESH:D064420
24158386-05|83 85|HL|MESH:D006689
24158386-06|36 44|toxicity|MESH:D064420
24158386-11|26 36|toxicities|MESH:D064420
24158386-11|58 69|neutropenia|MESH:D009503
24158386-11|79 95|thrombocytopenia|MESH:D013921
24158386-15|175 177|HL|MESH:D006689
24190587-01|90 118|psychobiological dysfunction|MESH:D008107
24190587-06|68 75|anxiety|MESH:D001008
24190587-06|80 90|depression|MESH:D003866
24190587-10|30 37|anxiety|MESH:D001008
24190587-10|42 52|depression|MESH:D003866
24209900-00|19 33|encephalopathy|MESH:D001927
24209900-01|89 96|cancers|MESH:D009369
24209900-01|107 115|sarcomas|MESH:D012509
24209900-01|117 125|lymphoma|MESH:D008223
24209900-01|127 161|gynecologic and testicular cancers|MESH:D009369
24209900-02|0 14|Encephalopathy|MESH:D001927
24209900-03|123 137|encephalopathy|MESH:D001927
24209900-04|130 136|Cancer|MESH:D009369
24209900-04|212 226|encephalopathy|MESH:D001927
24209900-05|51 65|encephalopathy|MESH:D001927
24209900-06|35 46|convulsions|MESH:D012640
24209900-06|86 119|non-convulsive status epilepticus|MESH:D013226
24209900-06|121 125|NCSE|MESH:D013226
24209900-10|44 58|encephalopathy|MESH:D001927
24209900-11|93 107|encephalopathy|MESH:D001927
24220752-00|30 41|nephropathy|MESH:D007674
24220752-00|72 78|cancer|MESH:D009369
24220752-01|91 102|nephropathy|MESH:D007674
24220752-01|139 145|cancer|MESH:D009369
24220752-03|31 50|acute renal failure|MESH:D058186
24220752-10|104 116|hypertension|MESH:D006973
24220752-12|57 63|cancer|MESH:D009369
24220752-13|0 12|Hypertension|MESH:D006973
24220752-15|17 28|nephropathy|MESH:D007674
24220752-17|0 12|Hypertension|MESH:D006973
24234943-00|0 46|Syndrome of inappropriate antidiuretic hormone|MESH:D007177
24234943-01|31 78|syndrome of inappropriate anti-diuretic hormone|MESH:D007177
24234943-01|80 85|SIADH|MESH:D007177
24234943-02|40 53|hyponatraemia|MESH:D007010
24234943-03|63 69|nausea|MESH:D009325
24234943-03|71 78|anxiety|MESH:D001008
24234943-03|83 92|confusion|MESH:D003221
24234943-04|172 177|SIADH|MESH:D007177
24234943-08|12 17|SIADH|MESH:D007177
24234943-09|81 93|hyponatremia|MESH:D007010
24234943-10|86 98|hyponatremia|MESH:D007010
24275640-00|20 34|cardiotoxicity|MESH:D066126
24275640-01|43 57|cardiotoxicity|MESH:D066126
24275640-05|49 71|cardiac disarrangement|MESH:D006331
24275640-05|73 81|necrosis|MESH:D009336
24275640-06|101 109|necrosis|MESH:D009336
24275640-07|78 86|necrosis|MESH:D009336
24275640-08|67 81|cardiotoxicity|MESH:D066126
24275640-10|52 60|toxicity|MESH:D064420
24275640-10|76 84|toxicity|MESH:D064420
24283660-00|19 26|seizure|MESH:D012640
24283660-01|43 51|seizures|MESH:D012640
24283660-03|27 35|seizures|MESH:D012640
24283660-03|52 60|seizures|MESH:D012640
24283660-05|0 8|Seizures|MESH:D012640
24283660-06|26 47|tonic-clonic seizures|MESH:D004830
24283660-07|65 73|seizures|MESH:D012640
24283660-07|120 143|end-stage liver disease|MESH:D058625
24283660-08|108 116|seizures|MESH:D012640
24283660-09|29 37|seizures|MESH:D012640
24283660-09|85 92|seizure|MESH:D012640
24283660-09|111 120|epileptic|MESH:D004827
24283660-10|69 77|seizures|MESH:D012640
24283660-11|126 134|seizures|MESH:D012640
24284476-03|42 49|amnesia|MESH:D000647
24284476-05|130 141|memory loss|MESH:D008569
24309294-02|81 88|amnesia|MESH:D000647
24309294-08|185 202|memory impairment|MESH:D008569
24333387-00|35 48|neurotoxicity|MESH:D020258
24333387-00|97 114|memory impairment|MESH:D008569
24333387-01|68 76|toxicity|MESH:D064420
24333387-01|113 128|memory impaired|MESH:D008569
24333387-02|24 38|Memory deficit|MESH:D008569
24333387-03|89 106|neuroinflammation|MESH:D007249
24333387-04|175 189|excitotoxicity|MESH:D064420
24333387-06|209 222|neurotoxicity|MESH:D020258
24333387-07|163 176|neurotoxicity|MESH:D020258
24333387-11|31 48|neuroinflammatory|MESH:D007249
24333387-12|71 84|neurotoxicity|MESH:D020258
24333387-12|120 137|memory impairment|MESH:D008569
24341598-00|99 110|nephropathy|MESH:D007674
24341598-01|45 56|nephropathy|MESH:D007674
24341598-09|74 93|acute renal failure|MESH:D058186
24341598-09|95 98|ARF|MESH:D058186
24341598-10|37 40|ARF|MESH:D058186
24345882-00|171 199|acute lymphoblastic leukemia|MESH:D054198
24345882-02|44 57|neurotoxicity|MESH:D020258
24345882-02|202 230|acute lymphoblastic leukemia|MESH:D054198
24345882-03|71 90|leukoencephalopathy|MESH:D056784
24345882-04|90 118|acute lymphoblastic leukemia|MESH:D054198
24345882-04|177 185|leukemia|MESH:D007938
24345882-06|44 63|leukoencephalopathy|MESH:D056784
24345882-08|41 59|attention problems|MESH:D003072
24434397-00|47 54|seizure|MESH:D012640
24434397-00|58 71|renal failure|MESH:D051437
24434397-01|34 56|chronic kidney disease|MESH:D051436
24434397-01|80 104|tubulointerstial disease|MESH:D004194
24434397-02|42 48|anemia|MESH:D000740
24434397-02|56 67|menorrhagia|MESH:D008595
24434397-02|72 103|deterioration of renal function|MESH:D051437
24434397-04|70 78|bleeding|MESH:D006470
24434397-05|73 97|tonic clonic convulsions|MESH:D004830
24434397-07|76 104|nervous system abnormalities|MESH:D009421
24434397-07|134 145|convulsions|MESH:D012640
24434397-09|31 41|convulsion|MESH:D012640
24434397-10|33 44|convulsions|MESH:D012640
24434397-10|67 75|overdose|MESH:D062787
24438483-00|37 62|cardiovascular depression|MESH:D002318
24438483-01|171 185|cardiotoxicity|MESH:D066126
24438483-02|125 139|cardiotoxicity|MESH:D066126
24438483-05|26 37|dysrhythmia|MESH:D001145
24438483-05|155 163|asystole|MESH:D006323
24438483-06|50 58|asystole|MESH:D006323
24438483-07|27 38|dysrhythmia|MESH:D001145
24438483-07|101 109|asystole|MESH:D006323
24438483-11|161 172|cardiotoxic|MESH:D066126
24451297-00|0 31|Drug-Induced Acute Liver Injury|MESH:D056486
24451297-01|69 94|drug-induced liver injury|MESH:D056486
24451297-02|40 52|liver damage|MESH:D056486
24451297-03|48 54|nausea|MESH:D009325
24451297-03|56 64|anorexia|MESH:D000855
24451297-03|76 90|abdominal pain|MESH:D015746
24451297-07|56 70|hepatic damage|MESH:D056486
24459006-00|23 38|agranulocytosis|MESH:D000380
24459006-00|43 59|thrombocytopenia|MESH:D013921
24459006-01|58 73|agranulocytosis|MESH:D000380
24459006-01|79 95|thrombocytopenia|MESH:D013921
24459006-03|39 55|blood dyscrasias|MESH:D006402
24459006-04|79 94|agranulocytosis|MESH:D000380
24459006-04|99 115|thrombocytopenia|MESH:D013921
24459006-06|43 66|bone marrow suppression|MESH:D001855
24464946-00|135 149|cardiotoxicity|MESH:D066126
24464946-01|44 61|myocardial strain|MESH:D009202
24464946-01|128 147|cardiac dysfunction|MESH:D006331
24464946-02|36 56|non-Hodgkin lymphoma|MESH:D008228
24464946-07|0 14|Cardiotoxicity|MESH:D066126
24464946-07|86 99|heart failure|MESH:D006333
24464946-08|46 60|cardiotoxicity|MESH:D066126
24464946-10|272 286|cardiotoxicity|MESH:D066126
24464946-11|63 77|cardiotoxicity|MESH:D066126
24464946-12|94 113|cardiac dysfunction|MESH:D006331
24535067-00|32 41|myoclonus|MESH:D009207
24535067-02|188 197|myoclonus|MESH:D009207
24535067-06|0 19|Myoclonic movements|MESH:D009069
24535067-07|16 20|pain|MESH:D010146
24535067-08|35 44|myoclonus|MESH:D009207
24535067-09|144 153|myoclonus|MESH:D009207
24554916-00|0 11|Cholestatic|MESH:D002779
24554916-00|46 55|poisoning|MESH:D011041
24554916-01|97 111|hepatotoxicity|MESH:D056486
24554916-02|0 9|Poisoning|MESH:D011041
24554916-02|60 75|acute hepatitis|MESH:D006505
24554916-02|87 106|acute liver failure|MESH:D017114
24554916-03|39 48|poisoning|MESH:D011041
24554916-03|111 122|cholestasis|MESH:D002779
24554916-03|150 161|cholestasis|MESH:D002779
24554916-03|218 232|hepatotoxicity|MESH:D056486
24571687-00|0 17|Vasovagal syncope|MESH:D019462
24571687-00|29 40|bradycardia|MESH:D001919
24571687-01|10 17|syncope|MESH:D013575
24571687-01|22 33|bradycardia|MESH:D001919
24571687-05|45 56|bradycardia|MESH:D001919
24571687-06|4 15|bradycardia|MESH:D001919
24582773-00|19 28|agitation|MESH:D011595
24582773-00|72 97|schizo-affective disorder|MESH:D011618
24582773-01|59 84|schizo-affective disorder|MESH:D011618
24582773-02|31 51|personality disorder|MESH:D010554
24582773-02|69 88|antisocial disorder|MESH:D000987
24582773-02|97 121|substance abuse disorder|MESH:D019966
24582773-03|114 123|agitation|MESH:D011595
24582773-03|207 221|aggressiveness|MESH:D010554
24582773-03|225 245|personality disorder|MESH:D010554
24582773-04|17 22|manic|MESH:D001714
24582773-04|33 42|akathisia|MESH:D017109
24582773-05|103 112|agitation|MESH:D011595
24582773-05|142 151|agitation|MESH:D011595
24587916-00|67 79|hypertension|MESH:D006973
24587916-01|30 42|hypertension|MESH:D006973
24587916-03|98 110|hypertension|MESH:D006973
24587916-11|77 89|hypertension|MESH:D006973
24587916-12|18 29|weight loss|MESH:D015431
24587916-13|136 148|hypertension|MESH:D006973
24588023-00|44 54|convulsive|MESH:D012640
24588023-00|55 63|seizures|MESH:D012640
24588023-01|49 57|seizures|MESH:D012640
24588023-02|2 12|convulsive|MESH:D012640
24588023-02|13 20|seizure|MESH:D012640
24588023-02|101 137|abnormal involuntary motor movements|MESH:D004409
24588023-03|99 107|seizures|MESH:D012640
24588023-04|55 65|convulsive|MESH:D012640
24588023-04|66 74|seizures|MESH:D012640
24588023-05|0 30|Generalised and focal seizures|MESH:D012640
24588023-06|53 60|seizure|MESH:D012640
24588023-08|40 48|seizures|MESH:D012640
24588023-08|131 155|congestive heart failure|MESH:D006333
24588023-08|162 173|hypothermic|MESH:D007035
24588023-09|105 113|seizures|MESH:D012640
24588023-10|14 24|convulsive|MESH:D012640
24588023-10|25 33|seizures|MESH:D012640
24588023-10|152 162|convulsive|MESH:D012640
24588023-10|163 171|seizures|MESH:D012640
24588023-11|106 116|convulsive|MESH:D012640
24588023-11|117 125|seizures|MESH:D012640
24588023-11|183 191|seizures|MESH:D012640
24588023-12|0 10|Convulsive|MESH:D012640
24588023-12|11 19|seizures|MESH:D012640
24588023-12|34 60|postoperative complication|MESH:D011183
24588023-13|168 176|seizures|MESH:D012640
24595967-00|0 30|Dysfunctional overnight memory|MESH:D008569
24595967-02|91 116|sleep-related impairments|MESH:D012893
24595967-06|27 52|impaired overnight memory|MESH:D008569
24595967-08|113 131|memory impairments|MESH:D008569
24614773-00|15 29|encephalopathy|MESH:D001927
24614773-01|62 71|confusion|MESH:D003221
24614773-01|73 83|aggression|MESH:D001523
24614773-01|85 108|auditory hallucinations|MESH:D006212
24614773-01|113 122|delusions|MESH:D003072
24614773-02|90 101|hemiparesis|MESH:D010291
24614773-02|168 187|hemiplegic migraine|MESH:D020325
24614773-05|68 82|encephalopathy|MESH:D001927
24614773-06|46 60|encephalopathy|MESH:D001927
24614773-06|90 102|encephalitis|MESH:D004660
24618873-00|0 37|Cerebellar and oculomotor dysfunction|MESH:D002526
24618873-00|0 37|Cerebellar and oculomotor dysfunction|MESH:D005128
24618873-01|67 71|pain|MESH:D010146
24618873-02|15 19|pain|MESH:D010146
24618873-03|28 34|nausea|MESH:D009325
24618873-03|36 44|vomiting|MESH:D014839
24618873-03|49 60|hypotension|MESH:D007022
24618873-04|17 50|impaired renal and liver function|MESH:D017093
24618873-04|17 50|impaired renal and liver function|MESH:D051437
24618873-04|81 85|pain|MESH:D010146
24618873-04|175 185|neurotoxic|MESH:D020258
24618873-04|225 237|irritability|MESH:D001523
24618873-04|242 249|seizure|MESH:D012640
24618873-06|107 116|dysmetria|MESH:D002524
24618873-06|118 128|dysarthria|MESH:D004401
24641119-00|0 15|Baboon syndrome|UNKNOWN_Disease
24641119-01|44 66|maculopapular eruption|MESH:D003875
24641119-02|44 59|baboon syndrome|UNKNOWN_Disease
24641119-03|0 15|Baboon syndrome|UNKNOWN_Disease
24641119-03|55 77|maculopapular eruption|MESH:D003875
24641119-04|86 101|baboon syndrome|UNKNOWN_Disease
24653743-00|10 30|Sudden Cardiac Death|MESH:D016757
24653743-00|59 78|Torsades de Pointes|MESH:D016171
24653743-01|133 152|atrial fibrillation|MESH:D001281
24653743-01|194 214|sudden cardiac death|MESH:D016757
24653743-02|65 83|torsade de pointes|MESH:D016171
24653743-04|179 198|torsades de pointes|MESH:D016171
24653743-05|102 121|atrial fibrillation|MESH:D001281
24658375-00|45 53|myositis|MESH:D009220
24658375-00|72 100|acute promyelocytic leukemia|MESH:D015473
24658375-01|68 96|acute promyelocytic leukemia|MESH:D015473
24658375-01|98 101|APL|MESH:D015473
24658375-02|40 48|myositis|MESH:D009220
24658375-03|49 52|APL|MESH:D015473
24659727-00|76 84|lymphoma|MESH:D008223
24659727-01|35 43|toxicity|MESH:D064420
24659727-01|131 139|lymphoma|MESH:D008223
24659727-04|0 11|Neutropenia|MESH:D009503
24659727-04|81 92|neutropenia|MESH:D009503
24659727-05|42 53|neutropenia|MESH:D009503
24659727-05|160 171|neutropenia|MESH:D009503
24659727-06|57 71|hepatotoxicity|MESH:D056486
24659727-07|31 45|renal toxicity|MESH:D007674
24659727-07|49 69|hemorrhagic cystitis|MESH:D006470
24659727-07|49 69|hemorrhagic cystitis|MESH:D003556
24659727-09|153 158|tumor|MESH:D009369
24664478-00|11 24|neurotoxicity|MESH:D020258
24664478-01|18 31|neurotoxicity|MESH:D020258
24664478-02|48 77|T-cell lymphoblastic lymphoma|MESH:D054218
24664478-04|52 60|leukemic|MESH:D007938
24664478-06|93 113|tumor lysis syndrome|MESH:D015275
24664478-06|115 118|TLS|MESH:D015275
24664478-10|56 77|peripheral neuropathy|MESH:D010523
24664478-13|4 14|neuropathy|MESH:D009422
24664478-15|68 81|neurotoxicity|MESH:D020258
24665854-00|18 32|hyperammonemic|MESH:D022124
24665854-00|33 47|encephalopathy|MESH:D001927
24665854-01|0 26|Neurological complications|MESH:D009422
24665854-03|18 32|hyperammonemic|MESH:D022124
24665854-03|33 47|encephalopathy|MESH:D001927
24665854-04|102 110|epilepsy|MESH:D004827
24665854-04|124 146|impaired consciousness|MESH:D003244
24665854-04|152 166|hyperammonemia|MESH:D022124
24671324-00|0 21|Necrotising fasciitis|MESH:D019115
24671324-00|101 131|Waldenstrom macroglobulinaemia|MESH:D008258
24671324-01|116 136|bacterial infections|MESH:D001424
24671324-01|161 173|malignancies|MESH:D009369
24671324-03|43 73|Waldenstrom macroglobulinaemia|MESH:D008258
24671324-03|87 108|necrotising fasciitis|MESH:D019115
24671324-03|117 128|neutropenia|MESH:D009503
24671324-05|53 73|bacterial infections|MESH:D001424
24675088-00|106 120|cardiotoxicity|MESH:D066126
24675088-01|17 23|cancer|MESH:D009369
24675088-02|85 99|cardiomyopathy|MESH:D009202
24675088-02|328 336|toxicity|MESH:D064420
24675088-04|47 71|subcellular degeneration|MESH:D009410
24675088-05|48 74|cardiomyocyte degeneration|MESH:D009410
24675088-05|76 87|hypertrophy|MESH:D006984
24675088-06|22 30|fibrosis|MESH:D005355
24675088-07|232 246|LV dysfunction|MESH:D018487
24675088-09|126 147|diastolic dysfunction|MESH:D018754
24675088-10|24 50|cardiomyocyte degeneration|MESH:D009410
24675088-12|41 55|LV dysfunction|MESH:D018487
24684312-00|99 111|hyperalgesia|MESH:D006930
24684312-00|116 125|allodynia|MESH:D006930
24684312-01|94 98|pain|MESH:D010146
24684312-01|114 126|hyperalgesia|MESH:D006930
24684312-01|131 140|allodynia|MESH:D006930
24684312-01|176 190|pain disorders|MESH:D013001
24684312-04|33 45|hyperalgesia|MESH:D006930
24684312-04|63 72|allodynia|MESH:D006930
24684312-05|9 31|secondary hyperalgesia|MESH:D006930
24684312-05|36 45|allodynia|MESH:D006930
24684312-08|19 31|hyperalgesia|MESH:D006930
24684312-09|34 46|hyperalgesia|MESH:D006930
24684312-11|41 63|secondary hyperalgesia|MESH:D006930
24684312-11|81 90|allodynia|MESH:D006930
24684312-12|115 137|secondary hyperalgesia|MESH:D006930
24684312-12|142 151|allodynia|MESH:D006930
24684312-13|58 70|hyperalgesic|MESH:D006930
24684312-13|75 84|allodynic|MESH:D006930
24691439-00|44 52|glaucoma|MESH:D005901
24691439-00|86 94|glaucoma|MESH:D005901
24691439-01|42 61|ocular hypertension|MESH:D009798
24691439-02|53 61|glaucoma|MESH:D005901
24691439-02|77 104|primary open-angle glaucoma|MESH:C562750
24691439-02|106 110|POAG|MESH:C562750
24691439-03|51 59|glaucoma|MESH:D005901
24691439-04|60 68|glaucoma|MESH:D005901
24691439-04|83 91|glaucoma|MESH:D005901
24691439-05|142 158|retinal ganglion|MESH:D012173
24691439-05|170 189|axonal degeneration|MESH:D009410
24691439-05|225 233|glaucoma|MESH:D005901
24691439-06|35 54|ocular hypertension|MESH:D009798
24691439-08|209 228|ocular hypertension|MESH:D009798
24691439-09|107 126|ocular hypertension|MESH:D009798
24691439-10|71 90|ocular hypertension|MESH:D009798
24691439-10|203 211|glaucoma|MESH:D005901
24709919-00|42 54|hyperalgesia|MESH:D006930
24709919-01|15 27|hyperalgesia|MESH:D006930
24709919-01|29 32|OIH|MESH:D006930
24709919-02|0 3|OIH|MESH:D006930
24709919-02|83 99|opioid addiction|MESH:D009293
24709919-03|117 120|OIH|MESH:D006930
24709919-04|0 3|OIH|MESH:D006930
24709919-07|25 28|OIH|MESH:D006930
24709919-08|56 59|OIH|MESH:D006930
24709919-09|48 51|OIH|MESH:D006930
24709919-10|98 101|OIH|MESH:D006930
24717468-09|60 71|hypotension|MESH:D007022
24717468-09|112 123|bradycardia|MESH:D001919
24717468-11|84 95|hypotension|MESH:D007022
24717468-11|99 110|bradycardia|MESH:D001919
24717468-12|20 31|hypotension|MESH:D007022
24717468-12|36 47|bradycardia|MESH:D001919
24717468-13|54 65|hypotension|MESH:D007022
24717468-13|69 80|bradycardia|MESH:D001919
24727461-00|48 73|mitochondrial dysfunction|MESH:D028361
24727461-00|97 111|cardiotoxicity|MESH:D066126
24727461-00|125 138|breast cancer|MESH:D001943
24727461-01|60 66|cancer|MESH:D009369
24727461-01|78 100|cardiovascular disease|MESH:D002318
24727461-02|31 45|cardiotoxicity|MESH:D066126
24727461-02|104 129|mitochondrial dysfunction|MESH:D028361
24727461-03|62 78|cardiac toxicity|MESH:D066126
24727461-03|147 160|breast cancer|MESH:D001943
24727461-04|24 37|breast tumors|MESH:D001943
24727461-05|0 20|Cardiac disturbances|MESH:D006331
24727461-06|28 48|cardiac disturbances|MESH:D006331
24727461-08|56 68|heart damage|MESH:D006331
24729111-00|19 33|myxoedema coma|MESH:D003128
24729111-00|19 33|myxoedema coma|MESH:D007037
24729111-01|36 47|bradycardia|MESH:D001919
24729111-01|49 60|hypothermia|MESH:D007035
24729111-01|65 84|respiratory failure|MESH:D012131
24729111-01|136 155|atrial fibrillation|MESH:D001281
24733133-00|40 52|thrombolysis|MESH:D055499
24733133-00|112 128|thrombocytopenia|MESH:D013921
24733133-00|134 144|thrombosis|MESH:D013927
24733133-01|71 87|thrombocytopenia|MESH:D013921
24733133-01|93 103|thrombosis|MESH:D013927
24733133-01|105 109|HITT|MESH:D013927
24733133-01|105 109|HITT|MESH:D013921
24733133-01|166 178|thrombolysis|MESH:D055499
24733133-02|48 59|amyloidosis|MESH:D000686
24733133-02|178 216|upper-extremity deep venous thrombosis|MESH:D056824
24733133-02|218 221|DVT|MESH:D020246
24733133-02|227 245|pulmonary embolism|MESH:D011655
24733133-02|275 291|thrombocytopenia|MESH:D013921
24733133-04|116 149|superior vena cava (SVC) syndrome|MESH:D013479
24733133-05|115 124|epistaxis|MESH:D004844
24733133-06|4 13|epistaxis|MESH:D004844
24733133-10|57 80|vision and hearing loss|MESH:D034381
24733133-10|57 80|vision and hearing loss|MESH:D014786
24733133-10|93 116|end-stage renal disease|MESH:D007676
24733133-11|41 52|amyloidosis|MESH:D000686
24733133-11|57 69|SVC syndrome|MESH:D013479
24733133-11|83 87|HITT|MESH:D013927
24733133-11|83 87|HITT|MESH:D013921
24739405-00|57 70|schizophrenia|MESH:D012559
24739405-01|87 100|schizophrenia|MESH:D012559
24739405-04|33 38|hyper|MESH:D006948
24739405-04|152 161|catalepsy|MESH:D002375
24739405-04|198 211|schizophrenia|MESH:D012559
24739405-06|67 72|hyper|MESH:D006948
24739405-06|120 129|catalepsy|MESH:D002375
24739405-09|77 86|catalepsy|MESH:D002375
24739405-11|75 84|catalepsy|MESH:D002375
24739405-12|100 113|schizophrenia|MESH:D012559
24742750-00|111 126|QT prolongation|MESH:D008133
24742750-02|114 129|QT prolongation|MESH:D008133
24742750-03|97 112|QT prolongation|MESH:D008133
24742750-06|83 101|Torsade de Pointes|MESH:D016171
24742750-06|103 106|TdP|MESH:D016171
24742750-07|73 76|TdP|MESH:D016171
24753331-00|21 29|toxicity|MESH:D064420
24753331-01|74 89|embryolethality|MESH:D020964
24753331-01|91 105|teratogenicity|MESH:D064793
24753331-01|114 140|ventricular septal defects|MESH:D006345
24753331-01|161 179|growth retardation|MESH:D005317
24753331-01|223 231|toxicity|MESH:D064420
24753331-02|90 98|toxicity|MESH:D064420
24753331-05|92 100|toxicity|MESH:D064420
24753331-06|0 8|Toxicity|MESH:D064420
24753331-06|18 33|embryolethality|MESH:D020964
24753331-06|35 49|teratogenicity|MESH:D064793
24753331-06|55 73|growth retardation|MESH:D005317
24753331-07|84 99|embryonic death|MESH:D020964
24753331-07|104 129|ventricular septal defect|MESH:D006345
24753331-08|60 71|teratogenic|MESH:D064793
24778426-00|9 23|Renal Toxicity|MESH:D007674
24778426-00|27 33|Cancer|MESH:D009369
24778426-02|65 79|nephrotoxicity|MESH:D007674
24778426-03|42 50|toxicity|MESH:D064420
24778426-04|63 77|nephrotoxicity|MESH:D007674
24778426-04|81 87|cancer|MESH:D009369
24778426-06|29 35|cancer|MESH:D009369
24778426-07|24 43|acute kidney injury|MESH:D058186
24778426-07|45 48|AKI|MESH:D058186
24778426-08|94 114|head and neck cancer|MESH:D006258
24778426-08|132 142|malignancy|MESH:D009369
24778426-09|66 80|nephrotoxicity|MESH:D007674
24778426-10|79 91|hypertension|MESH:D006973
24778426-10|135 149|nephrotoxicity|MESH:D007674
24778426-11|139 153|nephrotoxicity|MESH:D007674
24778426-12|126 138|hypertension|MESH:D006973
24778426-12|167 181|nephrotoxicity|MESH:D007674
24802403-00|27 35|seizures|MESH:D012640
24802403-00|37 68|learning and memory impairments|MESH:D008569
24802403-00|37 68|learning and memory impairments|MESH:D007859
24802403-01|0 20|Cognitive impairment|MESH:D003072
24802403-01|64 72|epilepsy|MESH:D004827
24802403-02|47 55|epilepsy|MESH:D004827
24802403-03|69 77|seizures|MESH:D012640
24802403-03|82 100|cognition deficits|MESH:D003072
24802403-04|80 98|cognitive deficits|MESH:D003072
24802403-06|77 85|seizures|MESH:D012640
24802403-06|87 107|cognitive impairment|MESH:D003072
24802403-09|80 100|cognitive impairment|MESH:D003072
24802403-10|94 102|epilepsy|MESH:D004827
24802403-10|144 164|cognitive impairment|MESH:D003072
24802403-10|176 184|seizures|MESH:D012640
24812279-00|52 66|cardiotoxicity|MESH:D066126
24812279-01|45 51|cancer|MESH:D009369
24812279-01|114 128|cardiotoxicity|MESH:D066126
24812279-02|51 64|heart failure|MESH:D006333
24812279-03|63 77|cardiotoxicity|MESH:D066126
24812279-09|154 168|cardiotoxicity|MESH:D066126
24816962-00|22 36|encephalopathy|MESH:D001927
24816962-02|56 70|encephalopathy|MESH:D001927
24816962-04|31 39|toxicity|MESH:D064420
24840785-00|39 49|arrhythmia|MESH:D001145
24840785-02|92 106|cardiotoxicity|MESH:D066126
24840785-03|69 78|poisoning|MESH:D011041
24840785-04|88 97|poisoning|MESH:D011041
24840785-05|110 120|arrhythmia|MESH:D001145
24840785-06|39 56|myocardial injury|MESH:D009202
24840785-06|71 83|cytotoxicity|MESH:D064420
24840785-07|46 63|myocardial injury|MESH:D009202
24840785-13|94 104|arrhythmia|MESH:D001145
24842192-00|90 118|left ventricular dysfunction|MESH:D018487
24842192-00|129 150|myocardial infarction|MESH:D009203
24842192-01|58 79|myocardial infarction|MESH:D009203
24842192-02|76 95|cardiac dysfunction|MESH:D006331
24842192-02|149 170|myocardial infarction|MESH:D009203
24842192-04|89 116|acute myocardial infarction|MESH:D009203
24842192-06|4 32|left ventricular dysfunction|MESH:D018487
24842192-07|131 136|tumor|MESH:D009369
24842192-07|137 145|necrosis|MESH:D009336
24842192-11|50 71|myocardial infarction|MESH:D009203
24881749-00|0 30|Neuroleptic malignant syndrome|MESH:D009459
24881749-00|121 141|Huntington's disease|MESH:D006816
24881749-00|177 190|breast cancer|MESH:D001943
24881749-01|66 96|neuroleptic malignant syndrome|MESH:D009459
24881749-01|225 245|Huntington's disease|MESH:D006816
24881749-03|22 35|breast cancer|MESH:D001943
24881749-04|48 78|neuroleptic malignant syndrome|MESH:D009459
24894748-00|45 56|bradycardia|MESH:D001919
24894748-01|12 29|sinus bradycardia|MESH:D012804
24894748-02|64 87|coronary artery disease|MESH:D003324
24894748-02|154 167|onychomycosis|MESH:D014009
24894748-03|121 130|confusion|MESH:D003221
24894748-04|46 63|sinus bradycardia|MESH:D012804
24894748-05|28 49|adverse drug reaction|MESH:D064420
24894748-05|124 141|sinus bradycardia|MESH:D012804
24894748-08|169 186|sinus bradycardia|MESH:D012804
24897009-00|19 40|peripheral neuropathy|MESH:D010523
24897009-01|29 45|optic neuropathy|MESH:D009901
24897009-01|71 85|polyneuropathy|MESH:D011115
24897009-02|111 122|visual loss|MESH:D014786
24897009-02|127 139|paresthesias|MESH:D010292
24897009-03|119 127|toxicity|MESH:D064420
24902786-00|48 65|memory impairment|MESH:D008569
24902786-01|74 91|memory impairment|MESH:D008569
24902786-07|66 85|impaired the memory|MESH:D008569
24902786-07|201 218|memory impairment|MESH:D008569
24902786-08|80 97|memory impairment|MESH:D008569
24911645-00|104 112|seizures|MESH:D012640
24911645-02|44 57|skin diseases|MESH:D012871
24911645-02|138 147|diarrheas|MESH:D003967
24911645-02|152 173|inflammatory diseases|MESH:D007249
24911645-04|86 93|seizure|MESH:D012640
24911645-04|329 337|seizures|MESH:D012640
24911645-05|43 50|seizure|MESH:D012640
24911645-09|128 146|status epilepticus|MESH:D013226
24911645-09|196 203|seizure|MESH:D012640
24923469-00|75 94|acute kidney injury|MESH:D058186
24923469-01|14 33|Acute kidney injury|MESH:D058186
24923469-01|35 38|AKI|MESH:D058186
24923469-03|160 171|nephrotoxic|MESH:D007674
24923469-03|206 209|AKI|MESH:D058186
24923469-08|0 3|AKI|MESH:D058186
24923469-10|15 18|AKI|MESH:D058186
24923469-12|0 3|AKI|MESH:D058186
24923469-13|79 89|infections|MESH:D007239
24923469-14|76 79|AKI|MESH:D058186
24923469-15|50 61|nephrotoxic|MESH:D007674
24923469-15|117 120|AKI|MESH:D058186
24927617-00|0 14|Rhabdomyolysis|MESH:D012206
24927617-00|20 46|hepatitis C virus infected|MESH:D006526
24927617-01|33 60|hepatitis C virus infection|MESH:D006526
24927617-03|110 124|rhabdomyolysis|MESH:D012206
24927617-04|75 83|toxicity|MESH:D064420
24927617-10|87 102|muscle toxicity|MESH:D009135
24928523-00|150 166|multiple myeloma|MESH:D009101
24928523-01|40 56|multiple myeloma|MESH:D009101
24928523-01|58 60|MM|MESH:D009101
24928523-02|212 214|MM|MESH:D009101
24928523-04|10 21|neutropenia|MESH:D009503
24928523-04|26 42|thrombocytopenia|MESH:D013921
24928523-04|146 155|cytopenia|MESH:D006402
24928523-05|0 21|Peripheral neuropathy|MESH:D010523
24928523-05|62 83|peripheral neuropathy|MESH:D010523
24971338-00|57 68|nephropathy|MESH:D007674
24971338-01|152 163|nephropathy|MESH:D007674
24971338-05|0 13|Renal lesions|MESH:D007674
24971338-06|27 38|proteinuria|MESH:D011507
24971338-06|91 107|renal impairment|MESH:D007674
24971338-07|52 66|kidney lesions|MESH:D007674
24971338-08|34 46|renal damage|MESH:D007674
24971338-09|40 52|renal damage|MESH:D007674
24975837-00|70 88|acute renal injury|MESH:D058186
24975837-01|91 110|acute kidney injury|MESH:D058186
24975837-01|222 244|acute tubular necrosis|MESH:D007683
24975837-02|51 63|inflammation|MESH:D007249
24975837-02|174 194|diabetic nephropathy|MESH:D003928
24975837-03|66 85|acute kidney injury|MESH:D058186
24975837-05|98 109|weight loss|MESH:D015431
24975837-05|202 224|acute tubular necrosis|MESH:D007683
24975837-07|83 102|acute kidney injury|MESH:D058186
24975837-07|120 128|necrotic|MESH:D009336
24975837-08|86 100|nephrotoxicity|MESH:D007674
24999722-00|80 108|birdshot retinochoroidopathy|MESH:C537630
24999722-01|120 148|birdshot retinochoroidopathy|MESH:C537630
24999722-02|50 78|birdshot retinochoroidopathy|MESH:C537630
24999722-05|52 64|inflammation|MESH:D007249
24999722-05|78 96|retinal vasculitis|MESH:D031300
24999722-06|22 30|cataract|MESH:D002386
24999722-06|35 62|raised intraocular pressure|MESH:D009798
24999722-07|21 33|inflammation|MESH:D007249
24999722-08|7 17|vasculitis|MESH:D014657
24999722-09|98 119|cystoid macular edema|MESH:D008269
24999722-12|24 54|increased intraocular pressure|MESH:D009798
24999722-12|67 75|cataract|MESH:D002386
24999722-13|92 104|inflammation|MESH:D007249
24999722-13|148 176|birdshot retinochoroidopathy|MESH:C537630
24999722-14|50 58|cataract|MESH:D002386
24999722-14|63 82|ocular hypertension|MESH:D009798
25006369-00|53 66|fasciculation|MESH:D005207
25006369-00|71 78|myalgia|MESH:D063806
25006369-01|82 102|muscle fasciculation|MESH:D005207
25006369-01|107 114|myalgia|MESH:D063806
25006369-02|95 108|fasciculation|MESH:D005207
25006369-02|113 120|myalgia|MESH:D063806
25006369-06|136 150|fasciculations|MESH:D005207
25006369-06|158 165|myalgia|MESH:D063806
25006369-07|47 67|muscle fasciculation|MESH:D005207
25006369-08|9 16|myalgia|MESH:D063806
25006369-10|136 149|fasciculation|MESH:D005207
25006369-10|154 161|myalgia|MESH:D063806
25006961-00|48 78|nephrogenic diabetes insipidus|MESH:D018500
25006961-01|45 75|nephrogenic diabetes insipidus|MESH:D018500
25006961-01|77 80|NDI|MESH:D018500
25006961-03|131 139|polyuria|MESH:D011141
25006961-12|116 119|NDI|MESH:D018500
25006961-12|164 172|polyuria|MESH:D011141
25031906-00|3 12|Dysguesia|MESH:D004408
25031906-01|41 50|dysguesia|MESH:D004408
25031906-03|47 59|hypertension|MESH:D006973
25031906-03|104 127|loss of taste sensation|MESH:D012678
25031906-05|38 47|dysguesia|MESH:D004408
25031906-06|97 106|dysguesia|MESH:D004408
25041770-00|0 14|Rhabdomyolysis|MESH:D012206
25041770-02|39 53|rhabdomyolysis|MESH:D012206
25041770-03|121 135|rhabdomyolysis|MESH:D012206
25041770-04|46 60|rhabdomyolysis|MESH:D012206
25041770-05|93 101|myopathy|MESH:D009135
25041770-06|82 96|rhabdomyolysis|MESH:D012206
25054547-00|117 122|apnea|MESH:D001049
25054547-01|0 32|Butyrylcholinesterase deficiency|MESH:C537417
25054547-01|63 68|apnea|MESH:D001049
25071004-00|8 14|anemia|MESH:D000740
25071004-01|17 33|hemolytic anemia|MESH:D000743
25071004-01|198 205|malaria|MESH:D008288
25071004-02|159 166|malaria|MESH:D008288
25071004-06|21 27|anemia|MESH:D000740
25080425-00|138 155|myocardial injury|MESH:D009202
25080425-01|95 114|myocardial ischemia|MESH:D017202
25080425-03|6 32|myocardial ischemic injury|MESH:D017202
25080425-05|140 162|ventricular remodeling|MESH:D020257
25080425-08|34 51|myocardial damage|MESH:D009202
25080425-09|96 115|myocardial ischemia|MESH:D017202
25084821-00|19 30|neutropenia|MESH:D009503
25084821-00|36 43|bipolar|MESH:D001714
25084821-00|57 81|hepatocellular carcinoma|MESH:D006528
25084821-01|117 133|blood dyscrasias|MESH:D006402
25084821-01|146 157|neutropenia|MESH:D009503
25084821-03|25 49|hepatocellular carcinoma|MESH:D006528
25084821-03|65 76|neutropenia|MESH:D009503
25084821-04|48 64|bipolar disorder|MESH:D001714
25084821-04|84 108|hepatocellular carcinoma|MESH:D006528
25084821-05|14 24|leucopenia|MESH:D007970
25084821-07|22 33|neutropenia|MESH:D009503
25084821-08|0 19|Hepatic dysfunction|MESH:D008107
25084821-08|77 82|fever|MESH:D005334
25096313-00|31 41|neuropathy|MESH:D009422
25096313-01|97 107|neuropathy|MESH:D009422
25096313-01|191 212|lateral epicondylitis|MESH:D013716
25096313-02|80 91|paresthesia|MESH:D010292
25096313-02|128 139|paresthesia|MESH:D010292
25096313-03|33 37|pain|MESH:D010146
25096313-08|127 148|lateral epicondylitis|MESH:D013716
25119790-00|34 48|nephrotoxicity|MESH:D007674
25119790-01|107 119|renal injury|MESH:D007674
25119790-02|8 19|proteinuria|MESH:D011507
25119790-03|16 28|renal injury|MESH:D007674
25119790-03|246 259|kidney injury|MESH:D007674
25119790-03|343 351|necrosis|MESH:D009336
25119790-10|75 86|nephropathy|MESH:D007674
25907210-00|19 26|tumours|MESH:D009369
25907210-01|116 127|lung cancer|MESH:D008175
25907210-01|247 253|cancer|MESH:D009369
25907210-02|38 44|cancer|MESH:D009369
25907210-02|85 91|tumour|MESH:D009369
25907210-03|146 152|cancer|MESH:D009369
25907210-04|173 179|cancer|MESH:D009369
25907210-05|30 41|lung cancer|MESH:D008175
25907210-06|0 13|Kidney cancer|MESH:D007680
25907210-06|190 205|prostate cancer|MESH:D011471
25907210-07|100 111|lung cancer|MESH:D008175
25907210-08|26 39|kidney cancer|MESH:D007680
25907210-08|73 88|prostate cancer|MESH:D011471
25951420-00|52 71|Parkinson's Disease|MESH:D010300
25951420-01|87 106|Parkinson's disease|MESH:D010300
25951420-02|124 143|Parkinson's disease|MESH:D010300
25951420-04|46 65|Parkinson's disease|MESH:D010300
25951420-05|92 111|Parkinson's disease|MESH:D010300
25986755-00|78 96|glomerulosclerosis|MESH:D005921
25986755-01|96 127|intrauterine growth retardation|MESH:D005317
25986755-01|129 133|IUGR|MESH:D005317
25986755-02|31 35|IUGR|MESH:D005317
25986755-02|57 75|glomerulosclerosis|MESH:D005921
25986755-03|34 52|glomerulosclerosis|MESH:D005921
25986755-04|49 67|glomerulosclerosis|MESH:D005921
25986755-05|15 19|IUGR|MESH:D005317
25986755-06|81 99|glomerulosclerosis|MESH:D005921
25986755-06|111 132|interstitial fibrosis|MESH:D005355
25986755-11|49 75|dysplasia of fetal kidneys|MESH:D007674
25986755-11|87 105|glomerulosclerosis|MESH:D005921
25986755-11|223 241|glomerulosclerosis|MESH:D005921
26002693-00|15 18|CML|MESH:D015464
26002693-01|111 135|chronic myeloid leukemia|MESH:D015464
26002693-01|137 140|CML|MESH:D015464
26002693-02|0 3|CML|MESH:D015464
26002693-03|56 59|CML|MESH:D015464
26002693-03|94 117|Philadelphia chromosome|MESH:D010677
26033014-00|0 6|Cancer|MESH:D009369
26033014-02|51 66|liver neoplasms|MESH:D008113
26033014-05|13 19|cancer|MESH:D009369
26033014-06|142 148|cancer|MESH:D009369
26033014-07|67 74|cancers|MESH:D009369
26033014-07|136 143|cancers|MESH:D009369
26033014-08|4 16|liver cancer|MESH:D008113
26033014-10|35 59|follicular cell lymphoma|MESH:D008224
26033014-10|74 82|lymphoma|MESH:D008223
26033014-11|35 46|lung cancer|MESH:D008175
26033014-12|58 70|liver cancer|MESH:D008113
26033014-12|154 169|liver neoplasms|MESH:D008113
26033014-13|31 43|liver cancer|MESH:D008113
26033014-13|64 72|lymphoma|MESH:D008223
26115410-03|184 190|cancer|MESH:D009369
26115410-04|106 112|cancer|MESH:D009369
26115410-05|108 114|cancer|MESH:D009369
26115410-06|75 81|cancer|MESH:D009369
44072-02|27 37|arrhythmia|MESH:D001145
44072-04|77 87|arrhythmia|MESH:D001145
44072-04|129 139|arrhythmia|MESH:D001145
753803-00|25 43|muscular dystrophy|MESH:D009136
753803-01|99 117|muscular dystrophy|MESH:D009136
753803-03|0 8|Myopathy|MESH:D009135
753803-03|38 46|myopathy|MESH:D009135
753803-04|20 32|myodystrophy|MESH:D009136
753803-06|62 71|myopathic|MESH:D009135
753803-06|152 160|myopathy|MESH:D009135
753803-07|73 82|myopathic|MESH:D009135
753803-07|261 270|myopathic|MESH:D009135
753803-08|283 292|myopathic|MESH:D009135
753803-09|101 118|myopathic disease|MESH:D009135
920167-03|17 50|cerebral and pulmonary hemorrhage|MESH:D006470
920167-03|17 50|cerebral and pulmonary hemorrhage|MESH:D002543
920167-03|17 50|cerebral and pulmonary hemorrhage|MESH:D008171
920167-05|33 44|embryopathy|MESH:D005315
920167-05|50 66|nasal hypoplasia|UNKNOWN_Disease
920167-05|71 89|stippled epiphyses|MESH:D002806
920167-05|91 116|chondrodysplasia punctata|MESH:D002806
920167-06|0 16|Nasal hypoplasia|UNKNOWN_Disease
920167-06|33 51|stippled epiphyses|MESH:D002806
1451544-00|25 37|hypertension|MESH:D006973
1451544-01|155 167|hypertension|MESH:D006973
1451544-03|27 35|headache|MESH:D006261
1451544-03|37 46|dizziness|MESH:D004244
1451544-03|48 59|palpitation|UNKNOWN_Disease
1451544-03|64 72|flushing|MESH:D005483
1451544-05|84 104|postural hypotension|MESH:D007024
2782734-00|116 126|asthmatics|MESH:D001249
2782734-01|102 108|asthma|MESH:D001249
2782734-03|7 16|asthmatic|MESH:D001249
2782734-05|127 133|tremor|MESH:D014202
2782734-10|82 88|tremor|MESH:D014202
2782734-10|110 122|palpitations|UNKNOWN_Disease
2983630-00|44 59|panic disorders|MESH:D016584
2983630-01|277 288|agoraphobia|MESH:D000379
2983630-01|294 307|panic attacks|MESH:D016584
2983630-01|311 325|panic disorder|MESH:D016584
2983630-02|67 74|anxiety|MESH:D001008
2983630-02|95 101|nausea|MESH:D009325
2983630-02|103 115|palpitations|UNKNOWN_Disease
2983630-02|117 129|restlessness|MESH:D011595
2983630-02|135 142|tremors|MESH:D014202
2983630-04|126 139|panic attacks|MESH:D016584
2983630-07|86 100|panic disorder|MESH:D016584
2983630-07|119 152|abnormalities in neuronal systems|MESH:D009421
2983630-08|14 31|anxiety disorders|MESH:D001008
3711722-00|78 91|heart failure|MESH:D006333
3711722-02|74 87|heart failure|MESH:D006333
3711722-03|21 35|cardiomyopathy|MESH:D009202
3711722-04|37 50|heart failure|MESH:D006333
3711722-05|189 206|rheumatic disease|MESH:D012216
3711722-05|218 241|myxomatous degeneration|UNKNOWN_Disease
3711722-06|81 97|coronary disease|MESH:D003327
3711722-08|19 42|coronary artery disease|MESH:D003324
3711722-08|209 225|coronary disease|MESH:D003327
6728873-03|71 85|clonic seizure|MESH:D012640
6728873-06|38 53|clonic seizures|MESH:D012640
6728873-07|24 38|tonic seizures|MESH:D012640
6728873-08|113 127|tonic seizures|MESH:D012640
6728873-11|39 47|toxicity|MESH:D064420
7248895-00|9 38|carcinoma of the renal pelvis|MESH:D010386
7248895-01|31 52|hydroureteronephrosis|MESH:D006869
7248895-01|106 115|hematuria|MESH:D006417
7248895-01|177 196|cerebral vasculitis|MESH:D020293
7248895-02|55 63|bleeding|MESH:D006470
7248895-03|60 89|carcinoma of the renal pelvis|MESH:D010386
7248895-04|50 70|hemorrhagic cystitis|MESH:D006470
7248895-04|50 70|hemorrhagic cystitis|MESH:D003556
7248895-04|139 148|carcinoma|MESH:D002277
7248895-04|226 256|carcinoma of the urinary tract|MESH:D014571
7248895-05|7 40|carcinomas of the urinary bladder|MESH:D001749
7248895-05|49 74|carcinoma of the prostate|MESH:D011471
7248895-06|30 59|carcinoma of the renal pelvis|MESH:D010386
7248895-07|16 36|urinary tract cancer|MESH:D014571
7248895-08|23 28|tumor|MESH:D009369
7248895-08|46 67|hydroureteronephrosis|MESH:D006869
7248895-09|103 123|obstructive uropathy|UNKNOWN_Disease
9578276-05|44 65|hyper- or hypotension|MESH:D007022
9578276-05|44 65|hyper- or hypotension|MESH:D006973
9578276-05|82 96|abdominal pain|MESH:D015746
9578276-05|102 110|vomiting|MESH:D014839
9578276-05|119 136|retained placenta|MESH:D018457
9578276-06|63 73|blood loss|MESH:D006473
9578276-07|8 18|blood loss|MESH:D006473
9578276-08|27 37|blood loss|MESH:D006473
11423811-00|134 144|chest pain|MESH:D002637
11423811-01|17 27|Chest pain|MESH:D002637
11423811-02|105 113|ischemia|MESH:D007511
11423811-03|217 227|chest pain|MESH:D002637
11423811-05|95 105|chest pain|MESH:D002637
11423811-06|48 56|toxicity|MESH:D064420
11423811-09|87 98|hypokinesis|MESH:D018476
11423811-11|169 186|tachydysrhythmias|UNKNOWN_Disease
11423811-11|198 215|sinus tachycardia|MESH:D013616
11423811-13|126 136|chest pain|MESH:D002637
12678199-00|19 37|torsade de pointes|MESH:D016171
12678199-01|67 85|torsade de pointes|MESH:D016171
12678199-01|87 90|TdP|MESH:D016171
12678199-02|43 46|TdP|MESH:D016171
12678199-02|114 125|hypokalemia|MESH:D007008
12678199-03|83 86|TdP|MESH:D016171
12678199-04|22 33|bradycardia|MESH:D001919
12678199-04|55 58|TdP|MESH:D016171
12678199-05|165 178|proarrhythmia|UNKNOWN_Disease
12678199-06|81 84|TdP|MESH:D016171
12678199-06|93 104|hypokalemia|MESH:D007008
12678199-06|109 123|hypomagnesemia|MESH:C537153
15696449-00|0 25|Acute renal insufficiency|MESH:D058186
15696449-00|69 97|primary systemic amyloidosis|MESH:C531616
15696449-01|26 54|primary systemic amyloidosis|MESH:C531616
15696449-01|56 58|AL|MESH:D000686
15696449-04|42 67|acute renal insufficiency|MESH:D058186
15696449-06|21 23|AL|MESH:D000686
15696449-07|0 25|Acute renal insufficiency|MESH:D058186
15696449-07|27 30|ARI|MESH:D058186
15696449-09|37 40|ARI|MESH:D058186
15696449-10|36 51|hypoalbuminemia|MESH:D034141
15696449-10|59 70|proteinuria|MESH:D011507
15696449-12|17 20|ARI|MESH:D058186
15696449-13|26 38|renal injury|MESH:D058186
15696449-14|8 22|tubular injury|UNKNOWN_Disease
15696449-14|49 61|renal injury|MESH:D058186
15696449-15|15 18|ARI|MESH:D058186
15696449-16|84 86|AL|MESH:D000686
17554526-00|0 25|Impaired fear recognition|MESH:D001925
17554526-07|191 216|impaired fear recognition|MESH:D001925
17554526-10|14 41|deficit in fear recognition|MESH:D001925
17554526-11|40 51|psychopaths|MESH:D001523
17554526-11|68 93|impaired fear recognition|MESH:D001925
17554526-11|95 115|amygdala dysfunction|UNKNOWN_Disease
17721298-00|0 14|Corneal ulcers|MESH:D003320
17721298-01|30 44|corneal ulcers|MESH:D003320
17721298-01|61 71|drug abuse|MESH:D019966
17721298-02|26 32|ulcers|MESH:D014456
17721298-03|32 46|corneal ulcers|MESH:D003320
17721298-03|63 73|drug abuse|MESH:D019966
17721298-04|28 42|corneal ulcers|MESH:D003320
17721298-05|4 18|corneal ulcers|MESH:D003320
17721298-06|71 86|substance abuse|MESH:D019966
17721298-08|4 14|infections|MESH:D007239
17721298-09|58 76|epithelial defects|UNKNOWN_Disease
17721298-10|85 99|corneal ulcers|MESH:D003320
17721298-11|0 10|Drug abuse|MESH:D019966
17721298-12|28 38|infections|MESH:D007239
17721298-13|80 95|substance abuse|MESH:D019966
18341442-00|78 97|idiopathic epilepsy|MESH:C562694
18341442-01|183 202|idiopathic epilepsy|MESH:C562694
18341442-03|35 54|idiopathic epilepsy|MESH:C562694
18341442-06|0 7|Seizure|MESH:D012640
18341442-08|7 14|seizure|MESH:D012640
18341442-08|68 76|seizures|MESH:D012640
18341442-08|118 125|seizure|MESH:D012640
18341442-08|186 194|seizures|MESH:D012640
18341442-08|298 305|seizure|MESH:D012640
18341442-09|23 31|lethargy|MESH:D053609
18341442-09|36 47|inappetence|UNKNOWN_Disease
18341442-10|171 190|idiopathic epilepsy|MESH:C562694
19681452-00|10 56|haemorrhagic infarction of the globus pallidus|MESH:D020520
19681452-00|10 56|haemorrhagic infarction of the globus pallidus|MESH:D002543
19681452-01|34 66|ischemic and haemorrhagic stroke|MESH:D002544
19681452-01|34 66|ischemic and haemorrhagic stroke|MESH:D020521
19681452-02|56 87|ischemia of the globus pallidus|MESH:D002545
19681452-03|13 40|globus pallidus infarctions|MESH:D020520
19681452-04|10 32|basal ganglia infarcts|MESH:D020520
19681452-05|26 44|cardiac arrhythmia|MESH:D001145
19681452-05|48 71|respiratory dysfunction|MESH:D012131
19681452-05|141 163|cerebral hypoperfusion|UNKNOWN_Disease
20009434-00|0 19|Acute renal failure|MESH:D058186
20009434-01|62 78|Burkitt lymphoma|MESH:D002051
20009434-01|94 120|hepatic and renal toxicity|MESH:D007674
20009434-01|94 120|hepatic and renal toxicity|MESH:D056486
20009434-02|20 39|acute renal failure|MESH:D058186
20009434-02|194 209|biliary atresia|MESH:D001656
20009434-03|60 64|PTLD|MESH:D008232
20009434-03|66 115|post-transplantation lymphoproliferative disorder|MESH:D008232
20009434-03|117 148|Burkitt-type malignant lymphoma|MESH:D002051
20009434-05|33 52|acute renal failure|MESH:D058186
20009434-06|31 42|hypovolemia|MESH:D020896
20009434-06|97 119|acute prerenal failure|UNKNOWN_Disease
20431083-00|25 45|cerebral microbleeds|UNKNOWN_Disease
20431083-00|51 75|intracerebral hemorrhage|MESH:D002543
20431083-01|24 44|Cerebral microbleeds|UNKNOWN_Disease
20431083-01|46 48|MB|UNKNOWN_Disease
20431083-01|81 105|intracerebral hemorrhage|MESH:D002543
20431083-01|107 110|ICH|MESH:D002543
20431083-02|44 46|MB|UNKNOWN_Disease
20431083-02|106 109|ICH|MESH:D002543
20431083-02|114 129|ischemic stroke|MESH:D002544
20431083-02|131 133|IS|MESH:D002544
20431083-02|135 160|transient ischemic attack|MESH:D002546
20431083-02|162 165|TIA|MESH:D002546
20431083-03|94 100|stroke|MESH:D020521
20431083-03|104 107|TIA|MESH:D002546
20431083-03|135 137|MB|UNKNOWN_Disease
20431083-03|199 202|ICH|MESH:D002543
20431083-03|246 248|IS|MESH:D002544
20431083-03|249 252|TIA|MESH:D002546
20431083-03|262 265|ICH|MESH:D002543
20431083-03|269 277|ischemic|MESH:D007511
20431083-04|83 86|ICH|MESH:D002543
20431083-04|116 118|MB|UNKNOWN_Disease
20431083-05|38 41|ICH|MESH:D002543
20431083-05|51 53|IS|MESH:D002544
20431083-05|54 57|TIA|MESH:D002546
20431083-05|59 61|MB|UNKNOWN_Disease
20431083-05|84 87|ICH|MESH:D002543
20431083-05|91 93|IS|MESH:D002544
20431083-05|94 97|TIA|MESH:D002546
20431083-06|28 30|MB|UNKNOWN_Disease
20431083-06|66 69|ICH|MESH:D002543
20431083-06|138 140|IS|MESH:D002544
20431083-06|141 144|TIA|MESH:D002546
20431083-07|30 32|MB|UNKNOWN_Disease
20431083-07|72 75|ICH|MESH:D002543
20431083-07|167 169|IS|MESH:D002544
20431083-07|170 173|TIA|MESH:D002546
20431083-08|67 69|MB|UNKNOWN_Disease
20431083-08|147 150|ICH|MESH:D002543
20431083-09|27 29|MB|UNKNOWN_Disease
20431083-09|53 56|ICH|MESH:D002543
20431083-09|96 98|MB|UNKNOWN_Disease
20431083-09|140 143|ICH|MESH:D002543
20595935-00|30 48|hyperprolactinemia|MESH:D006966
20595935-01|100 118|hyperprolactinemia|MESH:D006966
20595935-02|0 18|Macroprolactinemia|MESH:D015175
20595935-03|109 127|macroprolactinemia|MESH:D015175
20595935-04|86 104|hyperprolactinemia|MESH:D006966
20595935-07|93 110|macroprolactinoma|MESH:D015175
20595935-07|128 145|microprolactinoma|MESH:D015175
20595935-07|165 183|macroprolactinemia|MESH:D015175
20595935-07|215 233|pseudoprolactinoma|UNKNOWN_Disease
20595935-07|277 295|hyperprolactinemia|MESH:D006966
20595935-08|234 252|pseudoprolactinoma|UNKNOWN_Disease
20595935-08|276 294|hyperprolactinemia|MESH:D006966
20595935-09|97 115|hyperprolactinemia|MESH:D006966
20595935-10|150 168|hyperprolactinemia|MESH:D006966
35781-03|132 142|cataleptic|MESH:D002375
35781-05|147 156|catalepsy|MESH:D002375
35781-06|8 17|catalepsy|MESH:D002375
48835-00|65 78|hypoglycaemia|MESH:D007003
48835-01|30 43|hypoglycaemia|MESH:D007003
48835-03|35 48|hypoglycaemia|MESH:D007003
48835-06|0 12|Hypertension|MESH:D006973
48835-06|16 25|diabetics|MESH:D003920
48835-06|35 48|hypoglycaemia|MESH:D007003
89511-00|28 47|endometrial disease|MESH:D014591
89511-01|57 76|endometrial disease|MESH:D014591
89511-02|7 18|hyperplasia|MESH:D006965
89511-03|105 116|hyperplasia|MESH:D006965
89511-03|150 161|hyperplasia|MESH:D006965
89511-03|174 195|endometrial carcinoma|MESH:D016889
89511-03|352 363|hyperplasia|MESH:D006965
89511-03|369 379|malignancy|MESH:D009369
89511-04|105 128|endometrial hyperplasia|MESH:D004714
89511-04|132 141|carcinoma|MESH:D002277
146391-00|0 21|Pure red cell aplasia|MESH:D012010
146391-00|23 39|toxic dermatitis|MESH:D003875
146391-00|44 59|lymphadenopathy|MESH:D008206
146391-01|71 80|skin rash|MESH:D005076
146391-01|82 97|lymphadenopathy|MESH:D008206
146391-01|102 123|pure red cell aplasia|MESH:D012010
146391-03|0 9|Skin rash|MESH:D005076
146391-03|97 112|lymphadenopathy|MESH:D008206
146391-04|0 21|Pure red cell aplasia|MESH:D012010
146391-06|103 112|skin rash|MESH:D005076
146391-06|114 129|lymphadenopathy|MESH:D008206
146391-06|134 155|pure red cell aplasia|MESH:D012010
256433-00|63 73|infections|MESH:D007239
256433-00|77 83|cancer|MESH:D009369
256433-01|17 27|infections|MESH:D007239
256433-01|31 37|cancer|MESH:D009369
256433-01|72 83|neutropenia|MESH:D009503
256433-02|36 47|neutropenia|MESH:D009503
256433-03|35 46|neutropenia|MESH:D009503
256433-05|42 48|cancer|MESH:D009369
256433-07|0 9|Pneumonia|MESH:D011014
256433-07|30 39|infection|MESH:D007239
256433-08|80 90|infections|MESH:D007239
256433-09|40 50|pneumoniae|MESH:D011014
256433-09|145 179|gram-negative bacillary infections|MESH:D016905
256433-10|121 132|neutropenia|MESH:D009503
256433-12|0 8|Azotemia|MESH:D053099
256433-13|6 14|azotemia|MESH:D053099
256433-14|0 8|Azotemia|MESH:D053099
256433-15|72 86|renal toxicity|MESH:D007674
448423-00|10 33|subarachnoid hemorrhage|MESH:D013345
448423-00|80 109|acute renal artery thrombosis|MESH:D007674
448423-02|86 109|subarachnoid hemorrhage|MESH:D013345
448423-02|111 114|SAH|MESH:D013345
448423-03|94 104|thrombotic|MESH:D013927
448423-04|61 93|intracranial vascular thrombosis|MESH:D020767
448423-04|111 114|SAH|MESH:D013345
448423-04|148 155|thrombi|MESH:D013927
448423-04|224 248|thromboembolic phenomena|MESH:D013923
448423-05|27 34|thrombi|MESH:D013927
448423-05|155 162|thrombi|MESH:D013927
448423-05|180 218|disseminated intravascular coagulation|MESH:D004211
448423-05|229 255|consumption coagulopathies|MESH:D004211
448423-06|31 41|infarction|MESH:D007238
448423-06|63 98|thrombosis of a normal renal artery|MESH:D007674
448423-07|61 64|SAH|MESH:D013345
448423-07|114 117|SAH|MESH:D013345
448423-08|61 73|hypertension|MESH:D006973
573555-07|37 49|hypoglycemia|MESH:D007003
573555-07|51 69|hyperbilirubinemia|MESH:D006932
573555-07|71 83|polycythemia|MESH:D011086
573555-07|85 99|neonatal apnea|MESH:D001049
573555-07|105 116|bradycardia|MESH:D001919
573555-08|0 18|Growth retardation|MESH:D005317
611664-00|39 73|idiopathic orthostatic hypotension|MESH:C544351
611664-01|19 53|idiopathic orthostatic hypotension|MESH:C544351
611664-02|139 155|hypersensitivity|MESH:D004342
611664-05|21 33|hypertension|MESH:D006973
611664-09|87 121|idiopathic orthostatic hypotension|MESH:C544351
612112-06|122 126|pain|MESH:D010146
612112-06|131 140|myoclonia|MESH:D009207
612112-07|171 180|myoclonia|MESH:D009207
689020-00|32 38|tremor|MESH:D014202
689020-01|42 48|tremor|MESH:D014202
689020-03|58 64|tremor|MESH:D014202
689020-06|53 59|tremor|MESH:D014202
689020-08|50 56|tremor|MESH:D014202
733189-00|10 55|retinal artery and choriocapillaris occlusion|MESH:D015356
733189-02|39 85|retinal artery and choriocapillaris occlusions|MESH:D015356
733189-02|91 100|blindness|MESH:D001766
733189-04|62 67|palsy|MESH:D010243
733189-04|69 92|pupillary abnormalities|MESH:D011681
733189-04|111 122|hemorrhages|MESH:D006470
733189-04|128 133|edema|MESH:D004487
733189-05|32 43|visual loss|MESH:D014786
733189-05|118 139|chorioretinal atrophy|MESH:C566236
816141-00|27 43|hemolytic anemia|MESH:D000743
816141-01|15 28|renal disease|MESH:D007674
816141-01|55 71|hemolytic anemia|MESH:D000743
816141-05|38 55|hemolytic anemias|MESH:D000743
851038-00|41 53|parkinsonian|MESH:D010300
851038-01|0 11|Hypokalemia|MESH:D007008
851038-01|67 79|parkinsonian|MESH:D010300
851038-02|91 102|hypokalemia|MESH:D007008
891494-00|10 24|encephalopathy|MESH:D001927
891494-01|26 40|encephalopathy|MESH:D001927
891494-01|57 65|seizures|MESH:D012640
891494-03|4 18|encephalopathy|MESH:D001927
891494-04|96 100|rash|MESH:D005076
891494-05|88 96|seizures|MESH:D012640
895432-00|61 82|myocardial infarction|MESH:D009203
895432-01|64 85|myocardial infarction|MESH:D009203
895432-09|158 168|infarction|MESH:D007238
931801-00|51 63|renal damage|MESH:D007674
931801-01|0 10|Dehydrated|MESH:D003681
931801-01|34 53|acute renal failure|MESH:D058186
931801-02|90 103|renal failure|MESH:D051437
931801-04|36 48|renal damage|MESH:D007674
931801-06|109 122|renal damages|MESH:D007674
931801-07|40 52|renal damage|MESH:D007674
931801-08|54 67|renal lesions|MESH:D007674
931801-09|45 59|nephrotoxicity|MESH:D007674
946593-00|0 10|Paraplegia|MESH:D010264
946593-01|24 34|paraplegia|MESH:D010264
946593-03|143 174|central nervous system leukemia|MESH:D002493
946593-03|450 460|neurotoxic|MESH:D020258
946593-04|45 62|folate deficiency|MESH:C536409
946593-04|136 144|toxicity|MESH:D064420
946593-05|17 30|neurotoxicity|MESH:D020258
946593-05|106 137|central nervous system leukemia|MESH:D002493
946593-07|111 124|neurotoxicity|MESH:D020258
978847-02|270 299|enlargement of pulse pressure|MESH:D006973
978847-02|308 319|tachycardia|MESH:D013610
1117341-00|0 13|Hyperglycemic|MESH:D006943
1117341-01|114 127|hyperglycemia|MESH:D006943
1117341-01|184 194|glucosuria|MESH:D006030
1158089-00|0 11|Fatty liver|MESH:D005234
1158089-02|93 104|fatty liver|MESH:D005234
1158089-04|205 215|depression|MESH:D003866
1158089-07|126 136|depression|MESH:D003866
1158089-09|208 219|fatty liver|MESH:D005234
1280054-00|6 25|myeloencephalopathy|MESH:D001927
1280054-01|65 74|leukaemia|MESH:D007938
1280054-01|86 115|sensory and motor dysfunction|MESH:D007049
1280054-01|128 142|encephalopathy|MESH:D001927
1280707-02|141 151|arrhythmic|MESH:D001145
1280707-07|57 67|arrhythmia|MESH:D001145
1280707-09|28 38|arrhythmia|MESH:D001145
1289188-00|0 19|Acute renal failure|MESH:D058186
1289188-01|37 48|thalassemia|MESH:D013789
1289188-02|141 160|renal insufficiency|MESH:D051437
1289188-03|226 240|nephrotoxicity|MESH:D007674
1289188-04|117 136|acute renal failure|MESH:D058186
1359137-00|23 41|hyperprolactinemia|MESH:D006966
1359137-02|40 58|hyperprolactinemia|MESH:D006966
1359137-02|63 73|amenorrhea|MESH:D000568
1359137-02|74 88|oligomenorrhea|MESH:D009839
1359137-03|39 57|hyperprolactinemia|MESH:D006966
1359137-04|39 59|psychiatric symptoms|MESH:D011618
1359137-06|109 127|hyperprolactinemia|MESH:D006966
1359137-06|132 142|amenorrhea|MESH:D000568
1359137-06|143 155|galactorrhea|MESH:D005687
1360900-00|24 35|convulsions|MESH:D012640
1360900-01|58 68|convulsive|MESH:D012640
1360900-03|27 38|convulsions|MESH:D012640
1361574-08|103 114|convulsions|MESH:D012640
1395192-00|10 31|myocardial infarction|MESH:D009203
1395192-01|0 21|Myocardial infarction|MESH:D009203
1395192-02|0 5|Spasm|MESH:D013035
1395192-03|70 91|myocardial infarction|MESH:D009203
1420650-00|0 9|Asterixis|MESH:D020820
1420650-01|33 42|asterixis|MESH:D020820
1420650-02|108 117|asterixis|MESH:D020820
1420650-04|12 21|asterixis|MESH:D020820
1420650-04|57 70|neurotoxicity|MESH:D020258
1423336-00|24 35|hypotensive|MESH:D007022
1423336-00|58 70|parkinsonian|MESH:D010300
1423336-01|57 69|parkinsonian|MESH:D010300
1423336-02|21 32|hypotensive|MESH:D007022
1423336-03|39 50|hypotensive|MESH:D007022
1423336-04|119 130|hypotensive|MESH:D007022
1423336-06|131 142|hypotensive|MESH:D007022
1423336-07|40 51|hypotensive|MESH:D007022
1423336-08|4 15|hypotensive|MESH:D007022
1424076-00|0 59|Syndrome of inappropriate secretion of antidiuretic hormone|MESH:D007177
1424076-01|36 52|multiple myeloma|MESH:D009101
1424076-02|52 60|lethargy|MESH:D053609
1424076-02|65 73|weakness|MESH:D018908
1424076-02|90 102|hyponatremia|MESH:D007010
1424076-03|24 83|syndrome of inappropriate secretion of antidiuretic hormone|MESH:D007177
1449452-00|0 13|Heart failure|MESH:D006333
1449452-03|17 36|atrial fibrillation|MESH:D001281
1449452-04|33 46|heart failure|MESH:D006333
1449452-06|115 126|arrhythmias|MESH:D001145
1449452-11|151 172|myocardial infarction|MESH:D009203
1449452-11|174 176|MI|MESH:D009203
1522360-00|14 23|hemolysis|MESH:D006461
1522360-00|28 47|acute renal failure|MESH:D058186
1522360-01|0 13|Renal failure|MESH:D051437
1522360-02|14 23|hemolysis|MESH:D006461
1522360-02|35 54|acute renal failure|MESH:D058186
1522360-03|18 25|leprosy|MESH:D007918
1522360-03|40 49|hemolysis|MESH:D006461
1522360-03|54 73|acute renal failure|MESH:D058186
1556529-00|19 28|hepatitis|MESH:D056486
1556529-01|16 25|hepatitis|MESH:D056486
1556529-01|78 82|AIDS|MESH:D000163
1556529-02|26 35|hepatitis|MESH:D056486
1556529-04|36 40|AIDS|MESH:D000163
1563460-00|0 21|Thoracic hematomyelia|MESH:D020758
1563460-01|10 31|thoracic hematomyelia|MESH:D020758
1564030-00|0 5|Mania|MESH:D001714
1564030-01|117 127|depression|MESH:D003866
1564030-02|84 89|mania|MESH:D001714
1564030-03|18 27|depressed|MESH:D003866
1564030-03|75 80|mania|MESH:D001714
1564030-04|45 50|mania|MESH:D001714
1564030-04|54 63|hypomania|MESH:D001714
1564030-04|141 181|attention-deficit hyperactivity disorder|MESH:D001289
1564030-04|215 225|depression|MESH:D003866
1564030-04|231 240|psychotic|MESH:D011618
1564030-04|271 289|affective disorder|MESH:D019964
1564030-04|302 318|bipolar disorder|MESH:D001714
1564030-04|339 355|bipolar disorder|MESH:D001714
1564030-05|146 151|mania|MESH:D001714
1615846-00|43 64|hyperlipoproteinemias|MESH:D006951
1615846-01|207 221|hyperlipidemia|MESH:D006949
1615846-01|239 271|atherosclerotic vascular disease|MESH:D002340
1615846-07|0 8|Myositis|MESH:D009220
1615846-07|202 216|rhabdomyolysis|MESH:D012206
1615846-07|220 233|myoglobinuria|MESH:D009212
1655018-00|0 24|Hepatocellular carcinoma|MESH:D006528
1655018-00|28 44|Fanconi's anemia|MESH:D005199
1655018-01|65 81|Fanconi's anemia|MESH:D005199
1655018-02|77 87|septicemia|MESH:D018805
1655018-02|143 171|hemorrhagic bronchopneumonia|MESH:D001996
1655018-03|11 19|peliosis|MESH:D010382
1655018-03|33 47|hepatic tumors|MESH:D008113
1655018-03|113 137|hepatocellular carcinoma|MESH:D006528
1655018-04|74 91|hepatic neoplasms|MESH:D008113
1655018-04|96 104|peliosis|MESH:D010382
1655018-04|171 187|Fanconi's anemia|MESH:D005199
1735570-00|65 77|hypertensive|MESH:D006973
1735570-01|193 205|hypertensive|MESH:D006973
1735570-08|25 36|hypotension|MESH:D007022
1735570-08|70 81|bradycardia|MESH:D001919
1735570-08|135 146|tachycardia|MESH:D013610
1735570-09|98 110|hypertension|MESH:D006973
1735570-09|138 150|hypertensive|MESH:D006973
1735570-10|86 98|hypertension|MESH:D006973
1756784-00|0 42|Damage of substantia nigra pars reticulata|MESH:D001930
1756784-00|70 88|status epilepticus|MESH:D013226
1756784-01|69 86|epileptic seizure|MESH:D004827
1756784-02|27 55|prolonged status epilepticus|MESH:D013226
1756784-02|163 184|metabolic derangement|MESH:D008659
1756784-03|15 33|status epilepticus|MESH:D013226
1756784-05|89 107|status epilepticus|MESH:D013226
1756784-06|113 128|neuronal damage|MESH:D009422
1756784-08|146 161|vasogenic edema|MESH:D001929
1756784-09|98 106|seizures|MESH:D012640
1756784-11|71 86|neuronal damage|MESH:D009422
1756784-13|8 23|vasogenic edema|MESH:D001929
1756784-13|36 48|lesioned SNR|MESH:D001930
1756784-16|117 130|damage of SNR|MESH:D001930
1756784-19|71 99|neurotransmitter dysfunction|MESH:D001480
1756784-19|124 142|status epilepticus|MESH:D013226
1760851-00|8 22|cardiotoxicity|MESH:D066126
1760851-01|51 59|toxicity|MESH:D064420
1760851-01|73 87|cardiotoxicity|MESH:D066126
1760851-06|51 65|cardiotoxicity|MESH:D066126
1760851-06|292 306|cardiotoxicity|MESH:D066126
1779253-00|36 59|post-herpetic neuralgia|MESH:D051474
1779253-01|131 154|post-herpetic neuralgia|MESH:D051474
1779253-01|156 159|PHN|MESH:D051474
1779253-02|40 44|pain|MESH:D010146
1779253-04|188 196|mastitis|MESH:D008413
1779253-07|81 84|PHN|MESH:D051474
1779253-07|124 143|sensory disturbance|UNKNOWN_Disease
1779253-07|147 151|pain|MESH:D010146
1779253-09|149 152|PHN|MESH:D051474
1837756-00|31 39|paranoia|MESH:D010259
1837756-01|53 61|paranoid|MESH:D010259
1837756-02|14 22|paranoid|MESH:D010259
1837756-03|53 61|paranoid|MESH:D010259
1837756-03|111 144|depressive and psychotic symptoms|MESH:D011618
1837756-03|111 144|depressive and psychotic symptoms|MESH:D003866
1837756-04|12 32|depressive disorders|MESH:D003866
1837756-04|98 107|psychosis|MESH:D011605
1837756-04|168 177|psychosis|MESH:D011605
1837756-04|219 227|paranoid|MESH:D010259
1837756-05|46 54|paranoia|MESH:D010259
1837756-06|39 47|paranoid|MESH:D010259
1837756-06|165 173|paranoia|MESH:D010259
1858969-00|14 26|encephalitis|MESH:D004660
1858969-00|47 54|loiasis|MESH:D008118
1858969-01|14 26|encephalitis|MESH:D004660
1858969-01|126 136|filariasis|MESH:D005368
1858969-06|43 55|encephalitis|MESH:D004660
1858969-06|76 90|microfilaremia|UNKNOWN_Disease
1905439-00|0 8|Delirium|MESH:D003693
1905439-01|119 127|headache|MESH:D006261
1905439-05|4 12|delirium|MESH:D003693
1905439-06|76 84|delirium|MESH:D003693
1943082-00|51 59|ischemia|MESH:D007511
1943082-00|60 78|reperfusion injury|MESH:D015427
1943082-01|15 23|ischemic|MESH:D007511
1943082-01|51 68|liver dysfunction|MESH:D017093
1943082-02|42 56|hepatic injury|MESH:D056486
1943082-03|80 94|hepatic injury|MESH:D056486
1943082-04|49 57|ischemia|MESH:D007511
1943082-04|58 76|reperfusion injury|MESH:D015427
1943082-06|77 85|ischemia|MESH:D007511
1943082-06|86 104|reperfusion injury|MESH:D015427
2021990-09|62 73|hypotension|MESH:D007022
2083961-00|0 19|Acute renal failure|MESH:D058186
2083961-01|57 79|pulmonary tuberculosis|MESH:D014397
2083961-02|120 126|nausea|MESH:D009325
2083961-02|128 136|vomiting|MESH:D014839
2083961-02|141 146|fever|MESH:D005334
2131034-00|7 21|polyneuropathy|MESH:D011115
2131034-01|28 47|neurologic toxicity|MESH:D020258
2131034-02|21 38|axonal neuropathy|MESH:D056768
2131034-03|0 21|Neurologic toxicities|MESH:D020258
2131034-04|27 44|axonal neuropathy|MESH:D056768
2131034-05|121 134|neurotoxicity|MESH:D020258
2173761-05|53 64|hypotension|MESH:D007022
2173761-05|204 215|tachycardia|MESH:D013610
2217015-00|23 34|neutropenia|MESH:D009503
2217015-00|39 52|renal failure|MESH:D051437
2217015-00|77 91|hypothyroidism|MESH:D007037
2217015-01|46 59|renal failure|MESH:D051437
2217015-01|71 82|neutropenia|MESH:D009503
2217015-02|4 15|neutropenia|MESH:D009503
2217015-03|24 35|hypothyroid|MESH:D007037
2217015-04|60 71|hypothyroid|MESH:D007037
2217015-04|91 105|hypothyroidism|MESH:D007037
2239937-00|12 25|hypercalcemia|MESH:D006934
2239937-01|46 59|hypercalcemic|MESH:D006934
2239937-02|69 82|hypercalcemia|MESH:D006934
2239937-02|302 315|renal disease|MESH:D007674
2239937-03|28 41|hypercalcemic|MESH:D006934
2239937-03|135 148|hypercalcemic|MESH:D006934
2320485-00|19 35|hemolytic anemia|MESH:D000743
2320485-00|72 79|syncope|MESH:D013575
2320485-02|21 48|autoimmune hemolytic anemia|MESH:D000744
2320485-03|39 55|hemolytic anemia|MESH:D000743
2320485-03|98 118|emergency department|MESH:D004630
2320485-03|129 136|syncope|MESH:D013575
2320485-04|62 68|trauma|MESH:D014947
2320485-08|46 63|hemolytic anemias|MESH:D000743
2358093-00|46 67|hereditary angioedema|MESH:D054179
2358093-02|128 149|hereditary angioedema|MESH:D054179
2358093-05|0 23|Menstrual abnormalities|MESH:D008599
2358093-05|31 42|weight gain|MESH:D015430
2358093-05|50 63|muscle cramps|MESH:D009120
2358093-05|64 72|myalgias|MESH:D063806
2383364-00|90 95|burns|MESH:D002056
2383364-01|48 57|infection|MESH:D007239
2383364-01|75 79|burn|MESH:D002056
2383364-02|109 113|burn|MESH:D002056
2383364-04|12 16|burn|MESH:D002056
2383364-04|49 54|burns|MESH:D002056
2383364-05|4 8|burn|MESH:D002056
2383364-05|237 241|burn|MESH:D002056
2383364-07|83 87|pain|MESH:D010146
2383364-08|51 55|pain|MESH:D010146
2400986-00|15 28|neurotoxicity|MESH:D020258
2400986-01|24 34|neurotoxic|MESH:D020258
2400986-01|72 85|neurotoxicity|MESH:D020258
2400986-02|186 192|tumors|MESH:D009369
2400986-02|194 206|brain tumors|MESH:D001932
2400986-06|82 90|seizures|MESH:D012640
2400986-07|100 113|neurotoxicity|MESH:D020258
2400986-08|123 144|neurological symptoms|MESH:D009461
2400986-09|139 169|central nervous system disease|MESH:D002493
2400986-11|31 44|neurotoxicity|MESH:D020258
2400986-12|133 146|neurotoxicity|MESH:D020258
2400986-12|157 170|neurotoxicity|MESH:D020258
2429800-00|49 60|hypotension|MESH:D007022
2453942-01|82 92|neurotoxic|MESH:D020258
2453942-03|189 197|seizures|MESH:D012640
2453942-04|27 38|convulsions|MESH:D012640
2484903-01|47 56|hepatitis|MESH:D056486
2484903-01|99 122|hepatocellular necrosis|MESH:D047508
2484903-01|167 186|lupus-like syndrome|MESH:D008180
2484903-03|77 92|hyperthyroidism|MESH:D006980
2553470-00|69 87|status epilepticus|MESH:D013226
2553470-01|130 137|seizure|MESH:D012640
2553470-03|237 245|seizures|MESH:D012640
2553470-04|116 123|seizure|MESH:D012640
2553470-06|47 55|seizures|MESH:D012640
2553470-06|192 210|status epilepticus|MESH:D013226
2553470-06|242 250|seizures|MESH:D012640
2553470-07|70 88|status epilepticus|MESH:D013226
2553470-07|134 141|seizure|MESH:D012640
2553470-08|83 101|status epilepticus|MESH:D013226
2553470-08|106 118|brain damage|MESH:D001930
2553470-09|126 144|status epilepticus|MESH:D013226
2614930-00|19 30|bradycardia|MESH:D001919
2614930-00|49 69|autonomic neuropathy|MESH:D009422
2614930-01|15 23|diabetic|MESH:D003920
2614930-01|46 81|peripheral and autonomic neuropathy|MESH:D009422
2614930-01|46 81|peripheral and autonomic neuropathy|MESH:D010523
2614930-01|100 110|chest pain|MESH:D002637
2614930-02|21 35|atrial flutter|MESH:D001282
2614930-03|79 90|tachycardia|MESH:D013610
2614930-04|78 89|bradycardia|MESH:D001919
2625524-03|50 58|seizures|MESH:D012640
2625524-04|55 63|seizures|MESH:D012640
2625524-05|166 174|seizures|MESH:D012640
2625524-06|75 83|seizures|MESH:D012640
2650911-00|101 117|renal carcinomas|MESH:D002292
2650911-01|127 143|renal carcinomas|MESH:D002292
2650911-02|111 116|tumor|MESH:D009369
2650911-04|139 155|renal carcinomas|MESH:D002292
2710809-00|0 11|Bradycardia|MESH:D001919
2710809-01|54 66|postzosteric|MESH:D006562
2710809-01|67 87|trigeminal neuralgia|MESH:D014277
2710809-01|213 224|bradycardia|MESH:D001919
2710809-01|226 236|dysarthria|MESH:D004401
2710809-01|242 251|dysphagia|MESH:D003680
2710809-03|0 11|Bradycardia|MESH:D001919
2718706-00|11 22|hypotension|MESH:D007022
2718706-01|87 98|hypotensive|MESH:D007022
2718706-03|32 43|hypotension|MESH:D007022
2718706-06|7 18|hypotension|MESH:D007022
2718706-06|54 75|tachy- or bradycardia|MESH:D013610
2718706-06|54 75|tachy- or bradycardia|MESH:D001919
2718706-07|35 43|bleeding|MESH:D006470
2718706-08|7 18|hypotension|MESH:D007022
2718706-08|111 122|hypotension|MESH:D007022
2718706-09|6 17|hypotension|MESH:D007022
2718706-10|64 75|hypotension|MESH:D007022
2718706-10|97 108|tachycardia|MESH:D013610
2718706-10|121 133|hypertension|MESH:D006973
2765447-00|0 10|Convulsion|MESH:D012640
2765447-01|0 21|Tonic-clonic seizures|MESH:D004830
2767010-03|78 86|seizures|MESH:D012640
2767010-06|91 114|ventricular tachycardia|MESH:D017180
2767010-07|73 83|arrhythmia|MESH:D001145
2767010-08|96 107|arrhythmias|MESH:D001145
2767010-12|6 14|toxicity|MESH:D064420
2818777-00|24 38|hepatic injury|MESH:D056486
2818777-01|37 52|hepatic failure|MESH:D017093
2818777-02|70 84|hepatic injury|MESH:D056486
2818777-03|70 91|hepatocellular damage|MESH:D056486
2818777-03|99 120|drug hypersensitivity|MESH:D004342
2884595-01|27 36|pertussis|MESH:D014917
2884595-02|106 115|pertussis|MESH:D014917
2884595-04|59 68|pertussis|MESH:D014917
2884595-04|90 104|encephalopathy|MESH:D001927
2904523-00|23 35|hypertension|MESH:D006973
2904523-06|53 65|hypertension|MESH:D006973
2907577-00|47 66|acute renal failure|MESH:D058186
2907577-01|74 83|ischaemic|MESH:D007511
2907577-01|88 99|nephrotoxic|MESH:D007674
2907577-01|110 129|acute renal failure|MESH:D058186
2907577-01|131 134|ARF|MESH:D058186
2907577-02|194 213|acute renal failure|MESH:D058186
2907577-03|186 194|necrosis|MESH:D009336
2907577-06|196 199|ARF|MESH:D058186
2931989-01|147 151|acne|MESH:D000152
2931989-02|0 22|Blepharoconjunctivitis|MESH:D003231
2931989-02|49 57|dry eyes|MESH:D014985
2931989-02|59 73|blurred vision|MESH:D014786
2931989-02|105 120|photodermatitis|MESH:D010787
2931989-03|46 57|papilledema|MESH:D010211
2931989-03|59 78|pseudotumor cerebri|MESH:D011559
2931989-03|112 129|corneal opacities|MESH:D003318
2931989-05|74 98|congenital abnormalities|MESH:D000013
2931989-05|129 143|microphthalmos|MESH:D008850
2931989-05|153 166|hypertelorism|MESH:D006972
2931989-05|172 194|optic nerve hypoplasia|MESH:C563492
2933998-00|30 46|bronchial asthma|MESH:D001249
2933998-02|134 150|bronchial asthma|MESH:D001249
2933998-05|10 19|asthmatic|MESH:D001249
2933998-05|24 35|tremorgenic|MESH:D014202
2974281-00|73 90|heart hypertrophy|MESH:D006332
2974281-02|80 97|heart hypertrophy|MESH:D006332
2974281-03|123 140|heart hypertrophy|MESH:D006332
2974281-04|49 60|hypertrophy|MESH:D006984
2974281-05|102 122|hypertrophied hearts|MESH:D006332
2974281-06|109 122|hypertrophied|MESH:D006984
2974281-07|167 184|heart hypertrophy|MESH:D006332
3074291-00|93 99|asthma|MESH:D001249
3074291-01|132 138|asthma|MESH:D001249
3074291-05|88 94|nausea|MESH:D009325
3074291-05|96 104|vomiting|MESH:D014839
3074291-05|109 116|tremors|MESH:D014202
3074291-06|76 82|asthma|MESH:D001249
3083835-00|11 22|anaphylaxis|MESH:D000707
3083835-01|26 37|anaphylaxis|MESH:D000707
3083835-01|153 164|anaphylaxis|MESH:D000707
3083835-02|56 67|anaphylaxis|MESH:D000707
3084231-00|33 41|dementia|MESH:D003704
3084231-01|33 41|dementia|MESH:D003704
3084231-01|83 91|epilepsy|MESH:D004827
3084231-03|290 304|hyperammonemia|MESH:D022124
3088653-00|32 39|amnesia|MESH:D000647
3088653-01|90 107|retention deficit|MESH:D008569
3088653-02|68 75|amnesia|MESH:D000647
3088653-03|77 94|retention deficit|MESH:D008569
3088653-05|122 129|amnesia|MESH:D000647
3088653-06|58 62|pain|MESH:D010146
3088653-06|236 253|retention deficit|MESH:D008569
3109094-00|68 98|lesions of the urinary bladder|MESH:D001745
3109094-01|41 49|cystitis|MESH:D003556
3109094-01|134 139|edema|MESH:D004487
3109094-01|198 206|necroses|MESH:D009336
3109094-04|174 179|edema|MESH:D004487
3125850-00|63 84|muscle fasciculations|MESH:D005207
3125850-03|31 52|muscle fasciculations|MESH:D005207
3125850-04|33 54|muscle fasciculations|MESH:D005207
3125850-05|79 100|muscle fasciculations|MESH:D005207
3125850-06|74 95|muscle fasciculations|MESH:D005207
3125850-07|104 125|muscle fasciculations|MESH:D005207
3155884-00|57 68|cardiotoxic|MESH:D066126
3155884-00|111 119|diabetic|MESH:D003920
3155884-01|57 65|fibrosis|MESH:D005355
3155884-02|98 106|diabetes|MESH:D003920
3155884-02|119 130|cardiotoxic|MESH:D066126
3155884-03|112 120|fibrosis|MESH:D005355
3155884-04|70 78|diabetic|MESH:D003920
3155884-07|211 219|diabetic|MESH:D003920
3155884-08|181 189|diabetic|MESH:D003920
3191389-00|65 73|seizures|MESH:D012640
3191389-01|63 71|seizures|MESH:D012640
3191389-01|76 94|status epilepticus|MESH:D013226
3191389-02|183 191|seizures|MESH:D012640
3191389-04|74 82|seizures|MESH:D012640
3191389-05|44 52|seizures|MESH:D012640
3191389-05|77 84|seizure|MESH:D012640
3191389-05|93 105|brain damage|MESH:D001930
3191389-06|128 136|seizures|MESH:D012640
3289726-00|0 28|Acute neurologic dysfunction|MESH:D009422
3289726-00|67 83|malignant glioma|MESH:D005910
3289726-01|67 73|tumors|MESH:D009369
3289726-01|78 102|hematologic malignancies|MESH:D019337
3289726-02|148 155|cancers|MESH:D009369
3289726-02|166 182|malignant glioma|MESH:D005910
3289726-03|73 79|glioma|MESH:D005910
3289726-03|95 119|neurologic deterioration|MESH:D009422
3289726-05|50 59|confusion|MESH:D003221
3289726-05|61 72|papilledema|MESH:D010211
3289726-05|74 84|somnolence|MESH:D006970
3289726-05|102 116|motor deficits|UNKNOWN_Disease
3289726-05|140 147|seizure|MESH:D012640
3289726-07|85 90|tumor|MESH:D009369
3289726-07|110 115|edema|MESH:D004487
3289726-08|57 65|toxicity|MESH:D064420
3289726-08|101 117|malignant glioma|MESH:D005910
3297909-00|12 28|bile duct injury|MESH:D001649
3297909-01|26 34|jaundice|MESH:D007565
3297909-02|0 11|Cholestasis|MESH:D002779
3297909-04|10 18|fibrosis|MESH:D005355
3297909-05|51 76|drug-induced liver damage|MESH:D056486
3297909-06|34 55|bile duct destruction|MESH:D001649
3323259-01|75 97|cardiovascular disease|MESH:D002318
3323259-01|200 223|cardiovascular diseases|MESH:D002318
3323259-05|89 95|angina|MESH:D000787
3323259-05|100 112|hypertension|MESH:D006973
3323259-07|175 187|hypertension|MESH:D006973
3323259-08|107 113|angina|MESH:D000787
3323259-09|96 119|subarachnoid hemorrhage|MESH:D013345
3323259-09|121 138|migraine headache|MESH:D008881
3323259-09|140 148|dementia|MESH:D003704
3323259-09|154 160|stroke|MESH:D020521
3323259-10|90 98|headache|MESH:D006261
3323259-10|107 115|flushing|MESH:D005483
3323259-10|117 129|palpitations|UNKNOWN_Disease
3323259-10|131 136|edema|MESH:D004487
3323259-10|138 144|nausea|MESH:D009325
3323259-10|146 154|anorexia|MESH:D000855
3323259-10|160 169|dizziness|MESH:D004244
3323599-00|35 44|nephrosis|MESH:D009401
3323599-01|25 61|focal segmental glomerular sclerosis|MESH:D005923
3323599-01|63 67|FSGS|MESH:D005923
3323599-05|15 33|nephrotic syndrome|MESH:D009404
3323599-05|46 59|renal failure|MESH:D051437
3323599-07|46 50|FSGS|MESH:D005923
3323599-09|70 78|toxicity|MESH:D064420
3323599-09|138 142|FSGS|MESH:D005923
3323599-09|168 191|end-stage renal disease|MESH:D007676
3339945-00|13 26|neurotoxicity|MESH:D020258
3339945-01|63 76|neurotoxicity|MESH:D020258
3339945-02|154 162|seizures|MESH:D012640
3339945-05|39 47|seizures|MESH:D012640
3339945-06|71 81|neurotoxic|MESH:D020258
3375885-00|0 12|Hyperkalemia|MESH:D006947
3375885-01|40 60|rheumatoid arthritis|MESH:D001172
3375885-01|93 104|nephropathy|MESH:D007674
3375885-01|113 125|hyperkalemia|MESH:D006947
3375885-01|144 161|hypoaldosteronism|MESH:D006994
3375885-02|30 43|renal disease|MESH:D007674
3375885-02|72 102|type IV renal tubular acidosis|MESH:D006994
3375885-03|124 136|hyperkalemia|MESH:D006947
3383127-00|0 11|Hypotension|MESH:D007022
3383127-00|34 48|cardiotoxicity|MESH:D066126
3383127-01|28 39|hypotension|MESH:D007022
3383127-01|83 103|colorectal carcinoma|MESH:D015179
3383127-02|17 28|hypotension|MESH:D007022
3383127-02|56 84|left ventricular dysfunction|MESH:D018487
3383127-05|145 159|cardiotoxicity|MESH:D066126
3409843-00|6 21|aplastic anemia|MESH:D000741
3409843-01|16 31|aplastic anemia|MESH:D000741
3409843-01|69 78|epileptic|MESH:D004827
3409843-02|26 46|bone marrow toxicity|MESH:D001855
3423103-00|90 101|hypotension|MESH:D007022
3423103-00|106 117|bradycardia|MESH:D001919
3423103-03|22 33|hypotension|MESH:D007022
3423103-04|41 52|bradycardia|MESH:D001919
3423103-05|179 191|bradycardiac|MESH:D001919
3423103-06|106 117|hypotension|MESH:D007022
3423103-06|122 133|bradycardia|MESH:D001919
3423103-07|12 23|hypotension|MESH:D007022
3423103-07|109 120|bradycardia|MESH:D001919
3439580-00|0 12|Hypertension|MESH:D006973
3439580-00|16 29|neuroblastoma|MESH:D009447
3439580-01|0 12|Hypertension|MESH:D006973
3439580-01|59 72|neuroblastoma|MESH:D009447
3439580-03|35 47|hypertension|MESH:D006973
3439580-03|99 112|neuroblastoma|MESH:D009447
3439580-03|151 168|behavior disorder|MESH:D002653
3439580-04|44 49|tumor|MESH:D009369
3439580-04|83 95|hypertensive|MESH:D006973
3439580-05|228 240|hypertension|MESH:D006973
3439580-07|110 123|neuroblastoma|MESH:D009447
3475563-00|38 54|oral candidiasis|MESH:D002180
3475563-00|58 68|hoarseness|MESH:D006685
3475563-01|7 16|asthmatic|MESH:D001249
3475563-01|96 106|hoarseness|MESH:D006685
3475563-01|117 123|thrush|MESH:D002180
3475563-03|40 50|hoarseness|MESH:D006685
3475563-03|75 86|Candidiasis|MESH:D002177
3475563-05|5 11|thrush|MESH:D002180
3475563-05|58 68|hoarseness|MESH:D006685
3475563-06|163 173|hoarseness|MESH:D006685
3475563-07|98 108|hoarseness|MESH:D006685
3475563-07|112 123|candidiasis|MESH:D002177
3533179-00|17 31|cardiotoxicity|MESH:D066126
3533179-02|36 50|cardiotoxicity|MESH:D066126
3533179-02|118 132|cardiotoxicity|MESH:D066126
3533179-03|29 37|toxicity|MESH:D064420
3533179-03|224 238|cardiotoxicity|MESH:D066126
3533179-04|140 155|aplastic anemia|MESH:D000741
3533179-04|157 181|Wiskott-Aldrich syndrome|MESH:D014923
3533179-04|186 227|severe combined immunodeficiency syndrome|MESH:D016511
3533179-05|73 87|cardiotoxicity|MESH:D066126
3533179-06|33 57|congestive heart failure|MESH:D006333
3533179-08|0 14|Cardiotoxicity|MESH:D066126
3533179-09|0 24|Congestive heart failure|MESH:D006333
3533179-11|25 39|cardiotoxicity|MESH:D066126
3533179-11|126 141|aplastic anemia|MESH:D000741
3533179-11|146 164|immunodeficiencies|MESH:D007153
3533179-11|287 301|cardiotoxicity|MESH:D066126
3533179-12|45 53|toxicity|MESH:D064420
3538855-00|43 57|nephrotoxicity|MESH:D007674
3538855-01|43 57|nephrotoxicity|MESH:D007674
3538855-02|149 182|glomerular or tubular dysfunction|MESH:D007674
3538855-03|108 127|acute renal failure|MESH:D058186
3538855-04|100 113|liver disease|MESH:D008107
3538855-04|228 242|nephrotoxicity|MESH:D007674
3538855-05|16 35|acute renal failure|MESH:D058186
3538855-05|45 50|shock|MESH:D012769
3538855-07|106 120|nephrotoxicity|MESH:D007674
3685052-00|10 17|seizure|MESH:D012640
3685052-00|162 169|seizure|MESH:D012640
3685052-01|71 82|convulsions|MESH:D012640
3685052-02|111 118|seizure|MESH:D012640
3685052-03|18 25|seizure|MESH:D012640
3685052-03|67 74|seizure|MESH:D012640
3685052-04|89 96|seizure|MESH:D012640
3685052-05|68 75|seizure|MESH:D012640
3685052-06|25 36|hypothermia|MESH:D007035
3685052-06|128 139|hypothermia|MESH:D007035
3685052-06|143 150|seizure|MESH:D012640
3685052-07|10 17|seizure|MESH:D012640
3685052-07|93 100|seizure|MESH:D012640
3708328-00|18 26|seizures|MESH:D012640
3708328-01|91 113|temporal lobe epilepsy|MESH:D004833
3708328-01|189 199|convulsive|MESH:D012640
3708328-01|273 281|seizures|MESH:D012640
3708328-02|161 169|seizures|MESH:D012640
3708328-03|312 320|seizures|MESH:D012640
3708328-03|325 343|status epilepticus|MESH:D013226
3708328-04|121 132|convulsions|MESH:D012640
3708328-05|84 91|seizure|MESH:D012640
3708328-06|64 72|seizures|MESH:D012640
3708328-07|212 220|seizures|MESH:D012640
3708328-08|77 89|brain damage|MESH:D001930
3708328-09|127 138|convulsions|MESH:D012640
3708328-10|67 75|seizures|MESH:D012640
3746148-00|26 49|coronary artery disease|MESH:D003324
3746148-01|110 133|coronary artery disease|MESH:D003324
3746148-02|61 82|myocardial infarction|MESH:D009203
3746148-02|88 90|MI|MESH:D009203
3746148-02|107 126|anterior infarction|MESH:D056988
3746148-02|128 134|ANT-MI|MESH:D056988
3746148-02|151 170|inferior infarction|MESH:D056989
3746148-02|172 178|INF-MI|MESH:D056989
3746148-04|20 28|ischemic|MESH:D007511
3746148-04|40 50|depression|MESH:D003866
3746148-04|100 102|MI|MESH:D009203
3746148-04|121 127|ANT-MI|MESH:D056988
3746148-04|146 152|INF-MI|MESH:D056989
3746148-05|20 30|depression|MESH:D003866
3746148-05|62 64|MI|MESH:D009203
3746148-05|83 89|ANT-MI|MESH:D056988
3746148-05|108 114|INF-MI|MESH:D056989
3746148-06|103 113|depression|MESH:D003866
3746148-08|47 66|myocardial ischemia|MESH:D017202
3746148-09|103 126|coronary artery disease|MESH:D003324
3798047-00|0 11|Bradycardia|MESH:D001919
3798047-01|31 51|rheumatoid arthritis|MESH:D001172
3798047-02|29 40|bradycardia|MESH:D001919
3798047-04|42 59|sinus bradycardia|MESH:D012804
3798047-07|59 72|heart disease|MESH:D006331
3812624-00|13 31|downbeat nystagmus|MESH:D009759
3812624-00|36 47|oscillopsia|MESH:D015835
3812624-01|0 18|Downbeat nystagmus|MESH:D009759
3812624-02|62 80|downbeat nystagmus|MESH:D009759
3812624-03|4 13|nystagmus|MESH:D009759
3812624-05|17 35|downbeat nystagmus|MESH:D009759
3831029-00|60 75|cardiac failure|MESH:D006333
3831029-01|87 102|cardiac failure|MESH:D006333
3831029-04|3 14|arrhythmias|MESH:D001145
3831029-05|70 85|cardiac failure|MESH:D006333
3832950-00|27 35|epilepsy|MESH:D004827
3832950-01|69 77|epilepsy|MESH:D004827
3832950-01|83 99|infantile spasms|MESH:D013036
3832950-02|17 25|seizures|MESH:D012640
3832950-02|82 90|seizures|MESH:D012640
3832950-03|0 8|Seizures|MESH:D012640
3832950-03|61 69|seizures|MESH:D012640
3832950-03|89 97|seizures|MESH:D012640
3832950-06|38 48|drowsiness|MESH:D006970
3832950-06|53 59|ataxia|MESH:D001259
3833372-01|227 239|hypertensive|MESH:D006973
3833372-05|81 93|hypertension|MESH:D006973
3833372-06|91 98|fatigue|MESH:D005221
3833372-06|100 109|dizziness|MESH:D004244
3833372-06|115 123|weakness|MESH:D018908
3864191-00|11 22|nephropathy|MESH:D007674
3864191-01|81 92|nephropathy|MESH:D007674
3864191-02|43 61|hyperbilirubinemia|MESH:D006932
3864191-03|50 68|papillary necrosis|MESH:D007681
3864191-12|77 89|renal damage|MESH:D007674
3864191-12|181 190|hematuria|MESH:D006417
3864191-13|193 229|pathological renal medullary lesions|MESH:D058186
3864191-13|234 265|deterioration of renal function|MESH:D007674
3895875-00|55 76|myocardial infarction|MESH:D009203
3895875-01|41 62|myocardial infarction|MESH:D009203
3895875-02|68 92|ventricular fibrillation|MESH:D014693
3895875-02|106 129|ventricular tachycardia|MESH:D017180
3895875-02|164 185|myocardial infarction|MESH:D009203
3895875-03|110 133|ventricular tachycardia|MESH:D017180
3895875-03|217 228|arrhythmias|MESH:D001145
3895875-04|90 111|myocardial infarction|MESH:D009203
3895875-04|174 184|infarction|MESH:D007238
3895875-06|135 146|hypotension|MESH:D007022
3895875-06|237 245|asystole|MESH:D006323
3895875-07|100 121|myocardial infarction|MESH:D009203
3925479-00|55 64|catalepsy|MESH:D002375
3925479-01|93 102|catalepsy|MESH:D002375
3925479-01|196 205|catalepsy|MESH:D002375
3925479-02|61 70|catalepsy|MESH:D002375
3925479-03|64 73|catalepsy|MESH:D002375
3925479-04|71 80|catalepsy|MESH:D002375
3925479-05|93 102|catalepsy|MESH:D002375
3925479-06|47 56|catalepsy|MESH:D002375
3925479-07|71 80|catalepsy|MESH:D002375
3975902-00|0 26|Cardiovascular dysfunction|MESH:D002318
3975902-00|31 47|hypersensitivity|MESH:D004342
3975902-01|78 90|hypertension|MESH:D006973
3975902-02|145 190|disturbances within the cardiovascular system|MESH:D002318
3975902-03|68 84|hypersensitivity|MESH:D004342
3975902-10|92 114|metabolic disturbances|MESH:D008659
3975902-10|124 140|hypersensitivity|MESH:D004342
3975902-10|244 268|cardiomyopathic disorder|MESH:D009202
3987172-00|54 66|hypertension|MESH:D006973
3987172-01|26 34|overdose|MESH:D062787
3987172-01|52 64|hypertension|MESH:D006973
3987172-01|66 90|intracerebral hemorrhage|MESH:D002543
3987172-02|82 94|hypertension|MESH:D006973
3987172-06|87 93|stroke|MESH:D020521
3990093-00|23 43|glomerular sclerosis|MESH:D007674
3990093-00|73 82|nephrosis|MESH:D009401
3990093-01|34 55|mesangial dysfunction|MESH:D007674
3990093-01|75 95|glomerular sclerosis|MESH:D007674
3990093-03|41 52|proteinuric|MESH:D011507
3990093-04|12 32|glomerular sclerosis|MESH:D007674
3990093-06|15 24|sclerosis|MESH:D012598
3990093-08|258 267|sclerosis|MESH:D012598
3990093-10|43 52|nephrosis|MESH:D009401
3990093-10|72 92|glomerular sclerosis|MESH:D007674
4010471-00|38 46|seizures|MESH:D012640
4010471-02|109 117|seizures|MESH:D012640
4010471-03|116 123|seizure|MESH:D012640
4010471-04|23 30|seizure|MESH:D012640
4010471-05|44 51|seizure|MESH:D012640
4082192-00|51 65|nephrotoxicity|MESH:D007674
4082192-00|141 155|nephrotoxicity|MESH:D007674
4082192-01|39 55|tubular necrosis|MESH:D007683
4082192-03|96 110|nephrotoxicity|MESH:D007674
4082192-04|104 118|nephrotoxicity|MESH:D007674
4082192-06|119 133|nephrotoxicity|MESH:D007674
4082192-06|146 160|nephrotoxicity|MESH:D007674
4082192-10|54 68|nephrotoxicity|MESH:D007674
4082192-11|90 112|renal tubular necrosis|MESH:D007683
4082466-00|17 25|seizures|MESH:D012640
4082466-01|39 47|seizures|MESH:D012640
4082466-02|160 168|seizures|MESH:D012640
4082466-04|24 32|seizures|MESH:D012640
4082466-04|56 67|convulsions|MESH:D012640
4631913-00|33 55|Pseudomonas infections|MESH:D011552
4631913-02|0 12|Leukocytosis|MESH:D007964
4631913-03|97 107|leukopenia|MESH:D007970
4631913-04|165 174|infection|MESH:D007239
4631913-05|53 63|leukopenia|MESH:D007970
4631913-05|98 104|sepsis|MESH:D018805
6106951-02|78 89|convulsions|MESH:D012640
6106951-02|115 125|depression|MESH:D003866
6106951-03|58 69|convulsions|MESH:D012640
6106951-04|46 56|depression|MESH:D003866
6106951-04|117 128|convulsions|MESH:D012640
6106951-04|163 184|loss of consciousness|MESH:D014474
6106951-05|13 21|toxocity|MESH:D064420
6106951-05|49 59|salivation|MESH:D012798
6106951-05|102 116|muscle tremors|MESH:D014202
6106951-05|121 132|convulsions|MESH:D012640
6106951-07|51 62|convulsions|MESH:D012640
6106951-08|26 37|convulsions|MESH:D012640
6106951-09|64 75|convulsions|MESH:D012640
6106951-10|128 136|epilepsy|MESH:D004827
6299641-01|167 178|tachycardia|MESH:D013610
6299641-03|29 40|tachycardia|MESH:D013610
6299641-08|68 79|tachycardia|MESH:D013610
6305660-00|21 34|breast cancer|MESH:D001943
6305660-07|0 10|Mastodynia|MESH:D059373
6305660-08|109 119|mastodynia|MESH:D059373
6305660-08|169 179|mastodynia|MESH:D059373
6310832-00|6 16|infections|MESH:D007239
6310832-01|95 104|infection|MESH:D007239
6310832-04|45 55|infections|MESH:D007239
6310832-04|93 103|infections|MESH:D007239
6310832-05|34 44|infections|MESH:D007239
6310832-05|88 98|infections|MESH:D007239
6310832-06|89 98|infection|MESH:D007239
6310832-07|46 57|bacteremias|MESH:D016470
6310832-08|20 29|infection|MESH:D007239
6310832-08|56 76|abdominal infections|MESH:D059413
6310832-08|110 120|infections|MESH:D007239
6310832-08|144 168|urinary tract infections|MESH:D014552
6310832-09|10 20|infections|MESH:D007239
6310832-10|36 61|staphylococcal infections|MESH:D013203
6310832-10|129 146|fungal infections|MESH:D009181
6310832-12|58 71|CMV infection|MESH:D003586
6310832-13|25 53|Epstein Barr Virus infection|MESH:D020031
6310832-14|51 59|lymphoma|MESH:D008223
6316193-00|89 97|seizures|MESH:D012640
6316193-01|168 176|seizures|MESH:D012640
6316193-04|188 196|seizures|MESH:D012640
6321816-00|41 53|hypertension|MESH:D006973
6321816-01|50 62|hypertensive|MESH:D006973
6321816-02|64 76|hypertension|MESH:D006973
6321816-02|169 187|diabetes insipidus|MESH:D003919
6321816-04|107 119|hypertension|MESH:D006973
6321816-04|215 227|hypertension|MESH:D006973
6321816-05|126 138|hypertension|MESH:D006973
6321816-07|77 89|hypertension|MESH:D006973
6453500-00|0 15|Toxic hepatitis|MESH:D056486
6453500-01|13 31|toxic liver damage|MESH:D056486
6517710-00|0 17|Atrial thrombosis|MESH:D003328
6517710-02|102 119|atrial thrombosis|MESH:D003328
6517710-03|31 50|cardiac hypertrophy|MESH:D006332
6517710-03|76 99|myocardial degeneration|MESH:D009202
6517710-04|15 34|cardiac hypertrophy|MESH:D006332
6517710-05|123 133|thrombosis|MESH:D013927
6517710-05|222 239|atrial thrombosis|MESH:D003328
6529939-00|0 24|Alternating sinus rhythm|MESH:D001146
6529939-00|42 58|sinoatrial block|MESH:D012848
6529939-01|0 24|Alternating sinus rhythm|MESH:D001146
6529939-01|42 64|sinoatrial (S-A) block|MESH:D012848
6529939-01|122 128|angina|MESH:D000787
6529939-04|36 54|alternating rhythm|MESH:D001146
6529939-07|78 87|S-A block|MESH:D012848
6529939-12|105 114|S-A block|MESH:D012848
6529939-13|70 89|conduction disorder|MESH:D019955
6585590-00|18 32|cardiotoxicity|MESH:D066126
6585590-00|38 52|nephrotoxicity|MESH:D007674
6585590-00|85 97|immunocytoma|UNKNOWN_Disease
6585590-01|20 34|cardiotoxicity|MESH:D066126
6585590-01|40 54|nephrotoxicity|MESH:D007674
6585590-01|156 168|immunocytoma|UNKNOWN_Disease
6585590-02|15 20|tumor|MESH:D009369
6585590-03|0 5|Tumor|MESH:D009369
6585590-04|30 35|tumor|MESH:D009369
6585590-05|23 37|cardiotoxicity|MESH:D066126
6585590-06|30 42|renal damage|MESH:D007674
6585590-06|109 120|albuminuria|MESH:D000419
6585590-08|0 7|Ascites|MESH:D001201
6585590-08|12 23|hydrothorax|MESH:D006876
6585590-09|45 50|tumor|MESH:D009369
6585590-10|35 49|cardiotoxicity|MESH:D066126
6585590-10|55 69|nephrotoxicity|MESH:D007674
6585590-11|0 11|Albuminuria|MESH:D000419
6585590-11|19 31|renal damage|MESH:D007674
6585590-11|78 85|ascites|MESH:D001201
6585590-11|90 101|hydrothorax|MESH:D006876
6585590-11|153 167|cardiomyopathy|MESH:D009202
6615679-00|15 26|bradycardia|MESH:D001919
6615679-00|31 42|hypotension|MESH:D007022
6615679-01|120 131|bradycardia|MESH:D001919
6615679-01|143 154|hypotensive|MESH:D007022
6615679-04|101 112|bradycardia|MESH:D001919
6615679-04|117 128|hypotension|MESH:D007022
6627074-00|16 22|apnoea|MESH:D001049
6627074-01|76 98|neuromuscular blockade|MESH:D020879
6627074-05|125 131|apnoea|MESH:D001049
6631522-06|152 166|cardiotoxicity|MESH:D066126
6673474-00|56 67|hypotension|MESH:D007022
6673474-02|136 147|hypotension|MESH:D007022
6673474-03|38 49|hypotension|MESH:D007022
6673474-03|167 178|hypotension|MESH:D007022
6673474-03|262 273|hypotension|MESH:D007022
6673474-04|50 61|hypotension|MESH:D007022
6687006-02|4 17|hyperactivity|MESH:D006948
6687006-03|60 72|stereotypies|MESH:D019956
6687006-04|29 42|hyperactivity|MESH:D006948
6687006-04|165 175|neurotoxic|MESH:D020258
6695685-00|0 30|Accelerated junctional rhythms|MESH:D001145
6695685-01|76 106|accelerated junctional rhythms|MESH:D001145
6695685-02|0 30|Accelerated junctional rhythms|MESH:D001145
6695685-02|82 115|supraventricular tachyarrhythmias|MESH:D013617
6695685-04|25 35|chest pain|MESH:D002637
6806735-00|13 27|ovarian cancer|MESH:D010051
6806735-01|46 60|ovarian cancer|MESH:D010051
6806735-04|0 20|Hematologic toxicity|MESH:D006402
6806735-04|54 60|anemia|MESH:D000740
6806735-06|4 29|gastrointestinal toxicity|MESH:D005767
6806735-07|7 21|nephrotoxicity|MESH:D007674
6884395-00|13 32|dissecting aneurysm|MESH:D000784
6884395-01|23 42|dissecting aneurysm|MESH:D000784
6884395-01|85 97|hypertension|MESH:D006973
6884395-01|175 193|locked-in syndrome|MESH:D011782
6893265-00|25 39|hepatic damage|MESH:D056486
6893265-01|38 50|liver damage|MESH:D056486
6893265-02|134 158|chronic active hepatitis|MESH:D006521
6985297-00|15 26|bradycardia|MESH:D001919
6985297-01|64 79|anginal attacks|MESH:D000787
6985297-01|100 111|bradycardia|MESH:D001919
6985297-01|136 148|tachycardial|MESH:D013610
6985498-00|0 9|Hepatitis|MESH:D056486
6985498-00|14 36|renal tubular acidosis|MESH:D000141
6985498-01|31 50|acute cholecystitis|MESH:D041881
6985498-01|111 141|hepatic insufficiency syndrome|MESH:D048550
6985498-01|146 168|renal tubular acidosis|MESH:D000141
6985498-02|8 16|bleeding|MESH:D006470
7018927-00|87 105|hyperprolactinemia|MESH:D006966
7018927-04|56 74|hyperprolactinemia|MESH:D006966
7121659-00|57 70|renal failure|MESH:D051437
7121659-00|88 107|acute renal failure|MESH:D058186
7121659-00|116 128|thrombopenia|MESH:D013921
7121659-00|133 142|hemolysis|MESH:D006461
7121659-03|81 104|hematological disorders|MESH:D006402
7121659-04|28 50|acute tubular necrosis|MESH:D007683
7147232-00|26 37|hypotension|MESH:D007022
7147232-01|111 122|hypotension|MESH:D007022
7147232-05|33 44|hypotension|MESH:D007022
7147232-06|0 11|Hypotension|MESH:D007022
7147232-08|7 18|hypotension|MESH:D007022
7173007-02|44 50|nausea|MESH:D009325
7173007-02|55 64|dizziness|MESH:D004244
7173007-03|48 62|abdominal pain|MESH:D015746
7173007-05|128 136|toxicity|MESH:D064420
7176945-00|19 24|pains|MESH:D010146
7176945-01|48 52|pain|MESH:D010146
7176945-03|48 52|pain|MESH:D010146
7176945-04|24 38|fasciculations|MESH:D005207
7176945-04|118 122|pain|MESH:D010146
7176945-05|166 170|pain|MESH:D010146
7315949-00|27 32|spasm|MESH:D013035
7315949-03|132 139|hernias|MESH:D006547
7315949-08|106 111|spasm|MESH:D013035
7369302-00|66 75|amblyopia|MESH:D000550
7369302-01|6 15|blindness|MESH:D001766
7369302-01|33 48|tonic pupillary|MESH:D015845
7369302-01|195 205|leg cramps|MESH:D009120
7369302-03|12 27|tonic pupillary|MESH:D015845
7369302-03|117 125|toxicity|MESH:D064420
7378868-00|22 35|jaw stiffness|MESH:D014313
7378868-00|40 47|myalgia|MESH:D063806
7378868-02|29 42|jaw stiffness|MESH:D014313
7378868-03|14 20|apnoea|MESH:D001049
7378868-03|63 70|myalgia|MESH:D063806
7378868-06|20 42|prolonged jaw rigidity|MESH:D014313
7378868-06|47 54|myalgia|MESH:D063806
7411769-00|21 33|hyperkalemia|MESH:D006947
7411769-00|57 72|gouty arthritis|MESH:D015210
7411769-01|60 72|hyperkalemia|MESH:D006947
7411769-01|77 96|renal insufficiency|MESH:D051437
7411769-01|132 147|gouty arthritis|MESH:D015210
7411769-02|90 121|hyporeninemic hypoaidosteronism|MESH:D006994
7411769-03|177 194|diabetes mellitus|MESH:D003920
7411769-03|210 223|renal disease|MESH:D007674
7457821-06|7 11|pain|MESH:D010146
7457821-06|61 65|pain|MESH:D010146
7457821-06|69 77|swelling|MESH:D004487
7457821-07|64 81|respiratory upset|MESH:D012140
7457821-08|0 6|Nausea|MESH:D009325
7457821-08|11 19|vomiting|MESH:D014839
7457821-08|69 78|psychoses|MESH:D011605
7477981-00|17 28|dyskinesias|MESH:D004409
7477981-01|29 45|motor disability|MESH:D009069
7477981-01|50 61|dyskinesias|MESH:D004409
7477981-01|105 124|Parkinson's disease|MESH:D010300
7477981-02|102 113|dyskinesias|MESH:D004409
7477981-02|138 150|parkinsonian|MESH:D010300
7477981-02|151 167|motor disability|MESH:D009069
7477981-03|4 15|dyskinesias|MESH:D004409
7477981-03|100 120|dystonic dyskinesias|MESH:D020821
7477981-03|100 120|dystonic dyskinesias|MESH:D004409
7477981-03|145 156|dyskinesias|MESH:D004409
7477981-03|188 216|choreic mid-dose dyskinesias|MESH:D002819
7477981-03|188 216|choreic mid-dose dyskinesias|MESH:D004409
7477981-04|134 145|dyskinesias|MESH:D004409
7477981-04|166 178|parkinsonian|MESH:D010300
7477981-04|179 195|motor disability|MESH:D009069
7479194-00|125 138|drug toxicity|MESH:D064420
7479194-01|240 279|liver, blood, skin, and renal disorders|MESH:D008107
7479194-01|240 279|liver, blood, skin, and renal disorders|MESH:D006402
7479194-01|240 279|liver, blood, skin, and renal disorders|MESH:D007674
7479194-01|240 279|liver, blood, skin, and renal disorders|MESH:D012871
7479194-03|44 57|liver disease|MESH:D008107
7479194-05|98 117|erythema multiforme|MESH:D004892
7479194-05|122 146|Stevens-Johnson syndrome|MESH:D013262
7479194-06|16 42|toxic epidermal necrolysis|MESH:D013262
7479194-07|46 59|renal disease|MESH:D007674
7492040-00|65 86|myocardial infarction|MESH:D009203
7492040-01|87 108|myocardial infarction|MESH:D009203
7492040-01|110 112|MI|MESH:D009203
7492040-04|47 49|MI|MESH:D009203
7492040-05|84 86|MI|MESH:D009203
7492040-05|115 132|bradydysrhythmias|MESH:D001919
7492040-05|134 157|ventricular tachycardia|MESH:D017180
7492040-05|162 186|ventricular fibrillation|MESH:D014693
7492040-05|203 211|seizures|MESH:D012640
7492040-06|76 84|toxicity|MESH:D064420
7492040-06|143 145|MI|MESH:D009203
7492040-06|182 231|cardiovascular or central nervous system toxicity|MESH:D002493
7492040-06|182 231|cardiovascular or central nervous system toxicity|MESH:D002318
7644931-01|161 187|non-small cell lung cancer|MESH:D002289
7644931-03|149 159|toxicities|MESH:D064420
7644931-03|161 171|arthralgia|MESH:D018771
7644931-03|176 194|sensory neuropathy|MESH:D012678
7644931-05|0 10|Toxicities|MESH:D064420
7644931-06|41 63|hematologic toxicities|MESH:D006402
7661171-00|65 82|renal dysfunction|MESH:D007674
7661171-00|103 112|cirrhosis|MESH:D005355
7661171-01|91 108|renal dysfunction|MESH:D007674
7661171-01|129 138|cirrhotic|MESH:D005355
7661171-03|132 141|cirrhotic|MESH:D005355
7661171-07|263 272|cirrhosis|MESH:D005355
7671401-00|36 48|angio-oedema|MESH:D000799
7671401-01|78 87|urticaria|MESH:D014581
7671401-01|93 105|angio-oedema|MESH:D000799
7671401-02|62 74|hypertension|MESH:D006973
7671401-02|79 103|congestive heart failure|MESH:D006333
7671401-03|62 74|angio-oedema|MESH:D000799
7671401-04|138 150|angio-oedema|MESH:D000799
7727612-00|0 9|Myoclonus|MESH:D009207
7727612-03|64 73|myoclonus|MESH:D009207
7727612-04|14 24|neurotoxic|MESH:D020258
7739955-00|107 121|cardiomyopathy|MESH:D009202
7739955-01|94 113|circulatory failure|MESH:D012769
7739955-01|119 141|myocardial dysfunction|MESH:D009202
7739955-02|31 42|myocarditis|MESH:D009205
7739955-02|82 106|eosinophilic myocarditis|MESH:D009205
7739955-02|82 106|eosinophilic myocarditis|MESH:D004802
7739955-02|161 178|cardiogenic shock|MESH:D012770
7739955-04|159 171|dysrhythmias|MESH:D001145
7739955-05|72 83|hypotension|MESH:D007022
7739955-05|88 100|dysrhythmias|MESH:D001145
7739955-08|37 51|cardiac arrest|MESH:D006323
7739955-10|104 126|myocardial dysfunction|MESH:D009202
7931490-00|112 118|nausea|MESH:D009325
7931490-00|123 131|vomiting|MESH:D014839
7931490-01|252 258|nausea|MESH:D009325
7931490-01|263 271|vomiting|MESH:D014839
7931490-03|82 88|nausea|MESH:D009325
7931490-03|90 98|vomiting|MESH:D014839
7931490-05|98 106|vomiting|MESH:D014839
7931490-05|249 257|vomiting|MESH:D014839
7931490-06|58 64|nausea|MESH:D009325
7931490-06|81 89|vomiting|MESH:D014839
7931490-08|0 8|Headache|MESH:D006261
7931490-09|100 108|vomiting|MESH:D014839
7931490-09|211 219|vomiting|MESH:D014839
7949506-01|110 137|atrioventricular (AV) block|MESH:D054537
7949506-01|166 177|hypotension|MESH:D007022
7949506-02|41 59|hyperaldosteronism|MESH:D006929
7949506-03|88 96|AV block|MESH:D054537
7949506-03|108 119|hypotension|MESH:D007022
7949506-05|67 75|AV block|MESH:D054537
7967231-01|106 134|audiogenic tonic convulsions|MESH:D020195
7967231-02|101 112|convulsions|MESH:D012640
7967231-02|219 230|convulsions|MESH:D012640
7967231-03|63 71|epilepsy|MESH:D004827
8096565-00|11 32|myocardial infarction|MESH:D009203
8096565-02|46 67|myocardial infarction|MESH:D009203
8096565-02|128 144|cluster headache|MESH:D003027
8096565-03|41 64|ischaemic heart disease|MESH:D017202
8096565-03|68 87|Prinzmetal's angina|MESH:D000788
8135424-00|19 27|seizures|MESH:D012640
8135424-01|88 96|seizures|MESH:D012640
8135424-04|17 25|seizures|MESH:D012640
8135424-07|33 41|seizures|MESH:D012640
8135424-13|44 52|seizures|MESH:D012640
8135424-15|43 51|seizures|MESH:D012640
8135424-17|48 56|seizures|MESH:D012640
8135424-18|34 42|seizures|MESH:D012640
8160791-00|84 95|nephropathy|MESH:D007674
8160791-01|131 142|nephropathy|MESH:D007674
8160791-02|159 173|tubular damage|MESH:D007674
8160791-03|200 211|nephropathy|MESH:D007674
8160791-06|26 40|tubular damage|MESH:D007674
8160791-07|44 58|tubular damage|MESH:D007674
8160791-09|87 98|nephropathy|MESH:D007674
8184922-00|49 60|hypertrophy|MESH:D006984
8184922-01|86 105|cardiac hypertrophy|MESH:D006332
8184922-03|114 133|hypertrophic hearts|MESH:D006332
8184922-05|101 120|cardiac hypertrophy|MESH:D006332
8184922-06|134 153|cardiac hypertrophy|MESH:D006332
8188982-00|80 92|hypertensive|MESH:D006973
8188982-01|240 252|hypertensive|MESH:D006973
8188982-04|228 240|hypertension|MESH:D006973
8188982-04|279 290|hypotension|MESH:D007022
8188982-08|80 91|hypotension|MESH:D007022
8308951-00|61 85|intracerebral hemorrhage|MESH:D002543
8308951-01|24 32|hematoma|MESH:D006406
8308951-01|57 69|coagulopathy|MESH:D001778
8308951-03|44 56|coagulopathy|MESH:D001778
8308951-04|98 110|coagulopathy|MESH:D001778
8312343-02|37 62|idiopathic cardiomyopathy|MESH:D002311
8312343-02|70 94|congenital heart disease|MESH:D006331
8312343-02|160 187|hypertrophic cardiomyopathy|MESH:D002312
8312343-02|194 216|valvular heart disease|MESH:D006349
8312343-02|239 253|cardiomyopathy|MESH:D009202
8312343-08|50 59|infection|MESH:D007239
8312343-13|21 31|infections|MESH:D007239
8312343-14|0 26|Cytomegalovirus infections|MESH:D003586
8312343-16|86 101|atherosclerosis|MESH:D050197
8312343-17|0 8|Seizures|MESH:D012640
8312343-17|45 57|hypertension|MESH:D006973
8312343-18|31 59|lymphoproliferative disorder|MESH:D008232
8312983-00|0 8|Delirium|MESH:D003693
8312983-04|126 136|somnolence|MESH:D006970
8312983-04|141 162|movement difficulties|MESH:D020820
8312983-05|11 30|cognitive disorders|MESH:D003072
8312983-05|40 48|delirium|MESH:D003693
8312983-06|49 61|hyperkinetic|MESH:D006948
8312983-06|62 70|delirium|MESH:D003693
8318674-00|0 15|Pulmonary edema|MESH:D011654
8318674-00|20 25|shock|MESH:D012769
8318674-00|58 66|lymphoma|MESH:D008223
8318674-01|69 78|lymphomas|MESH:D008223
8318674-02|37 42|fever|MESH:D005334
8318674-02|44 52|diarrhea|MESH:D003967
8318674-02|54 59|shock|MESH:D012769
8318674-02|61 76|pulmonary edema|MESH:D011654
8318674-02|78 97|acute renal failure|MESH:D058186
8318674-02|99 117|metabolic acidosis|MESH:D000138
8318674-02|119 130|weight gain|MESH:D015430
8318674-02|135 147|leukocytosis|MESH:D007964
8318674-03|65 74|infection|MESH:D007239
8318674-06|71 76|shock|MESH:D012769
8318674-06|81 116|adult respiratory distress syndrome|MESH:D012128
8392553-00|60 74|cardiac injury|MESH:D006331
8392553-01|108 122|cardiomyopathy|MESH:D009202
8392553-02|87 103|ischemic lesions|MESH:D007511
8392553-02|108 116|fibrosis|MESH:D005355
8392553-05|104 120|ischemic lesions|MESH:D007511
8392553-05|125 133|fibrosis|MESH:D005355
8392553-10|57 71|cardiac injury|MESH:D006331
8511251-00|16 35|myocardial ischemia|MESH:D017202
8511251-01|20 39|myocardial ischemia|MESH:D017202
8511251-02|4 12|ischemia|MESH:D007511
8511251-02|33 54|coronary artery spasm|MESH:D003329
8603459-00|20 34|cardiotoxicity|MESH:D066126
8603459-02|84 98|cardiotoxicity|MESH:D066126
8603459-08|91 103|hypertrophic|MESH:D006984
8603459-09|30 38|toxicity|MESH:D064420
8603459-09|168 176|toxicity|MESH:D064420
8603459-12|104 118|cardiotoxicity|MESH:D066126
8603459-13|99 113|cardiotoxicity|MESH:D066126
8659767-01|55 67|dysrhythmias|MESH:D001145
8659767-02|173 194|myocardial infarction|MESH:D009203
8659767-04|33 56|ventricular tachycardia|MESH:D017180
8659767-04|58 60|VT|MESH:D017180
8659767-07|0 2|VT|MESH:D017180
8659767-09|27 48|myocardial infarction|MESH:D009203
8659767-09|144 146|VT|MESH:D017180
8659767-12|88 90|VT|MESH:D017180
8659767-12|145 157|dysrhythmias|MESH:D001145
8667442-00|0 20|Milk-alkali syndrome|MESH:D006934
8667442-00|61 79|hypoparathyroidism|MESH:D007011
8667442-01|0 20|Milk-alkali syndrome|MESH:D006934
8667442-01|89 109|peptic ulcer disease|MESH:D010437
8667442-02|22 27|ulcer|MESH:D014456
8667442-02|97 117|milk-alkali syndrome|MESH:D006934
8667442-02|168 181|hypercalcemia|MESH:D006934
8667442-02|183 192|alkalosis|MESH:D000471
8667442-02|198 214|renal impairment|MESH:D051437
8667442-03|0 20|Milk-alkali syndrome|MESH:D006934
8667442-04|37 55|hypoparathyroidism|MESH:D007011
8667442-04|158 178|milk-alkali syndrome|MESH:D006934
8667442-06|77 97|milk-alkali syndrome|MESH:D006934
8667442-06|110 133|hypercalcemic emergency|MESH:D006934
8748050-00|0 14|Encephalopathy|MESH:D001927
8748050-00|49 79|neuroleptic malignant syndrome|MESH:D009459
8748050-00|84 102|serotonin syndrome|MESH:D020230
8748050-01|32 46|encephalopathy|MESH:D001927
8748050-01|119 138|unipolar depression|MESH:D003866
8748050-02|56 86|neuroleptic malignant syndrome|MESH:D009459
8748050-02|88 91|NMS|MESH:D009459
8748050-02|96 114|serotonin syndrome|MESH:D020230
8748050-02|116 118|SS|MESH:D020230
8748050-04|4 7|NMS|MESH:D009459
8748050-04|13 27|encephalopathy|MESH:D001927
8748050-04|104 107|NMS|MESH:D009459
8748050-04|112 114|SS|MESH:D020230
8755612-00|22 27|tumor|MESH:D009369
8755612-00|39 50|hemorrhagic|MESH:D006470
8755612-00|85 90|tumor|MESH:D009369
8755612-01|90 101|hemorrhagic|MESH:D006470
8755612-01|102 118|pituitary tumors|MESH:D010911
8755612-02|203 214|hemorrhagic|MESH:D006470
8755612-05|28 34|tumors|MESH:D009369
8755612-05|44 55|hemorrhagic|MESH:D006470
8755612-07|94 105|hemorrhagic|MESH:D006470
8755612-08|47 58|hemorrhagic|MESH:D006470
8755612-08|156 167|hemorrhagic|MESH:D006470
8755612-08|189 200|hemorrhagic|MESH:D006470
8755612-09|4 15|hemorrhagic|MESH:D006470
8808730-00|102 120|bladder irritation|MESH:D001745
8808730-01|169 200|irritation of the urinary tract|MESH:D014570
8808730-02|9 17|cystitis|MESH:D003556
8819482-00|70 89|myocardial ischemia|MESH:D017202
8819482-00|111 128|coronary stenosis|MESH:D023921
8819482-01|49 68|myocardial ischemia|MESH:D017202
8819482-01|103 120|coronary stenosis|MESH:D023921
8819482-02|19 43|coronary artery stenosis|MESH:D023921
8819482-03|36 44|stenosis|MESH:D003251
8819482-05|283 291|stenosis|MESH:D003251
8819482-06|263 271|stenosis|MESH:D003251
8819482-07|37 56|myocardial ischemia|MESH:D017202
8819482-07|82 90|stenosis|MESH:D003251
8825380-00|98 109|nephropathy|MESH:D007674
8825380-01|140 151|nephropathy|MESH:D007674
8825380-01|178 196|glomerular disease|MESH:D007674
8825380-02|104 118|growth failure|MESH:D006130
8825380-02|144 155|nephropathy|MESH:D007674
8825380-03|4 18|glomerulopathy|MESH:D007674
8825380-04|223 236|renal disease|MESH:D007674
8825380-05|86 97|nephropathy|MESH:D007674
8825380-06|150 161|nephropathy|MESH:D007674
8825380-07|56 78|glomerular hypertrophy|MESH:D007674
8825380-07|102 120|glomerulosclerosis|MESH:D005921
8825380-07|122 147|tubulointerstitial injury|UNKNOWN_Disease
8825380-08|17 28|nephropathy|MESH:D007674
8825380-09|110 121|proteinuria|MESH:D011507
8825380-09|209 234|tubulointerstitial damage|MESH:D007674
8825380-10|96 107|nephropathy|MESH:D007674
8829135-00|51 58|amnesia|MESH:D000647
8829135-01|83 132|learning and post-training consolidation deficits|MESH:D007859
8829135-02|185 192|amnesia|MESH:D000647
8829135-05|79 86|amnesia|MESH:D000647
8957205-00|85 96|hypercapnic|MESH:D006935
8957205-10|74 85|hypercapnic|MESH:D006935
8985298-00|39 50|hepatitis B|MESH:D006509
8985298-01|92 103|hepatitis B|MESH:D006509
8985298-06|55 66|hepatitis B|MESH:D006509
8985298-09|27 38|hepatitis B|MESH:D006509
8996419-00|34 56|venous thromboembolism|MESH:D054556
8996419-01|88 110|venous thromboembolism|MESH:D054556
8996419-01|112 115|VTE|MESH:D054556
8996419-03|71 74|VTE|MESH:D054556
8996419-06|42 62|deep-vein thrombosis|MESH:D020246
8996419-06|64 81|venous thrombosis|MESH:D020246
8996419-06|238 241|VTE|MESH:D054556
8996419-07|62 65|VTE|MESH:D054556
8996419-07|168 171|VTE|MESH:D054556
8996419-10|50 53|VTE|MESH:D054556
8996419-11|19 22|VTE|MESH:D054556
8996419-11|80 100|deep-vein thrombosis|MESH:D020246
8996419-11|118 128|thrombosis|MESH:D013927
8996419-11|142 159|venous thrombosis|MESH:D020246
8996419-12|18 21|VTE|MESH:D054556
8996419-13|44 47|VTE|MESH:D054556
8996419-14|68 71|VTE|MESH:D054556
8996419-15|58 61|VTE|MESH:D054556
8996419-16|69 72|VTE|MESH:D054556
9061777-00|51 58|seizure|MESH:D012640
9061777-00|80 92|brain damage|MESH:D001930
9061777-01|85 92|seizure|MESH:D012640
9061777-02|61 85|tonic and clonic seizure|MESH:D012640
9061777-03|107 114|seizure|MESH:D012640
9061777-04|14 21|seizure|MESH:D012640
9061777-05|77 84|seizure|MESH:D012640
9061777-05|132 139|seizure|MESH:D012640
9061777-06|0 12|Brain damage|MESH:D001930
9061777-07|21 35|neuronal death|MESH:D009410
9061777-08|52 64|brain damage|MESH:D001930
9061777-10|28 46|status epilepticus|MESH:D013226
9061777-10|193 205|brain damage|MESH:D001930
9071336-00|59 72|breast cancer|MESH:D001943
9071336-00|248 261|breast cancer|MESH:D001943
9071336-01|44 56|cytotoxicity|MESH:D064420
9071336-02|212 225|breast cancer|MESH:D001943
9071336-03|164 175|neutropenia|MESH:D009503
9071336-03|291 302|neutropenia|MESH:D009503
9071336-04|25 35|toxicities|MESH:D064420
9071336-08|55 68|breast cancer|MESH:D001943
9125676-00|13 26|proarrhythmia|UNKNOWN_Disease
9125676-00|69 97|ventricular tachyarrhythmias|MESH:D017180
9125676-01|75 94|torsades de pointes|MESH:D016171
9125676-01|132 151|torsades de pointes|MESH:D016171
9125676-01|203 231|ventricular tachyarrhythmias|MESH:D017180
9125676-02|41 64|coronary artery disease|MESH:D003324
9125676-02|78 100|dilated cardiomyopathy|MESH:D002311
9125676-02|127 150|ventricular tachycardia|MESH:D017180
9125676-02|154 178|ventricular fibrillation|MESH:D014693
9125676-02|233 260|ventricular tachyarrhythmia|MESH:D017180
9125676-04|58 81|ventricular tachycardia|MESH:D017180
9125676-04|85 109|ventricular fibrillation|MESH:D014693
9125676-05|17 44|ventricular tachyarrhythmia|MESH:D017180
9125676-05|105 132|ventricular tachyarrhythmia|MESH:D017180
9125676-06|28 47|torsades de pointes|MESH:D016171
9125676-07|126 145|torsades de pointes|MESH:D016171
9125676-08|79 98|torsades de pointes|MESH:D016171
9125676-09|48 67|torsades de pointes|MESH:D016171
9125676-10|54 77|ventricular tachycardia|MESH:D017180
9125676-11|31 46|cardiac disease|MESH:D006331
9125676-11|61 80|torsades de pointes|MESH:D016171
9125676-12|0 19|Torsades de pointes|MESH:D016171
9125676-13|175 194|torsades de pointes|MESH:D016171
9125676-14|107 126|torsades de pointes|MESH:D016171
9125676-15|20 48|ventricular tachyarrhythmias|MESH:D017180
9125676-15|94 104|arrhythmia|MESH:D001145
9128918-00|8 26|hyperprolactinemia|MESH:D006966
9128918-04|40 58|hyperprolactinemia|MESH:D006966
9128918-05|0 18|Hyperprolactinemia|MESH:D006966
9128918-06|18 36|hyperprolactinemia|MESH:D006966
9128918-07|15 33|hyperprolactinemia|MESH:D006966
9128918-08|68 86|hyperprolactinemia|MESH:D006966
9128918-09|315 333|hyperprolactinemia|MESH:D006966
9128918-09|399 417|hyperprolactinemia|MESH:D006966
9128918-10|31 49|hyperprolactinemia|MESH:D006966
9128918-10|151 169|hyperprolactinemia|MESH:D006966
9132810-00|43 62|leukoencephalopathy|MESH:D056784
9132810-01|157 176|leukoencephalopathy|MESH:D056784
9132810-01|199 227|acute lymphoblastic leukemia|MESH:D054198
9132810-03|36 55|loss of myelination|MESH:D003711
9132810-03|60 68|necrosis|MESH:D009336
9132810-04|35 54|leukoencephalopathy|MESH:D056784
9158667-00|0 10|Thrombotic|MESH:D013927
9158667-00|28 56|acute promyelocytic leukemia|MESH:D015473
9158667-01|10 29|acute renal failure|MESH:D058186
9158667-01|38 64|occlusion of renal vessels|UNKNOWN_Disease
9158667-01|83 111|acute promyelocytic leukemia|MESH:D015473
9158667-01|113 116|APL|MESH:D015473
9158667-02|20 39|acute renal failure|MESH:D058186
9158667-02|46 49|APL|MESH:D015473
9158667-03|45 59|thromboembolic|MESH:D013923
9158667-03|106 109|APL|MESH:D015473
9158667-04|73 76|APL|MESH:D015473
9158667-05|41 60|acute renal failure|MESH:D058186
9158667-05|120 123|APL|MESH:D015473
9158667-06|70 73|APL|MESH:D015473
9158667-07|0 10|Thrombotic|MESH:D013927
9197951-00|71 76|mania|MESH:D001714
9197951-01|157 162|manic|MESH:D001714
9197951-02|77 98|pupillary oscillation|MESH:D011681
9197951-02|201 206|manic|MESH:D001714
9197951-03|36 57|pupillary oscillation|MESH:D011681
9197951-03|110 115|manic|MESH:D001714
9197951-04|57 78|pupillary oscillation|MESH:D011681
9197951-04|134 139|manic|MESH:D001714
9272404-01|66 70|pain|MESH:D010146
9272404-02|139 143|pain|MESH:D010146
9272404-04|7 11|pain|MESH:D010146
9272404-04|143 147|pain|MESH:D010146
9272404-05|60 64|pain|MESH:D010146
9272404-06|72 76|pain|MESH:D010146
9272404-07|95 99|pain|MESH:D010146
9272404-07|160 164|pain|MESH:D010146
9272404-07|239 243|pain|MESH:D010146
9272404-10|28 32|pain|MESH:D010146
9272404-10|82 86|pain|MESH:D010146
9323412-00|13 23|depression|MESH:D003866
9323412-01|45 78|postoperative nausea and vomiting|MESH:D020250
9323412-02|33 58|major depression disorder|MESH:D003865
9323412-03|63 81|depressive episode|MESH:D003866
9323412-04|87 93|nausea|MESH:D009325
9323412-04|148 167|depression disorder|MESH:D003866
9382023-00|0 12|Hypertensive|MESH:D006973
9382023-01|59 71|hypertensive|MESH:D006973
9382023-02|56 68|hypertension|MESH:D006973
9428298-00|60 66|asthma|MESH:D001249
9428298-01|132 138|asthma|MESH:D001249
9428298-02|37 43|asthma|MESH:D001249
9428298-04|17 37|cardiac dysrhythmias|MESH:D001145
9428298-05|12 23|hypokalemia|MESH:D007008
9538487-00|0 28|Hyperosmolar nonketotic coma|MESH:D006944
9538487-00|61 91|nephrogenic diabetes insipidus|MESH:D018500
9538487-01|45 61|manic depression|MESH:D001714
9538487-01|102 131|hyperosmolar, nonketotic coma|MESH:D006944
9538487-02|31 39|polyuria|MESH:D011141
9538487-02|44 54|polydipsia|MESH:D059606
9538487-03|20 34|hyperglycaemia|UNKNOWN_Disease
9538487-03|48 56|polyuric|MESH:D011141
9538487-03|138 168|nephrogenic diabetes insipidus|MESH:D018500
9538487-04|44 59|type 2 diabetes|MESH:D003924
9538487-04|69 77|polyuria|MESH:D011141
9538487-04|85 115|nephrogenic diabetes insipidus|MESH:D018500
9538487-04|159 170|dehydration|MESH:D003681
9570197-01|77 133|deterioration of left ventricular (LV) systolic function|MESH:D018487
9570197-03|136 146|chest pain|MESH:D002637
9570197-07|153 207|deterioration of LV systolic and diastolic performance|MESH:D018487
9646784-00|16 32|thrombocytopenia|MESH:D013921
9646784-00|46 61|thromboembolism|MESH:D013923
9646784-03|72 88|thrombocytopenia|MESH:D013921
9646784-03|109 121|osteoporosis|MESH:D010024
9646784-03|123 135|eosinophilia|MESH:D004802
9646784-03|137 151|skin reactions|MESH:D012871
9646784-03|153 171|allergic reactions|MESH:D004342
9646784-03|183 199|thrombocytopenia|MESH:D013921
9646784-03|204 212|alopecia|MESH:D000505
9725303-00|37 57|ureteric obstruction|MESH:D014517
9725303-01|49 65|ureteric calculi|MESH:D014514
9725303-01|73 85|HIV-infected|MESH:D015658
9725303-01|214 226|urolithiasis|MESH:D052878
9725303-02|12 32|Ureteric obstruction|MESH:D014517
9725303-04|83 113|ureteric stones or obstruction|MESH:D014514
9725303-04|83 113|ureteric stones or obstruction|MESH:D014517
9725303-04|131 144|HIV infection|MESH:D015658
9759693-00|0 16|Ischemic colitis|MESH:D017091
9759693-03|29 47|coronary vasospasm|MESH:D003329
9759693-03|49 68|myocardial ischemia|MESH:D017202
9759693-03|74 95|myocardial infarction|MESH:D009203
9759693-04|51 67|ischemic colitis|MESH:D017091
9759693-04|85 93|migraine|MESH:D008881
9782254-00|95 114|Parkinson's disease|MESH:D010300
9782254-00|219 231|bradykinesia|MESH:D018476
9782254-00|233 241|rigidity|MESH:D009127
9782254-00|262 273|dyskinesias|MESH:D004409
9782254-02|58 77|Parkinson's Disease|MESH:D010300
9782254-03|141 152|dyskinesias|MESH:D004409
9782254-04|95 107|bradykinesia|MESH:D018476
9782254-04|112 120|rigidity|MESH:D009127
9782254-05|56 78|homonymous hemianopsia|MESH:D006423
9782254-07|112 131|Parkinson's disease|MESH:D010300
9782254-08|114 122|bleeding|MESH:D006470
9831002-00|0 30|Neuroleptic malignant syndrome|MESH:D009459
9831002-01|35 65|neuroleptic malignant syndrome|MESH:D009459
9831002-02|90 118|multicystic encephalomalacia|MESH:D004678
9831002-02|144 175|hypoxic-ischemic encephalopathy|MESH:D020925
9831002-02|243 273|neuroleptic malignant syndrome|MESH:D009459
9831002-06|40 70|neuroleptic malignant syndrome|MESH:D009459
9869655-10|60 84|intrahepatic cholestasis|MESH:D002780
9881641-00|24 35|hypotension|MESH:D007022
9881641-03|20 31|hypotension|MESH:D007022
9881641-04|0 11|Hypotension|MESH:D007022
9881641-05|48 59|hypotension|MESH:D007022
9881641-05|127 138|hypotension|MESH:D007022
9881641-06|48 59|hypotension|MESH:D007022
9881641-07|120 131|hypotension|MESH:D007022
9889429-00|103 115|hypertension|MESH:D006973
9889429-00|133 142|psoriasis|MESH:D011565
9889429-01|9 18|psoriatic|MESH:D011565
9889429-01|33 45|hypertension|MESH:D006973
9889429-02|53 65|hypertensive|MESH:D006973
9889429-04|171 191|gingival hyperplasia|MESH:D005885
9889429-05|70 82|hypertensive|MESH:D006973
9889429-05|83 92|psoriatic|MESH:D011565
9889429-05|196 216|gingival hyperplasia|MESH:D005885
10087562-00|0 18|Torsade de pointes|MESH:D016171
10087562-00|19 42|ventricular tachycardia|MESH:D017180
10087562-00|111 133|dilated cardiomyopathy|MESH:D002311
10087562-00|138 162|congestive heart failure|MESH:D006333
10087562-01|74 87|heart failure|MESH:D006333
10087562-01|101 123|dilated cardiomyopathy|MESH:D002311
10087562-01|151 174|ventricular arrhythmias|MESH:D001145
10087562-01|189 204|QT prolongation|MESH:D008133
10087562-01|209 227|torsade de pointes|MESH:D016171
10087562-01|228 251|ventricular tachycardia|MESH:D017180
10087562-02|15 33|torsade de pointes|MESH:D016171
10087562-02|34 57|ventricular tachycardia|MESH:D017180
10087562-02|138 149|arrhythmias|MESH:D001145
10219427-03|108 115|dyspnea|MESH:D004417
10219427-03|117 138|loss of consciousness|MESH:D014474
10219427-03|152 170|macro-papular rash|MESH:D003875
10219427-03|261 265|pain|MESH:D010146
10219427-05|94 101|allergy|MESH:D004342
10327032-00|18 47|hyperammonemic encephalopathy|MESH:D001927
10327032-00|18 47|hyperammonemic encephalopathy|MESH:D022124
10327032-00|51 57|cancer|MESH:D009369
10327032-00|143 154|dehydration|MESH:D003681
10327032-00|159 168|infection|MESH:D007239
10327032-01|22 28|cancer|MESH:D009369
10327032-01|71 100|hyperammonemic encephalopathy|MESH:D001927
10327032-01|71 100|hyperammonemic encephalopathy|MESH:D022124
10327032-02|39 52|liver disease|MESH:D008107
10327032-03|9 38|hyperammonemic encephalopathy|MESH:D001927
10327032-03|9 38|hyperammonemic encephalopathy|MESH:D022124
10327032-05|55 63|azotemia|MESH:D053099
10327032-05|90 110|bacterial infections|MESH:D001424
10327032-05|132 141|infection|MESH:D007239
10327032-05|169 180|dehydration|MESH:D003681
10327032-06|54 68|hyperammonemia|MESH:D022124
10327032-06|99 119|bacterial infections|MESH:D001424
10327032-08|15 44|hyperammonemic encephalopathy|MESH:D001927
10327032-08|15 44|hyperammonemic encephalopathy|MESH:D022124
10327032-09|0 8|Azotemia|MESH:D053099
10327032-09|39 59|bacterial infections|MESH:D001424
10390729-04|129 141|hypoactivity|MESH:D009069
10390729-04|211 224|hyperactivity|MESH:D006948
10390729-06|130 142|hypoactivity|MESH:D009069
10390729-06|168 181|hyperactivity|MESH:D006948
10401555-00|41 71|learning and memory impairment|MESH:D008569
10401555-00|41 71|learning and memory impairment|MESH:D007859
10401555-02|119 128|allodynia|MESH:D006930
10401555-02|133 145|hyperalgesia|MESH:D006930
10401555-04|107 140|impairment of learning and memory|MESH:D008569
10401555-04|107 140|impairment of learning and memory|MESH:D007859
10427794-00|18 32|liver toxicity|MESH:D056486
10427794-01|44 64|rheumatoid arthritis|MESH:D001172
10427794-01|95 104|hepatitis|MESH:D056486
10427794-03|20 29|hepatitis|MESH:D056486
10427794-03|157 173|hypersensitivity|MESH:D004342
10427794-04|37 51|liver toxicity|MESH:D056486
10427794-04|102 116|hepatic damage|MESH:D056486
10462057-00|153 168|aplastic anemia|MESH:D000741
10462057-01|148 163|aplastic anemia|MESH:D000741
10462057-07|3 11|necrosis|MESH:D009336
10462057-07|154 162|necrosis|MESH:D009336
10462057-11|51 66|aplastic anemia|MESH:D000741
10462057-11|242 257|aplastic anemia|MESH:D000741
10510854-03|256 265|catalepsy|MESH:D002375
10672628-00|78 87|catalepsy|MESH:D002375
10672628-01|95 104|catalepsy|MESH:D002375
10672628-04|82 91|catalepsy|MESH:D002375
10672628-05|94 103|catalepsy|MESH:D002375
10672628-07|0 9|Catalepsy|MESH:D002375
10672628-09|101 110|catalepsy|MESH:D002375
10677406-00|10 38|left ventricular dysfunction|MESH:D018487
10677406-00|63 86|coronary artery disease|MESH:D003324
10677406-00|130 150|myocardial ischaemia|MESH:D017202
10677406-01|89 117|left ventricular dysfunction|MESH:D018487
10677406-01|135 158|coronary artery disease|MESH:D003324
10677406-02|144 153|ischaemia|MESH:D007511
10677406-03|27 40|stable angina|MESH:D060050
10677406-03|66 89|coronary artery disease|MESH:D003324
10677406-07|71 81|depression|MESH:D003866
10677406-11|30 53|coronary artery disease|MESH:D003324
10677406-11|74 83|ischaemia|MESH:D007511
10677406-11|116 144|left ventricular dysfunction|MESH:D018487
10677406-11|161 180|myocardial stunning|MESH:D017682
10677406-12|19 28|ischaemia|MESH:D007511
10677406-12|126 149|coronary artery disease|MESH:D003324
10713017-00|16 38|pulmonary hypertension|MESH:D006976
10713017-00|109 131|pulmonary hypertension|MESH:D006976
10713017-01|99 129|primary pulmonary hypertension|MESH:D006976
10713017-01|131 134|PPH|MESH:D006976
10713017-03|96 118|pulmonary hypertension|MESH:D006976
10713017-04|104 126|pulmonary hypertension|MESH:D006976
10713017-05|39 61|pulmonary hypertension|MESH:D006976
10713017-05|78 81|PPH|MESH:D006976
10713017-07|67 70|PPH|MESH:D006976
10713017-07|84 106|pulmonary hypertension|MESH:D006976
10713017-07|136 158|pulmonary hypertension|MESH:D006976
10713017-09|109 112|PPH|MESH:D006976
10713017-12|50 53|PPH|MESH:D006976
10713017-12|245 248|PPH|MESH:D006976
10713017-13|116 138|pulmonary hypertension|MESH:D006976
10726030-00|36 52|thrombocytopenia|MESH:D013921
10726030-00|57 67|thrombosis|MESH:D013927
10726030-01|97 107|thrombosis|MESH:D013927
10726030-02|120 130|thrombotic|MESH:D013927
10726030-04|0 8|Bleeding|MESH:D006470
10726030-05|6 14|bleeding|MESH:D006470
10726030-06|90 106|thrombocytopenia|MESH:D013921
10726030-06|127 139|osteoporosis|MESH:D010024
10726030-06|141 153|eosinophilia|MESH:D004802
10726030-06|155 169|skin reactions|MESH:D012871
10726030-06|171 189|allergic reactions|MESH:D004342
10726030-06|201 217|thrombocytopenia|MESH:D013921
10726030-06|219 227|alopecia|MESH:D000505
10726030-06|246 258|hyperkalemia|MESH:D006947
10726030-06|260 277|hypoaldosteronism|MESH:D006994
10726030-06|283 291|priapism|MESH:D011317
10726030-07|149 153|HITT|MESH:D013927
10726030-07|149 153|HITT|MESH:D013921
10726030-07|158 170|osteoporosis|MESH:D010024
10764869-00|20 36|optic neuropathy|MESH:D009901
10764869-01|39 55|optic neuropathy|MESH:D009901
10764869-04|106 133|ischemic optic neuropathies|MESH:D018917
10764869-05|0 23|Deterioration of vision|MESH:D015354
10764869-06|81 101|optic nerve toxicity|MESH:D009901
10770468-00|0 13|Hypercalcemia|MESH:D006934
10770468-00|15 25|arrhythmia|MESH:D001145
10770468-01|21 28|bipolar|MESH:D001714
10770468-01|89 102|hypercalcemia|MESH:D006934
10770468-01|114 129|bradyarrhythmia|MESH:D001919
10770468-01|187 194|bipolar|MESH:D001714
10770468-01|228 241|hypercalcemia|MESH:D006934
10770468-02|27 40|hypercalcemia|MESH:D006934
10770468-03|27 41|hypercalcemias|MESH:D006934
10770468-03|147 161|hypercalcemias|MESH:D006934
10770468-03|173 185|malignancies|MESH:D009369
10770468-03|265 278|hypercalcemia|MESH:D006934
10770468-05|106 113|bipolar|MESH:D001714
10770468-05|167 174|bipolar|MESH:D001714
10770468-08|14 27|hypercalcemia|MESH:D006934
10770468-08|64 71|bipolar|MESH:D001714
10770468-08|105 118|hypercalcemia|MESH:D006934
10933650-00|15 29|nephrotoxicity|MESH:D007674
10933650-01|107 115|toxicity|MESH:D064420
10933650-02|16 24|toxicity|MESH:D064420
10933650-05|51 67|tubular necrosis|MESH:D007683
10933650-07|126 140|nephrotoxicity|MESH:D007674
10939760-00|25 45|acute nephrotoxicity|MESH:D058186
10939760-01|13 33|acute nephrotoxicity|MESH:D058186
10939760-01|78 91|toxoplasmosis|MESH:D014123
10939760-03|49 57|oliguria|MESH:D009846
10939760-03|59 73|abdominal pain|MESH:D015746
10939760-03|75 88|renal failure|MESH:D051437
10939760-03|121 134|renal calculi|MESH:D007669
10939760-05|63 81|ureteral lithiasis|MESH:D052878
10960401-00|0 18|Downbeat nystagmus|MESH:D009759
10960401-01|58 67|dizziness|MESH:D004244
10960401-01|73 94|downbeating nystagmus|MESH:D009759
10975596-00|94 115|myocardial infarction|MESH:D009203
10975596-01|275 296|myocardial infarction|MESH:D009203
10975596-05|75 86|tachycardia|MESH:D013610
10975596-05|149 160|tachycardia|MESH:D013610
10975596-07|110 121|arrhythmias|MESH:D001145
10985896-00|86 120|ovarian and fallopian tube cancers|MESH:D005185
10985896-00|86 120|ovarian and fallopian tube cancers|MESH:D010051
10985896-00|133 160|carcinoma of the peritoneum|MESH:D010534
10985896-01|135 149|ovarian cancer|MESH:D010051
10985896-01|170 178|toxicity|MESH:D064420
10985896-01|246 264|erythrodysesthesia|MESH:D060831
10985896-01|267 285|hand-foot syndrome|MESH:D060831
10985896-01|292 302|stomatitis|MESH:D013280
10985896-03|37 70|ovarian or fallopian tube cancers|MESH:D005185
10985896-03|37 70|ovarian or fallopian tube cancers|MESH:D010051
10985896-03|82 102|peritoneal carcinoma|MESH:D010534
10985896-06|50 68|hand-foot syndrome|MESH:D060831
10985896-06|73 83|stomatitis|MESH:D013280
10985896-07|30 38|diarrhea|MESH:D003967
10985896-11|72 80|toxicity|MESH:D064420
10985896-11|82 92|stomatitis|MESH:D013280
10985896-11|94 112|hand-foot syndrome|MESH:D060831
10985896-12|130 144|ovarian cancer|MESH:D010051
10986547-00|32 45|bipolar mania|MESH:D001714
10986547-02|100 113|bipolar mania|MESH:D001714
10986547-04|51 67|bipolar disorder|MESH:D001714
10986547-04|69 74|manic|MESH:D001714
10986547-05|43 48|Mania|MESH:D001714
10986547-07|42 64|Extrapyramidal Symptom|MESH:D001480
10986547-07|66 69|EPS|MESH:D001480
10986547-10|55 59|EPSs|MESH:D001480
10986547-11|91 102|weight gain|MESH:D015430
10986547-11|225 235|somnolence|MESH:D006970
10986547-12|92 105|bipolar mania|MESH:D001714
11026989-00|14 28|pupil dilation|MESH:D015878
11026989-01|33 47|pupil dilation|MESH:D015878
11026989-02|157 171|pupil dilation|MESH:D015878
11026989-07|9 27|Pupillary dilation|MESH:D015878
11026989-11|13 31|Pupillary dilation|MESH:D015878
11105626-00|10 34|isotretinoin embryopathy|MESH:C535670
11105626-00|50 56|anotia|MESH:D065817
11105626-00|61 86|Taussig-Bing malformation|MESH:D004310
11105626-01|63 69|anotia|MESH:D065817
11105626-01|74 99|Taussig-Bing malformation|MESH:D004310
11135381-00|73 92|stress incontinence|MESH:D014550
11135381-01|120 147|urinary stress incontinence|MESH:D014550
11135381-03|125 144|stress incontinence|MESH:D014550
11135381-04|92 137|a significant rise in systolic blood pressure|MESH:D006973
11135381-05|46 54|headache|MESH:D006261
11135381-06|157 176|stress incontinence|MESH:D014550
11176729-00|94 107|heart failure|MESH:D006333
11176729-02|131 144|heart failure|MESH:D006333
11176729-02|146 149|CHF|MESH:D006333
11176729-03|101 104|CHF|MESH:D006333
11176729-05|58 61|CHF|MESH:D006333
11176729-06|131 142|hypotension|MESH:D007022
11176729-06|147 164|renal dysfunction|MESH:D007674
11176729-07|196 207|hypotension|MESH:D007022
11176729-07|229 246|renal dysfunction|MESH:D007674
11176729-07|250 262|hyperkalemia|MESH:D006947
11176729-10|192 200|diabetes|MESH:D003920
11176729-11|89 92|CHF|MESH:D006333
11229942-00|35 47|cardiotoxity|MESH:D066126
11229942-00|70 95|cocaine and ethanol abuse|MESH:D000437
11229942-00|70 95|cocaine and ethanol abuse|MESH:D019970
11229942-01|25 53|abuse of cocaine and ethanol|MESH:D000437
11229942-01|25 53|abuse of cocaine and ethanol|MESH:D019970
11229942-03|15 31|cardiac toxicity|MESH:D066126
11229942-04|74 88|cardiotoxicity|MESH:D066126
11229942-07|56 79|cardiovascular collapse|UNKNOWN_Disease
11229942-09|76 102|decrease in cardiac output|MESH:D002303
11229942-10|0 23|Ventricular arrhythmias|MESH:D001145
11229942-10|106 129|ventricular tachycardia|MESH:D017180
11229942-12|40 56|cardiac toxicity|MESH:D066126
11229942-13|70 91|myocardial depression|MESH:D009202
11299446-00|13 25|Parkinsonism|MESH:D010302
11299446-01|41 60|Parkinson's disease|MESH:D010302
11366874-00|13 32|irregular heartbeat|MESH:D001145
11366874-01|84 104|irregular heart beat|MESH:D001145
11366874-01|115 126|bradycardia|MESH:D001919
11366874-02|0 11|Bradycardia|MESH:D001919
11380496-00|93 108|Graves' disease|MESH:D006111
11380496-01|83 93|vasculitis|MESH:D014657
11380496-01|129 144|Graves' disease|MESH:D006111
11380496-03|109 119|vasculitis|MESH:D014657
11380496-03|185 200|Graves' disease|MESH:D006111
11380496-04|66 81|Graves' disease|MESH:D006111
11380496-05|54 69|hyperthyroidism|MESH:D006980
11380496-05|77 92|Graves' disease|MESH:D006111
11380496-05|147 157|vasculitis|MESH:D014657
11380496-10|68 83|Graves' disease|MESH:D006111
11380496-12|133 153|vasculitic disorders|MESH:D014652
11380496-13|90 95|fever|MESH:D005334
11380496-13|97 108|oral ulcers|MESH:D019226
11380496-13|113 127|polyarthralgia|MESH:D018771
11380496-14|125 135|vasculitis|MESH:D014657
11385188-00|14 27|heart disease|MESH:D006331
11385188-01|31 44|heart disease|MESH:D006331
11385188-02|25 48|coronary artery disease|MESH:D003324
11385188-04|35 68|abnormal left ventricular filling|MESH:D018487
11385188-05|17 54|coronary artery or myocardial disease|MESH:D009202
11385188-05|17 54|coronary artery or myocardial disease|MESH:D003324
11395263-01|122 143|myocardial infarction|MESH:D009203
11395263-02|112 133|myocardial infarction|MESH:D009203
11401944-00|62 85|ventricular tachycardia|MESH:D017180
11401944-00|98 114|long-QT syndrome|MESH:D008133
11401944-01|119 137|torsade de pointes|MESH:D016171
11401944-01|139 142|TdP|MESH:D016171
11401944-01|149 164|QT prolongation|MESH:D008133
11401944-02|122 125|TdP|MESH:D016171
11401944-03|365 380|QT prolongation|MESH:D008133
11401944-06|151 166|QT prolongation|MESH:D008133
11401944-07|124 127|TdP|MESH:D016171
11401944-09|216 219|TdP|MESH:D016171
11401944-09|226 241|QT prolongation|MESH:D008133
11425091-00|62 77|preterm infants|MESH:D007235
11425091-01|69 79|hemorrhage|MESH:D006470
11425091-01|101 106|cysts|MESH:D003560
11425091-02|79 97|subependymal cysts|MESH:D003560
11425091-02|79 97|subependymal cysts|MESH:D001927
11425091-02|101 116|preterm infants|MESH:D007235
11425091-03|118 161|premature (< 36 weeks of gestation) infants|MESH:D007235
11425091-05|86 99|cocaine abuse|MESH:D019970
11425091-07|17 35|subependymal cysts|MESH:D003560
11425091-07|17 35|subependymal cysts|MESH:D001927
11425091-08|17 35|subependymal cysts|MESH:D003560
11425091-08|17 35|subependymal cysts|MESH:D001927
11425091-09|48 65|subependymal cyst|MESH:D003560
11425091-09|48 65|subependymal cyst|MESH:D001927
11425091-09|79 94|preterm infants|MESH:D007235
11439380-00|12 22|neuropathy|MESH:D009422
11439380-00|58 73|prostate cancer|MESH:D011471
11439380-01|47 57|neuropathy|MESH:D009422
11439380-02|53 68|prostate cancer|MESH:D011471
11439380-08|23 33|neuropathy|MESH:D009422
11439380-11|0 10|Neuropathy|MESH:D009422
11439380-12|38 59|peripheral neuropathy|MESH:D010523
11474137-00|83 95|hearing loss|MESH:D034381
11474137-01|71 82|ototoxicity|MESH:D006311
11474137-01|240 251|ototoxicity|MESH:D006311
11474137-02|121 132|ototoxicity|MESH:D006311
11474137-09|152 163|ototoxicity|MESH:D006311
11708428-00|19 26|anxiety|MESH:D001008
11708428-01|55 62|anxiety|MESH:D001008
11708428-06|0 7|Anxiety|MESH:D001008
11708428-08|9 16|Anxiety|MESH:D001008
11708428-12|45 52|anxiety|MESH:D001008
11745287-00|83 120|squamous cell carcinoma of the cervix|MESH:D002294
11745287-00|83 120|squamous cell carcinoma of the cervix|MESH:D002583
11745287-01|143 161|cervical carcinoma|MESH:D002583
11745287-02|222 254|squamous cell cervical carcinoma|MESH:D002294
11745287-02|222 254|squamous cell cervical carcinoma|MESH:D002583
11745287-02|291 299|toxicity|MESH:D064420
11745287-03|96 104|toxicity|MESH:D064420
11745287-05|26 42|myelosuppression|MESH:D001855
11745287-05|63 74|neutropenia|MESH:D009503
11745287-05|91 97|anemia|MESH:D000740
11745287-05|114 130|thrombocytopenia|MESH:D013921
11745287-05|151 168|neutropenic fever|MESH:D009503
11745287-05|151 168|neutropenic fever|MESH:D005334
11745287-07|30 38|toxicity|MESH:D064420
11745287-07|48 54|nausea|MESH:D009325
11745287-07|71 77|emesis|MESH:D014839
11745287-07|94 101|fatigue|MESH:D005221
11745287-07|117 126|mucositis|MESH:D052016
11745287-07|134 144|stomatitis|MESH:D013280
11745287-07|160 172|constipation|MESH:D003248
11745287-07|188 199|weight loss|MESH:D015431
11745287-07|215 233|hand-foot syndrome|MESH:D060831
11745287-07|253 267|skin reactions|MESH:D012871
11745287-08|117 135|cervical carcinoma|MESH:D002583
11799346-00|22 27|mania|MESH:D001714
11799346-00|29 41|antibiomania|MESH:D001714
11799346-01|58 63|manic|MESH:D001714
11799346-01|149 154|mania|MESH:D001714
11799346-03|44 49|mania|MESH:D001714
11799346-07|76 81|manic|MESH:D001714
11799346-08|127 132|mania|MESH:D001714
11799346-10|46 51|mania|MESH:D001714
11799346-12|89 94|mania|MESH:D001714
11799346-12|161 166|manic|MESH:D001714
11799346-13|43 55|antibiomania|MESH:D001714
11835460-00|17 35|ocular dyskinesias|MESH:D015835
11835460-00|39 58|Parkinson's disease|MESH:D010300
11835460-01|17 35|ocular dyskinesias|MESH:D015835
11835460-02|54 75|choreatic dyskinesias|MESH:D002819
11835460-03|235 253|ocular dyskinesias|MESH:D015835
11915580-00|81 93|dysmenorrhea|MESH:D004412
11915580-01|8 20|dysmenorrhea|MESH:D004412
11915580-03|131 143|dysmenorrhea|MESH:D004412
11915580-04|60 72|dysmenorrhea|MESH:D004412
11915580-09|18 22|pain|MESH:D010146
11915580-11|51 62|pelvic pain|MESH:D017699
11915580-12|0 13|Low back pain|MESH:D017116
11915580-13|0 8|Headache|MESH:D006261
11915580-14|41 49|headache|MESH:D006261
11915580-15|124 136|dysmenorrhea|MESH:D004412
11936424-00|90 107|glomerular injury|MESH:D007674
11936424-00|145 154|nephrosis|MESH:D009401
11936424-01|178 189|proteinuria|MESH:D011507
11936424-01|212 223|hypertrophy|MESH:D006984
11936424-01|238 256|glomerulosclerosis|MESH:D005921
11936424-01|310 319|nephrotic|MESH:D009404
11936424-02|0 9|Nephrosis|MESH:D009401
11936424-08|29 40|proteinuria|MESH:D011507
11936424-09|4 22|glomerulosclerosis|MESH:D005921
11936424-12|108 116|neprotic|MESH:D009401
11988250-00|0 22|Pulmonary hypertension|MESH:D006976
11988250-01|32 42|hypoxaemia|MESH:D000860
11988250-01|140 164|patent ductus arteriosus|MESH:D004374
11988250-03|0 10|Hypoxaemia|MESH:D000860
11988250-04|102 112|hypoxaemia|MESH:D000860
12051122-00|0 12|Hyponatremia|MESH:D007010
12051122-00|17 64|syndrome of inappropriate anti-diuretic hormone|MESH:D007177
12051122-01|124 136|hyponatremia|MESH:D007010
12051122-01|144 204|syndrome of inappropriate secretion of anti-diuretic hormone|MESH:D007177
12051122-01|206 211|SIADH|MESH:D007177
12051122-02|110 122|hyponatremia|MESH:D007010
12051122-02|130 135|SIADH|MESH:D007177
12051122-03|32 44|hyponatremia|MESH:D007010
12051122-03|52 57|SIADH|MESH:D007177
12051122-06|63 71|leukemia|MESH:D007938
12051122-06|75 83|lymphoma|MESH:D008223
12051122-08|77 89|hyponatremia|MESH:D007010
12051122-08|97 102|SIADH|MESH:D007177
12051122-09|38 43|SIADH|MESH:D007177
12059909-00|8 16|toxicity|MESH:D064420
12059909-03|9 17|toxicity|MESH:D064420
12059909-03|35 47|haemorrhagic|MESH:D006470
12059909-03|48 56|cystitis|MESH:D003556
12059909-04|73 81|cystitis|MESH:D003556
12059909-05|8 16|cystitis|MESH:D003556
12059909-09|8 16|cystitis|MESH:D003556
12059909-10|36 44|toxicity|MESH:D064420
12059909-11|25 46|interstitial cystitis|MESH:D018856
12119460-00|114 128|gastric cancer|MESH:D013274
12119460-02|158 172|gastric cancer|MESH:D013274
12119460-02|174 177|AGC|MESH:D013274
12119460-02|215 223|toxicity|MESH:D064420
12119460-03|95 103|toxicity|MESH:D064420
12119460-05|91 94|AGC|MESH:D013274
12119460-08|139 142|AGC|MESH:D013274
12119460-08|169 172|AGC|MESH:D013274
12119460-12|10 20|toxicities|MESH:D064420
12119460-12|56 66|leukopenia|MESH:D007970
12119460-12|82 98|thrombocytopenia|MESH:D013921
12119460-12|113 120|vomitus|MESH:D014839
12119460-12|133 141|diarrhea|MESH:D003967
12119460-12|156 166|stomatitis|MESH:D013280
12119460-12|179 197|hand-foot syndrome|MESH:D060831
12119460-13|23 48|hemolytic-uremic syndrome|MESH:D006463
12119460-13|50 53|HUS|MESH:D006463
12119460-14|93 96|AGC|MESH:D013274
12119460-15|112 115|HUS|MESH:D006463
12165618-00|19 31|leukocyturia|UNKNOWN_Disease
12165618-00|51 74|impaired renal function|MESH:D007674
12165618-00|78 122|human immunodeficiency virus type 1-infected|MESH:D015658
12165618-03|57 71|nephrotoxicity|MESH:D007674
12165618-03|90 134|human immunodeficiency virus type 1-infected|MESH:D015658
12165618-07|56 68|leukocyturia|UNKNOWN_Disease
12165618-08|19 31|leukocyturia|UNKNOWN_Disease
12165618-08|136 145|hematuria|MESH:D006417
12165618-10|33 45|leukocyturia|UNKNOWN_Disease
12165618-10|157 169|leukocyturia|UNKNOWN_Disease
12165618-11|55 67|leukocyturia|UNKNOWN_Disease
12165618-12|44 56|leukocyturia|UNKNOWN_Disease
12165618-13|53 67|nephrotoxicity|MESH:D007674
12165618-14|115 127|leukocyturia|UNKNOWN_Disease
12165618-15|100 112|leukocyturia|UNKNOWN_Disease
12165618-16|33 45|leukocyturia|UNKNOWN_Disease
12165618-18|4 36|impairment of the renal function|MESH:D007674
12165618-18|103 118|nephrolithiasis|MESH:D053040
12165618-19|21 35|nephrotoxicity|MESH:D007674
12165618-19|131 143|leukocyturia|UNKNOWN_Disease
12359538-00|58 68|chest pain|MESH:D002637
12359538-01|83 102|myocardial necrosis|MESH:D009202
12359538-01|130 151|myocardial infarction|MESH:D009203
12359538-01|153 155|MI|MESH:D009203
12359538-01|203 213|chest pain|MESH:D002637
12359538-03|84 94|chest pain|MESH:D002637
12359538-03|121 123|MI|MESH:D009203
12359538-04|66 68|MI|MESH:D009203
12372954-00|6 28|interstitial nephritis|MESH:D009395
12372954-01|26 48|interstitial nephritis|MESH:D009395
12372954-01|50 53|AIN|MESH:D009395
12372954-02|51 56|fever|MESH:D005334
12372954-02|61 80|acute renal failure|MESH:D058186
12372954-03|76 98|retinal vein occlusion|MESH:D012170
12372954-04|40 45|fever|MESH:D005334
12372954-04|50 59|skin rash|MESH:D005076
12372954-05|38 48|arthralgia|MESH:D018771
12372954-05|53 58|fever|MESH:D005334
12372954-05|90 102|eosinophilia|MESH:D004802
12372954-05|107 120|renal failure|MESH:D051437
12372954-05|132 135|AIN|MESH:D009395
12372954-08|69 72|AIN|MESH:D009395
12452552-00|0 30|Neuroleptic malignant syndrome|MESH:D009459
12452552-00|65 73|bleeding|MESH:D006470
12452552-00|92 113|chronic renal failure|MESH:D007676
12452552-01|15 36|chronic renal failure|MESH:D007676
12452552-01|38 41|CRF|MESH:D007676
12452552-01|53 83|neuroleptic malignant syndrome|MESH:D009459
12452552-01|85 88|NMS|MESH:D009459
12452552-02|39 42|NMS|MESH:D009459
12452552-02|63 71|bleeding|MESH:D006470
12452552-03|26 29|NMS|MESH:D009459
12452552-03|48 51|CRF|MESH:D007676
12452552-03|85 93|bleeding|MESH:D006470
12487093-03|19 31|hypertension|MESH:D006973
12487093-06|33 40|seizure|MESH:D012640
12498738-00|62 76|cardiomyopathy|MESH:D009202
12498738-01|107 121|cardiomyopathy|MESH:D009202
12498738-02|52 77|mitochondrial dysfunction|MESH:D028361
12498738-03|286 294|toxicity|MESH:D064420
12498738-11|190 215|mitochondrial dysfunction|MESH:D028361
12498738-11|220 234|cardiomyopathy|MESH:D009202
12498738-11|285 291|cancer|MESH:D009369
12523489-00|16 29|hyperactivity|MESH:D006948
12523489-00|105 118|hyperactivity|MESH:D006948
12523489-01|96 109|hyperactivity|MESH:D006948
12523489-02|46 78|decreased the locomotor activity|MESH:D004409
12523489-10|73 86|hyperactivity|MESH:D006948
12523489-10|160 173|hyperactivity|MESH:D006948
12523489-12|165 178|hyperactivity|MESH:D006948
12523489-12|282 295|hyperactivity|MESH:D006948
12535818-00|27 42|bradyarrhythmia|MESH:D001919
12535818-00|98 117|atrial fibrillation|MESH:D001281
12535818-00|128 149|myocardial infarction|MESH:D009203
12535818-01|98 117|atrial fibrillation|MESH:D001281
12535818-01|119 121|AF|MESH:D001281
12535818-01|145 160|bradyarrhythmia|MESH:D001919
12535818-02|30 45|bradyarrhythmia|MESH:D001919
12535818-02|173 196|ventricular arrhythmias|MESH:D001145
12535818-03|85 87|AF|MESH:D001281
12535818-03|159 180|myocardial infarction|MESH:D009203
12535818-03|182 184|MI|MESH:D009203
12535818-04|49 64|bradyarrhythmia|MESH:D001919
12535818-09|85 87|AF|MESH:D001281
12535818-09|103 105|MI|MESH:D009203
12535818-09|128 143|bradyarrhythmia|MESH:D001919
12559315-02|44 52|cystitis|MESH:D003556
12559315-09|74 95|interstitial cystitis|MESH:D018856
12559315-09|142 154|mastocytosis|MESH:D008415
12559315-10|66 74|cystitis|MESH:D003556
12644816-00|77 92|prostate cancer|MESH:D011471
12644816-01|115 142|haematological malignancies|MESH:D019337
12644816-03|124 139|prostate cancer|MESH:D011471
12644816-09|25 37|constipation|MESH:D003248
12644816-09|47 57|drowsiness|MESH:D006970
12644816-09|59 68|dizziness|MESH:D004244
12644816-09|73 77|rash|MESH:D005076
12644816-10|12 41|peripheral sensory neuropathy|MESH:D010523
12644816-11|82 103|peripheral neuropathy|MESH:D010523
12644816-12|167 188|peripheral neuropathy|MESH:D010523
12677626-00|0 31|Central nervous system toxicity|MESH:D020258
12677626-01|27 70|Central nervous system and cardiac toxicity|MESH:D066126
12677626-01|27 70|Central nervous system and cardiac toxicity|MESH:D020258
12677626-03|23 41|grand mal seizures|MESH:D004830
12677626-05|119 137|grand mal seizures|MESH:D004830
12677626-06|4 12|seizures|MESH:D012640
12677626-07|35 58|cardiovascular toxicity|MESH:D002318
12677626-09|55 71|cardiac toxicity|MESH:D066126
12677626-09|186 197|convulsions|MESH:D012640
12677626-10|46 77|central nervous system toxicity|MESH:D020258
12677626-10|112 128|cardiac toxicity|MESH:D066126
12699527-00|42 60|myotonia congenita|MESH:D009224
12699527-00|99 117|myotonic disorders|MESH:D020967
12699527-01|0 18|Myotonia congenita|MESH:D009224
12699527-01|20 22|MC|MESH:D009224
12699527-01|112 145|sustained membrane depolarisation|UNKNOWN_Disease
12699527-02|84 96|muscle spasm|MESH:D013035
12699527-03|4 17|muscle spasms|MESH:D013035
12699527-04|71 89|myotonic condition|MESH:D020967
12699527-05|0 8|Myotonia|MESH:D009222
12699527-06|14 16|MC|MESH:D009224
12699527-08|28 49|ion channel disorders|UNKNOWN_Disease
12699527-08|60 82|malignant hyperthermia|MESH:D008305
12752472-00|38 46|epilepsy|MESH:D004827
12752472-01|9 14|Apnea|MESH:D001049
12752472-01|40 48|seizures|MESH:D012640
12752472-03|112 120|epilepsy|MESH:D004827
12752472-04|38 47|epileptic|MESH:D004827
12752472-04|131 147|hyperventilation|MESH:D006985
12752472-07|13 29|hyperventilation|MESH:D006985
12752472-08|58 67|epileptic|MESH:D004827
12752472-10|7 16|epileptic|MESH:D004827
12752472-13|84 92|epilepsy|MESH:D004827
12828076-00|45 64|acute liver failure|MESH:D017114
12828076-00|84 92|overdose|MESH:D062787
12828076-01|157 176|acute liver failure|MESH:D017114
12828076-02|81 100|acute liver failure|MESH:D017114
12828076-03|91 110|acute liver failure|MESH:D017114
12828076-04|16 21|tumor|MESH:D009369
12828076-04|22 30|necrosis|MESH:D009336
12828076-05|65 84|acute liver failure|MESH:D017114
12828076-06|51 70|acute liver failure|MESH:D017114
12828076-06|90 98|overdose|MESH:D062787
12828076-06|179 188|hepatitis|MESH:D056486
12828076-09|75 94|acute liver failure|MESH:D017114
12828076-09|190 195|tumor|MESH:D009369
12828076-09|196 204|necrosis|MESH:D009336
12865514-00|46 65|Parkinson's disease|MESH:D010300
12865514-01|118 137|Parkinson's disease|MESH:D010300
12865514-03|52 71|Parkinson's disease|MESH:D010300
12865514-03|129 141|bradykinesia|MESH:D018476
12865514-03|143 151|rigidity|MESH:D009127
12865514-03|174 185|dyskinesias|MESH:D004409
12865514-04|162 181|Parkinson's Disease|MESH:D010300
12865514-05|152 171|Parkinson's Disease|MESH:D010300
12865514-06|22 30|akinesia|MESH:D004409
12865514-06|32 40|rigidity|MESH:D009127
12865514-06|42 48|tremor|MESH:D014202
12865514-11|93 112|Parkinson's disease|MESH:D010300
12865514-13|60 84|drug-induced dyskinesias|MESH:D004409
12912689-00|68 82|retinoblastoma|MESH:D012175
12912689-01|90 98|toxicity|MESH:D064420
12912689-01|153 167|retinoblastoma|MESH:D012175
12912689-02|50 74|abnormal ocular motility|MESH:D015835
12912689-03|18 42|abnormal ocular motility|MESH:D015835
12912689-03|75 89|retinoblastoma|MESH:D012175
12912689-04|135 140|tumor|MESH:D009369
12912689-06|106 120|retinoblastoma|MESH:D012175
12912689-07|201 209|necrosis|MESH:D009336
12912689-08|68 75|rupture|MESH:D012421
12912689-09|78 86|fibrosis|MESH:D005355
12912689-10|36 44|toxicity|MESH:D064420
12948256-00|15 31|optic neuropathy|MESH:D009901
12948256-01|63 79|optic neuropathy|MESH:D009901
12948256-02|40 56|optic neuropathy|MESH:D009901
12948256-02|97 135|tuberculosis of the lung or lymph node|MESH:D014388
12948256-02|97 135|tuberculosis of the lung or lymph node|MESH:D014397
12948256-04|26 42|optic neuropathy|MESH:D009901
12948256-06|32 49|visual impairment|MESH:D014786
12948256-06|66 83|diabetes mellitus|MESH:D003920
12948256-06|85 93|glaucoma|MESH:D005901
12948256-07|33 49|optic neuropathy|MESH:D009901
12948256-08|98 115|diabetes mellitus|MESH:D003920
12948256-08|117 125|glaucoma|MESH:D005901
12950111-00|26 49|gustatory hyperhidrosis|MESH:D013547
12950111-01|0 23|Gustatory hyperhidrosis|MESH:D013547
12950111-01|34 42|sweating|MESH:D013547
12950111-04|17 40|gustatory hyperhidrosis|MESH:D013547
12950111-04|184 197|hyperhidrosis|MESH:D006945
12950111-05|79 87|sweating|MESH:D013547
12950111-05|165 173|sweating|MESH:D013547
12950111-07|34 43|dry mouth|MESH:D014987
12950111-07|50 61|sore throat|MESH:D010612
12950111-07|105 113|headache|MESH:D006261
12950111-08|170 193|gustatory hyperhidrosis|MESH:D013547
14616590-04|124 128|pain|MESH:D010146
14616590-06|29 45|thrombophlebitis|MESH:D013924
14616590-09|0 4|Pain|MESH:D010146
14616590-09|45 61|thrombophlebitis|MESH:D013924
14616590-10|166 182|thrombophlebitis|MESH:D013924
14748761-02|185 197|malignancies|MESH:D009369
14748761-03|78 84|cancer|MESH:D009369
14748761-08|72 83|cardiotoxic|MESH:D066126
14748761-09|225 241|cardiac diseases|MESH:D006331
15018178-00|41 49|necrosis|MESH:D009336
15018178-00|66 82|hemolytic anemia|MESH:D000743
15018178-01|97 113|hemolytic anemia|MESH:D000743
15018178-01|176 191|cerebral anoxia|MESH:D002534
15018178-02|53 61|necrosis|MESH:D009336
15018178-03|26 34|necrosis|MESH:D009336
15094729-00|45 65|visual field defects|MESH:D014786
15094729-01|45 65|visual field defects|MESH:D014786
15094729-01|188 195|seizure|MESH:D012640
15094729-05|205 224|visual field defect|MESH:D014786
15094729-07|32 61|deterioration in visual field|MESH:D014786
15094729-08|24 44|visual field defects|MESH:D014786
15094729-09|89 109|visual field defects|MESH:D014786
15094729-09|183 191|toxicity|MESH:D064420
15096374-00|25 35|dermatitis|MESH:D003872
15096374-00|56 86|facial inflammatory dermatoses|MESH:D005148
15096374-01|209 216|rosacea|MESH:D012393
15096374-01|221 240|perioral dermatitis|MESH:D019557
15096374-02|25 35|dermatitis|MESH:D003872
15096374-03|38 68|inflammatory facial dermatoses|MESH:D005148
15096374-04|102 109|rosacea|MESH:D012393
15096374-04|134 138|acne|MESH:D000152
15096374-06|25 31|eczema|MESH:D004485
15096374-06|45 66|periocular dermatitis|MESH:D019557
15096374-07|18 35|atopic dermatitis|MESH:D003876
15096374-07|56 71|papular rosacea|MESH:D012393
15096374-08|71 81|dermatitis|MESH:D003872
15229250-01|49 87|structural deficits in the human brain|MESH:D001930
15229250-02|132 155|metabolic abnormalities|MESH:D008659
15229250-03|226 246|cognitive impairment|MESH:D003072
15229250-04|91 161|abnormalities in the cortex, hippocampus, white matter, and ventricles|MESH:D001930
15229250-06|155 166|hypertrophy|MESH:D006984
15229250-08|131 158|impaired memory performance|MESH:D008569
15229250-10|23 34|hypertrophy|MESH:D006984
15229250-10|109 116|gliosis|MESH:D005911
15229250-10|130 145|neuronal damage|MESH:D009422
15229250-11|117 129|brain injury|MESH:D001930
15265979-01|92 106|hepatotoxicity|MESH:D056486
15265979-03|19 31|hepatomegaly|MESH:D006529
15265979-06|51 63|hepatomegaly|MESH:D006529
15265979-07|130 141|weight loss|MESH:D015431
15265979-08|118 126|hepatoma|MESH:D006528
15265979-10|74 85|hepatotoxic|MESH:D056486
15265979-10|172 186|hepatotoxicity|MESH:D056486
15276093-01|98 118|hypercholesterolemia|MESH:D006937
15276093-01|129 141|dyslipidemia|MESH:D050171
15276093-03|31 43|dyslipidemia|MESH:D050171
15276093-05|145 157|dyslipidemia|MESH:D050171
15276093-06|127 135|myopathy|MESH:D009135
15276093-10|0 8|Flushing|MESH:D005483
15276093-12|136 144|myopathy|MESH:D009135
15282950-00|61 78|myocardial injury|MESH:D009202
15282950-01|152 169|myocardial damage|MESH:D009202
15282950-04|72 80|necrosis|MESH:D009336
15321332-00|24 31|anxiety|MESH:D001008
15321332-04|36 61|psychological disturbance|MESH:D001008
15366550-00|56 74|diabetes insipidus|MESH:D003919
15366550-02|51 80|neurogenic diabetes insipidus|MESH:D018500
15366550-02|82 84|DI|MESH:D003919
15366550-02|101 123|traumatic brain injury|MESH:D001930
15366550-03|102 112|polydipsia|MESH:D059606
15366550-04|38 52|nephrogenic DI|MESH:D018500
15366550-04|175 189|nephrogenic DI|MESH:D018500
15366550-05|212 226|nephrogenic DI|MESH:D018500
15366550-05|241 254|neurogenic DI|MESH:D018500
15366550-05|268 280|brain trauma|MESH:D001930
15366550-06|56 69|neurogenic DI|MESH:D018500
15482540-00|42 48|anemia|MESH:D000740
15482540-01|69 88|chronic hepatitis C|MESH:D019698
15482540-01|98 114|hemolytic anemia|MESH:D000743
15482540-02|83 89|anemia|MESH:D000740
15482540-03|36 55|chronic hepatitis C|MESH:D019698
15482540-04|72 78|anemia|MESH:D000740
15482540-05|27 33|anemia|MESH:D000740
15482540-06|64 70|anemia|MESH:D000740
15482540-08|129 135|anemia|MESH:D000740
15605432-00|73 93|mitochondrial injury|MESH:D028361
15605432-01|158 172|cardiotoxicity|MESH:D066126
15605432-06|96 116|mitochondrial injury|MESH:D028361
15605432-07|55 85|mitochondrial oxidative damage|MESH:D028361
15605432-08|26 46|mitochondrial injury|MESH:D028361
15609701-00|16 30|coronary spasm|MESH:D003329
15609701-00|49 71|dilated cardiomyopathy|MESH:D002311
15609701-00|98 121|ventricular tachycardia|MESH:D017180
15609701-01|35 58|ventricular dysfunction|MESH:D018754
15609701-01|66 88|dilated cardiomyopathy|MESH:D002311
15609701-01|154 177|ventricular tachycardia|MESH:D017180
15609701-01|179 181|VT|MESH:D017180
15609701-02|64 66|VT|MESH:D017180
15609701-03|80 82|VT|MESH:D017180
15609701-06|0 18|Coronary vasospasm|MESH:D003329
15614572-04|94 111|oral stereotypies|MESH:D009062
15614572-04|116 125|catalepsy|MESH:D002375
15614572-05|47 56|catalepsy|MESH:D002375
15614572-06|55 64|catalepsy|MESH:D002375
15614572-06|167 176|catalepsy|MESH:D002375
15614572-07|125 134|catalepsy|MESH:D002375
15614572-08|46 55|catalepsy|MESH:D002375
15614572-11|242 251|catalepsy|MESH:D002375
15625689-00|0 24|Swallowing abnormalities|MESH:D020447
15625689-00|29 39|dyskinesia|MESH:D004409
15625689-00|43 62|Parkinson's disease|MESH:D010300
15625689-01|0 30|Gastrointestinal abnormalities|MESH:D005767
15625689-01|34 53|Parkinson's disease|MESH:D010300
15625689-01|55 57|PD|MESH:D010300
15625689-02|72 74|PD|MESH:D010300
15625689-02|118 128|dyskinesia|MESH:D004409
15625689-03|8 18|dyskinetic|MESH:D004409
15625689-04|26 35|dysphagia|MESH:D003680
15625689-04|67 86|Parkinson's Disease|MESH:D010300
15625689-06|36 46|dyskinetic|MESH:D004409
15625689-07|0 10|Dyskinetic|MESH:D004409
15625689-09|22 31|dysphagia|MESH:D003680
15625689-09|47 49|PD|MESH:D010300
15625689-10|22 32|dyskinetic|MESH:D004409
15625689-11|90 99|dysphagia|MESH:D003680
15625689-11|154 156|PD|MESH:D010300
15627798-00|58 86|tubulointerstitial nephritis|MESH:D009395
15627798-01|84 92|fibrosis|MESH:D005355
15627798-09|44 52|fibrosis|MESH:D005355
15627798-11|80 108|tubulointerstitial nephritis|MESH:D009395
15630069-00|36 49|schizophrenia|MESH:D012559
15630069-01|45 62|diabetes mellitus|MESH:D003920
15630069-01|98 111|schizophrenia|MESH:D012559
15630069-01|293 301|diabetes|MESH:D003920
15630069-03|66 79|schizophrenia|MESH:D012559
15630069-06|34 47|schizophrenia|MESH:D012559
15630069-06|51 75|schizoaffective disorder|MESH:D011618
15630069-07|80 99|insulin sensitivity|MESH:D007333
15630069-07|139 157|insulin resistance|MESH:D007333
15630069-10|38 57|insulin sensitivity|MESH:D007333
15630069-10|212 230|insulin resistance|MESH:D007333
15630069-11|36 54|insulin resistance|MESH:D007333
15630069-13|90 108|insulin resistance|MESH:D007333
15630069-14|62 80|insulin resistance|MESH:D007333
15815446-00|6 23|cerebral ischemia|MESH:D002545
15815446-00|65 77|hypertension|MESH:D006973
15815446-01|27 59|middle cerebral artery occlusion|MESH:D020244
15815446-01|77 89|hypertensive|MESH:D006973
15815446-01|132 144|hypertension|MESH:D006973
15815446-01|148 169|ischemic brain injury|MESH:D001930
15815446-02|134 146|hypertension|MESH:D006973
15815446-02|151 154|HTN|MESH:D006973
15815446-02|248 260|hypertension|MESH:D006973
15815446-02|265 268|HTN|MESH:D006973
15815446-02|329 341|hypertension|MESH:D006973
15815446-03|37 49|brain injury|MESH:D001930
15815446-03|129 134|edema|MESH:D004487
15815446-05|0 12|Brain injury|MESH:D001930
15815446-05|32 51|ischemic hemisphere|MESH:D002545
15815446-05|72 75|HTN|MESH:D006973
15815446-05|120 123|HTN|MESH:D006973
15815446-06|39 42|HTN|MESH:D006973
15815446-06|81 84|HTN|MESH:D006973
15815446-07|59 62|HTN|MESH:D006973
15815446-07|163 166|HTN|MESH:D006973
15815446-08|78 90|hypertension|MESH:D006973
15815446-08|101 113|brain injury|MESH:D001930
15815446-08|118 123|edema|MESH:D004487
15815446-08|144 156|hypertension|MESH:D006973
15815446-08|179 194|vasogenic edema|MESH:D001929
15817013-00|23 42|atrial fibrillation|MESH:D001281
15817013-00|74 84|hemorrhage|MESH:D006470
15817013-00|89 95|stroke|MESH:D020521
15817013-01|48 58|hemorrhage|MESH:D006470
15817013-01|63 69|stroke|MESH:D020521
15817013-01|103 122|atrial fibrillation|MESH:D001281
15817013-04|150 169|atrial fibrillation|MESH:D001281
15817013-05|42 50|bleeding|MESH:D006470
15817013-05|61 68|strokes|MESH:D020521
15817013-08|20 31|hemorrhages|MESH:D006470
15817013-09|11 17|stroke|MESH:D020521
15817013-10|30 40|hemorrhage|MESH:D006470
15817013-10|145 151|stroke|MESH:D020521
15859361-00|45 59|skin reactions|MESH:D003875
15859361-02|20 36|hypersensitivity|MESH:D004342
15859361-05|105 124|cutaneous reactions|MESH:D003875
15859361-06|36 52|hypersensitivity|MESH:D004342
15859361-07|33 47|skin reactions|MESH:D003875
15859361-12|80 88|erythema|MESH:D004890
15859361-12|98 107|urticaria|MESH:D014581
15859361-12|108 118|angioedema|MESH:D000799
15859361-14|38 48|angioedema|MESH:D000799
15859361-15|21 37|hypersensitivity|MESH:D004342
15882284-00|83 106|end-stage renal disease|MESH:D007676
15882284-01|150 173|end-stage renal disease|MESH:D007676
15882284-01|175 179|ESRD|MESH:D007676
15882284-02|82 86|ESRD|MESH:D007676
15882284-03|84 88|ESRD|MESH:D007676
15882284-04|91 95|ESRD|MESH:D007676
15882284-10|12 16|ESRD|MESH:D007676
15882284-10|168 179|nephropathy|MESH:D007674
15882284-11|134 138|ESRD|MESH:D007676
15882284-12|61 65|ESRD|MESH:D007676
15953230-00|25 33|overdose|MESH:D062787
15953230-00|47 68|prolonged QT syndrome|MESH:D008133
15953230-01|29 38|poisoning|MESH:D011041
15953230-02|15 30|QT prolongation|MESH:D008133
15953230-02|35 48|hypocalcaemia|MESH:D006996
15953230-03|4 19|QT prolongation|MESH:D008133
15987266-00|82 91|epileptic|MESH:D004827
15987266-01|112 120|epilepsy|MESH:D004827
15987266-02|218 236|status epilepticus|MESH:D013226
15991002-03|152 159|anxiety|MESH:D001008
15991002-04|70 77|anxiety|MESH:D001008
15991002-05|79 86|anxiety|MESH:D001008
15991002-10|92 99|anxiety|MESH:D001008
15991002-12|94 101|anxiety|MESH:D001008
16034922-01|64 83|menopausal symptoms|MESH:D008594
16034922-02|59 81|cardiovascular disease|MESH:D002318
16034922-02|83 95|osteoporosis|MESH:D010024
16034922-02|100 108|dementia|MESH:D003704
16034922-03|63 76|heart disease|MESH:D006331
16034922-03|78 100|venous thromboembolism|MESH:D054556
16034922-03|102 108|stroke|MESH:D020521
16034922-03|110 137|transient ischaemic attacks|MESH:D002546
16034922-03|139 152|breast cancer|MESH:D001943
16034922-03|154 171|colorectal cancer|MESH:D015179
16034922-03|173 187|ovarian cancer|MESH:D010051
16034922-03|189 207|endometrial cancer|MESH:D016889
16034922-03|209 228|gallbladder disease|MESH:D005705
16034922-03|250 258|dementia|MESH:D003704
16034922-03|260 269|fractures|MESH:D050723
16034922-12|88 110|venous thromboembolism|MESH:D054556
16034922-12|153 159|stroke|MESH:D020521
16034922-12|177 190|breast cancer|MESH:D001943
16034922-12|211 230|gallbladder disease|MESH:D005705
16034922-13|69 75|stroke|MESH:D020521
16034922-13|80 99|gallbladder disease|MESH:D005705
16034922-14|89 98|fractures|MESH:D050723
16034922-14|103 115|colon cancer|MESH:D003110
16034922-15|143 151|dementia|MESH:D003704
16034922-16|17 39|cardiovascular disease|MESH:D002318
16034922-16|117 139|venous thromboembolism|MESH:D054556
16034922-19|55 77|venous thromboembolism|MESH:D054556
16034922-20|72 87|chronic disease|MESH:D002908
16083708-00|0 25|Drug-induced liver injury|MESH:D056486
16083708-01|78 103|drug-induced liver injury|MESH:D056486
16083708-01|105 109|DILI|MESH:D056486
16083708-02|90 94|DILI|MESH:D056486
16083708-03|4 16|liver damage|MESH:D056486
16083708-03|64 75|cholestatic|MESH:D002779
16083708-05|124 128|DILI|MESH:D056486
16083708-08|97 105|jaundice|MESH:D007565
16083708-09|43 68|fulminant hepatic failure|MESH:D017114
16083708-10|55 63|jaundice|MESH:D007565
16083708-11|70 74|DILI|MESH:D056486
16092435-00|72 86|cardiotoxicity|MESH:D066126
16092435-01|48 62|myocardiopathy|MESH:D009202
16092435-02|69 85|cardiac toxicity|MESH:D066126
16092435-03|66 80|cardiotoxicity|MESH:D066126
16112787-00|96 110|nephrotoxicity|MESH:D007674
16112787-01|293 309|renal impairment|MESH:D007674
16112787-05|149 169|renal tubular injury|MESH:D007674
16112787-07|67 81|nephrotoxicity|MESH:D007674
16112787-08|96 103|atrophy|MESH:D001284
16112787-08|105 117|desquamation|UNKNOWN_Disease
16112787-08|123 131|necrosis|MESH:D009336
16112787-10|89 103|nephrotoxicity|MESH:D007674
16112787-10|183 196|kidney damage|MESH:D007674
16309808-00|51 73|restless legs syndrome|MESH:D012148
16309808-01|79 101|restless legs syndrome|MESH:D012148
16309808-01|103 106|RLS|MESH:D012148
16309808-02|29 32|RLS|MESH:D012148
16309808-02|170 173|RLS|MESH:D012148
16309808-03|164 167|RLS|MESH:D012148
16309808-04|112 115|RLS|MESH:D012148
16309808-05|58 80|postprandial dyspepsia|MESH:D004415
16309808-05|95 98|RLS|MESH:D012148
16309808-06|40 43|RLS|MESH:D012148
16309808-06|101 104|RLS|MESH:D012148
16309808-07|80 83|RLS|MESH:D012148
16309808-07|177 180|RLS|MESH:D012148
16309808-08|95 98|RLS|MESH:D012148
16323982-00|33 58|coronary arterial disease|MESH:D003324
16323982-01|86 101|prostate cancer|MESH:D011471
16323982-02|248 263|prostate cancer|MESH:D011471
16323982-04|108 130|coronary heart disease|MESH:D003327
16323982-05|23 48|coronary arteriosclerosis|MESH:D003324
16323982-05|223 247|hyperglyceridemic effect|MESH:D050171
16369751-00|15 29|cardiotoxicity|MESH:D066126
16369751-01|0 14|Cardiotoxicity|MESH:D066126
16369751-01|91 103|malignancies|MESH:D009369
16369751-02|65 79|cardiotoxicity|MESH:D066126
16369751-03|34 46|colon cancer|MESH:D003110
16369751-04|108 123|precordial pain|MESH:D002637
16369751-04|129 154|right bundle branch block|MESH:D002037
16369751-05|9 24|precordial pain|MESH:D002637
16369751-06|7 22|precordial pain|MESH:D002637
16369751-06|87 101|cardiotoxicity|MESH:D066126
16369751-09|15 31|cardiac symptoms|MESH:D009461
16369751-11|117 131|cardiotoxicity|MESH:D066126
16369751-12|61 75|cardiotoxicity|MESH:D066126
16565833-00|128 142|cardiotoxicity|MESH:D066126
16565833-01|32 46|cardiotoxicity|MESH:D066126
16565833-02|12 26|cardiac damage|MESH:D006331
16565833-04|107 121|cardiotoxicity|MESH:D066126
16565833-09|71 91|cardiomyocyte damage|MESH:D009202
16565833-09|134 140|Cancer|MESH:D009369
16565833-10|82 96|cardiac damage|MESH:D006331
16723784-00|74 105|atrial fibrillation and flutter|MESH:D001281
16723784-00|74 105|atrial fibrillation and flutter|MESH:D001282
16723784-01|90 109|atrial fibrillation|MESH:D001281
16723784-01|111 113|AF|MESH:D001281
16723784-01|119 133|atrial flutter|MESH:D001282
16723784-01|135 138|AFL|MESH:D001282
16723784-02|44 62|torsade de pointes|MESH:D016171
16723784-02|64 67|Tdp|MESH:D016171
16723784-04|83 85|AF|MESH:D001281
16723784-04|93 96|AFL|MESH:D001282
16723784-07|17 32|QT prolongation|MESH:D008133
16723784-07|69 80|bradycardia|MESH:D001919
16723784-07|119 128|dizziness|MESH:D004244
16723784-07|141 148|fatigue|MESH:D005221
16723784-08|25 40|QT prolongation|MESH:D008133
16723784-08|42 45|Tdp|MESH:D016171
16723784-09|32 35|Tdp|MESH:D016171
16723784-09|41 52|hypokalemia|MESH:D007008
16723784-10|87 90|Tdp|MESH:D016171
16723784-10|164 167|Tdp|MESH:D016171
16731636-00|31 50|cardiac hypertrophy|MESH:D006332
16731636-05|0 14|LV hypertrophy|MESH:D006332
16731636-06|12 26|LV hypertrophy|MESH:D006332
16731636-08|78 95|cardiac inotropic|MESH:D006331
16731636-08|109 120|hypertrophy|MESH:D006984
16801510-00|13 29|long QT syndrome|MESH:D008133
16801510-01|25 41|long QT syndrome|MESH:D008133
16801510-03|43 67|QT interval prolongation|MESH:D008133
16801510-06|135 150|QT prolongation|MESH:D008133
16801510-08|53 72|torsades de pointes|MESH:D016171
16801510-10|145 156|hypokalemia|MESH:D007008
16801510-11|13 37|QT interval prolongation|MESH:D008133
16801510-12|111 126|QT prolongation|MESH:D008133
16801510-13|0 16|Long QT syndrome|MESH:D008133
16810074-00|14 26|hypertension|MESH:D006973
16810074-01|54 66|hypertension|MESH:D006973
16810074-01|84 104|arterial dysfunction|MESH:D018754
16810074-02|13 25|hypertension|MESH:D006973
16810074-04|116 128|hypertension|MESH:D006973
16810074-10|98 110|hypertension|MESH:D006973
16810074-12|94 106|hypertensive|MESH:D006973
16810074-14|204 216|hypertension|MESH:D006973
16867246-00|61 84|extrapyramidal syndrome|MESH:D001480
16867246-00|96 109|schizophrenic|MESH:D012559
16867246-01|5 28|Extrapyramidal syndrome|MESH:D001480
16867246-01|30 33|EPS|MESH:D001480
16867246-02|154 167|schizophrenia|MESH:D012559
16867246-03|73 76|EPS|MESH:D001480
16867246-03|80 93|schizophrenic|MESH:D012559
16867246-04|155 168|schizophrenic|MESH:D012559
16867246-04|189 192|EPS|MESH:D001480
16867246-04|208 211|EPS|MESH:D001480
16867246-08|232 245|schizophrenia|MESH:D012559
16867246-09|76 79|EPS|MESH:D001480
16876986-00|77 85|seizures|MESH:D012640
16876986-01|100 108|epilepsy|MESH:D004827
16876986-02|126 134|seizures|MESH:D012640
16876986-04|12 20|seizures|MESH:D012640
16876986-05|27 45|status epilepticus|MESH:D013226
16876986-05|122 130|seizures|MESH:D012640
16876986-06|164 172|seizures|MESH:D012640
16876986-06|225 243|status epilepticus|MESH:D013226
16880771-00|31 59|impairs associative learning|MESH:D007859
16880771-02|92 98|stroke|MESH:D020521
16880771-07|35 63|impaired novel word learning|MESH:D007859
16880771-12|130 136|stroke|MESH:D020521
16906379-00|20 30|vasculitis|MESH:D014657
16906379-00|58 78|polyarteritis nodosa|MESH:D010488
16906379-01|54 77|palmoplantar pustulosis|MESH:D011565
16906379-01|88 93|fever|MESH:D005334
16906379-01|95 103|myalgias|MESH:D063806
16906379-01|105 119|polyneuropathy|MESH:D011115
16906379-01|125 140|testicular pain|MESH:D013733
16906379-03|102 122|polyarteritis nodosa|MESH:D010488
16906379-05|65 75|vasculitis|MESH:D014657
16906379-06|95 115|polyarteritis nodosa|MESH:D010488
16911931-00|14 25|hepatitis B|MESH:D006509
16911931-00|84 95|hepatitis B|MESH:D006509
16911931-01|21 32|hepatitis B|MESH:D006509
16911931-01|107 118|hepatitis B|MESH:D006509
16911931-02|94 105|hepatitis B|MESH:D006509
16911931-03|166 184|cirrhotic diseases|MESH:D008103
16920333-00|64 72|seizures|MESH:D012640
16920333-02|116 124|seizures|MESH:D012640
16920333-02|202 209|seizure|MESH:D012640
16920333-03|81 89|seizures|MESH:D012640
16920333-03|117 124|seizure|MESH:D012640
16920333-04|84 92|seizures|MESH:D012640
16920333-05|45 53|seizures|MESH:D012640
16920333-05|123 131|seizures|MESH:D012640
16920333-05|159 166|seizure|MESH:D012640
17028363-00|0 19|Acute renal failure|MESH:D058186
17028363-02|0 11|Nephropathy|MESH:D007674
17028363-03|44 63|acute renal failure|MESH:D058186
17028363-04|4 16|renal injury|MESH:D058186
17028363-05|54 62|fibrosis|MESH:D005355
17028363-06|96 104|fibrosis|MESH:D005355
17028363-06|117 124|atrophy|MESH:D001284
17028363-07|95 107|renal injury|MESH:D058186
17028363-07|167 178|nephropathy|MESH:D007674
17028363-07|241 254|renal failure|MESH:D051437
17035713-00|92 103|nephropathy|MESH:D007674
17035713-01|113 125|renal damage|MESH:D007674
17035713-01|141 146|tumor|MESH:D009369
17035713-04|0 8|Toxicity|MESH:D064420
17035713-06|107 115|necrosis|MESH:D009336
17035713-11|106 114|necrosis|MESH:D009336
17035713-12|86 94|toxicity|MESH:D064420
17035713-14|67 78|nephropathy|MESH:D007674
17042797-00|116 134|status epilepticus|MESH:D013226
17042797-01|10 28|status epilepticus|MESH:D013226
17042797-02|95 103|seizures|MESH:D012640
17042797-02|134 152|status epilepticus|MESH:D013226
17042797-04|162 180|status epilepticus|MESH:D013226
17042797-06|86 104|status epilepticus|MESH:D013226
17042797-07|100 108|seizures|MESH:D012640
17042797-07|201 209|seizures|MESH:D012640
17042797-09|115 137|temporal lobe epilepsy|MESH:D004833
17069550-00|50 67|autistic disorder|MESH:D001321
17069550-01|88 94|autism|MESH:D001321
17069550-02|191 197|autism|MESH:D001321
17069550-03|48 54|autism|MESH:D001321
17069550-05|65 77|irritability|MESH:D001523
17069550-08|88 97|headaches|MESH:D006261
17069550-09|153 159|autism|MESH:D001321
17069550-09|174 184|aggression|MESH:D001523
17069550-09|186 207|behavioral dyscontrol|MESH:D002653
17069550-09|213 224|inattention|MESH:D019958
17151160-00|90 103|schizophrenia|MESH:D012559
17151160-01|124 137|schizophrenia|MESH:D012559
17151160-02|98 111|schizophrenia|MESH:D012559
17151160-02|119 144|schizophreniform disorder|MESH:D011618
17151160-02|155 179|schizoaffective disorder|MESH:D011618
17151160-05|42 54|parkinsonism|MESH:D010302
17151160-05|59 68|akathisia|MESH:D017109
17151160-06|0 22|Extrapyramidal symptom|MESH:D001480
17151160-07|19 30|weight gain|MESH:D015430
17151160-11|42 53|weight gain|MESH:D015430
17151160-11|59 70|weight gain|MESH:D015430
17159032-00|18 35|visual field loss|MESH:D014786
17159032-06|33 59|visual field abnormalities|MESH:D014786
17159032-08|159 179|visual field defects|MESH:D014786
17223814-00|15 37|atrioventricular block|MESH:D054537
17223814-01|123 146|carcinoma of the breast|MESH:D001943
17223814-04|20 31|bradycardic|MESH:D001919
17223814-05|29 51|atrioventricular block|MESH:D054537
17223814-06|128 142|cardiotoxicity|MESH:D066126
17255138-02|24 51|acute myocardial infarction|MESH:D009203
17255138-02|53 56|AMI|MESH:D009203
17255138-03|53 56|AMI|MESH:D009203
17255138-03|61 72|GI bleeding|MESH:D006471
17255138-08|104 107|AMI|MESH:D009203
17255138-10|86 89|AMI|MESH:D009203
17255138-10|90 101|GI bleeding|MESH:D006471
17255138-11|4 7|AMI|MESH:D009203
17255138-11|11 19|toxicity|MESH:D064420
17297207-00|16 26|arrhythmia|MESH:D001145
17297207-00|45 59|severe malaria|MESH:D016778
17297207-01|41 55|severe malaria|MESH:D016778
17297207-01|69 77|jaundice|MESH:D007565
17297207-01|97 107|arrhythmia|MESH:D001145
17297207-01|109 142|premature ventricular contraction|MESH:D018879
17297207-02|56 61|fever|MESH:D005334
17297207-02|63 68|chill|MESH:D023341
17297207-02|70 78|vomiting|MESH:D014839
17297207-02|80 88|jaundice|MESH:D007565
17297207-04|216 230|severe malaria|MESH:D016778
17297207-04|236 244|jaundice|MESH:D007565
17297207-05|34 41|vomitus|MESH:D014839
17297207-05|43 51|diarrhea|MESH:D003967
17297207-05|53 61|tinnitus|MESH:D014012
17297207-05|63 78|loss of hearing|MESH:D034381
17297207-06|52 63|palpitation|UNKNOWN_Disease
17297207-06|111 144|premature ventricular contraction|MESH:D018879
17297207-06|146 149|PVC|MESH:D018879
17297207-06|191 207|sinoatrial block|MESH:D012848
17297207-09|60 63|PVC|MESH:D018879
17297207-11|62 72|arrhythmic|MESH:D001145
17297207-11|104 114|arrhythmic|MESH:D001145
17297207-11|138 149|arrhythmias|MESH:D001145
17297207-11|168 178|arrhythmia|MESH:D001145
17297207-11|196 199|PVC|MESH:D018879
17297207-12|105 115|arrhythmic|MESH:D001145
17297207-12|162 176|heart diseases|MESH:D006331
17297207-12|194 214|electrolyte disorder|MESH:D014883
17297207-12|216 227|hypokalemia|MESH:D007008
17297207-12|260 268|vomiting|MESH:D014839
17297207-12|276 284|diarrhea|MESH:D003967
17297207-12|288 295|malaria|MESH:D008288
17346443-00|22 42|lichenoid dermatitis|MESH:D017512
17346443-00|76 90|Wilson disease|MESH:D006527
17346443-00|126 133|anxiety|MESH:D001008
17346443-01|0 16|Wilson's disease|MESH:D006527
17346443-01|121 129|toxicity|MESH:D064420
17346443-01|161 206|hepatic, neurologic and psychiatric disorders|MESH:D009422
17346443-01|161 206|hepatic, neurologic and psychiatric disorders|MESH:D001523
17346443-01|161 206|hepatic, neurologic and psychiatric disorders|MESH:D056486
17346443-02|20 36|Wilson's disease|MESH:D006527
17346443-02|42 63|chronic liver disease|MESH:D008107
17346443-02|133 140|anxiety|MESH:D001008
17346443-02|149 159|depression|MESH:D003866
17346443-03|93 113|lichenoid dermatitis|MESH:D017512
17346443-04|83 99|Wilson's disease|MESH:D006527
17346443-05|194 210|Wilson's disease|MESH:D006527
17346443-06|14 30|Wilson's disease|MESH:D006527
17346443-06|90 101|skin lesion|MESH:D012871
17346443-07|57 73|Wilson's disease|MESH:D006527
17346443-07|151 167|Wilson's disease|MESH:D006527
17351238-00|11 33|drop in blood pressure|MESH:D007022
17351238-01|49 59|chest pain|MESH:D002637
17351238-01|71 81|chest pain|MESH:D002637
17351238-04|63 85|drop in blood pressure|MESH:D007022
17351238-08|63 79|syncopal episode|MESH:D013575
17356399-00|0 20|Acute encephalopathy|MESH:D020803
17356399-00|25 43|cerebral vasospasm|MESH:D020301
17356399-00|149 177|acute lymphoblastic leukemia|MESH:D054198
17356399-01|90 118|acute lymphoblastic leukemia|MESH:D054198
17356399-01|120 123|ALL|MESH:D054198
17356399-02|22 42|acute encephalopathy|MESH:D020803
17356399-02|76 83|aphasia|MESH:D001037
17356399-02|85 97|incontinence|MESH:D014549
17356399-02|99 120|visual hallucinations|MESH:D006212
17356399-02|138 146|weakness|MESH:D018908
17356399-02|160 178|cerebral vasospasm|MESH:D020301
17379047-00|195 207|hypertensive|MESH:D006973
17379047-01|46 58|hypertension|MESH:D006973
17379047-02|29 41|hypertension|MESH:D006973
17379047-02|147 159|hypertensive|MESH:D006973
17379047-03|172 194|essential hypertension|MESH:C562386
17379047-05|14 36|essential hypertension|MESH:C562386
17379047-17|17 28|hypokalemia|MESH:D007008
17379047-20|217 228|hypokalemia|MESH:D007008
17384765-00|114 134|cognitive impairment|MESH:D003072
17384765-03|202 214|Pb poisoning|MESH:D007855
17384765-04|38 116|impairments in learning, attention, inhibitory control, and arousal regulation|MESH:D007859
17384765-04|38 116|impairments in learning, attention, inhibitory control, and arousal regulation|MESH:D019958
17384765-06|100 135|cognitive and affective dysfunction|MESH:D003072
17384765-06|100 135|cognitive and affective dysfunction|MESH:D019964
17384765-07|119 137|cognitive deficits|MESH:D003072
17445520-00|27 41|panic disorder|MESH:D016584
17445520-00|46 56|depression|MESH:D003866
17445520-00|62 75|panic attacks|MESH:D016584
17445520-01|40 54|panic disorder|MESH:D016584
17445520-01|56 58|PD|MESH:D016584
17445520-01|78 94|major depression|MESH:D003865
17445520-01|100 113|panic attacks|MESH:D016584
17445520-01|115 118|MDP|MESH:D003865
17445520-01|115 118|MDP|MESH:D016584
17445520-01|158 174|Mental Disorders|MESH:D001523
17445520-01|246 259|panic attacks|MESH:D016584
17445520-02|38 40|PD|MESH:D016584
17445520-02|50 53|MDP|MESH:D003865
17445520-02|50 53|MDP|MESH:D016584
17445520-02|63 79|major depression|MESH:D003865
17445520-02|88 101|panic attacks|MESH:D016584
17445520-02|103 105|MD|MESH:D003865
17445520-04|173 180|anxiety|MESH:D001008
17445520-05|43 45|PD|MESH:D016584
17445520-05|79 82|MDP|MESH:D003865
17445520-05|79 82|MDP|MESH:D016584
17445520-05|115 117|MD|MESH:D003865
17445520-05|161 173|panic attack|MESH:D016584
17445520-06|18 20|PD|MESH:D016584
17445520-06|25 28|MDP|MESH:D003865
17445520-06|25 28|MDP|MESH:D016584
17445520-06|85 87|MD|MESH:D003865
17445520-07|3 15|panic attack|MESH:D016584
17445520-08|18 20|MD|MESH:D003865
17445520-09|54 67|panic attacks|MESH:D016584
17445520-09|98 100|PD|MESH:D016584
17445520-09|104 107|MDP|MESH:D003865
17445520-09|104 107|MDP|MESH:D016584
17484470-00|64 86|failing left ventricle|MESH:D006333
17484470-01|100 122|dilated cardiomyopathy|MESH:D002311
17484470-01|138 158|mitral regurgitation|MESH:D008944
17484470-01|160 162|MR|MESH:D008944
17484470-01|197 199|MR|MESH:D008944
17484470-02|100 102|MR|MESH:D008944
17484470-03|72 85|heart failure|MESH:D006333
17484470-07|6 19|heart failure|MESH:D006333
17484470-07|123 125|MR|MESH:D008944
17484470-09|57 70|heart failure|MESH:D006333
17496739-00|32 39|seizure|MESH:D012640
17496739-01|46 59|neurotoxicity|MESH:D020258
17496739-02|35 58|end-stage renal disease|MESH:D007676
17496739-02|149 155|tremor|MESH:D014202
17496739-02|194 203|confusion|MESH:D003221
17496739-02|235 255|tonic-clonic seizure|MESH:D004830
17496739-02|257 261|GTCS|MESH:D004830
17496739-02|332 346|bronchiectasis|MESH:D001987
17496739-02|352 371|secondary infection|MESH:D060085
17496739-03|78 90|leukocytosis|MESH:D007964
17496739-04|31 41|dysarthria|MESH:D004401
17496739-06|49 53|GTCS|MESH:D004830
17496739-07|59 69|infarction|MESH:D007238
17496739-07|74 95|organic brain lesions|UNKNOWN_Disease
17496739-09|21 35|encephalopathy|MESH:D001927
17496739-09|64 70|uremic|MESH:D006463
17496739-10|114 128|encephalopathy|MESH:D001927
17543491-00|35 55|vocal cord paralysis|MESH:D014826
17543491-02|22 41|vocal nerve palsies|MESH:D014826
17543491-03|96 105|paralysis|MESH:D010243
17543491-09|68 88|vocal cord paralysis|MESH:D014826
17543491-11|135 155|vocal cord paralysis|MESH:D014826
17543491-12|58 78|vocal cord paralysis|MESH:D014826
17543491-13|21 30|paralysis|MESH:D010243
17543491-13|221 230|paralysis|MESH:D010243
17543491-14|44 64|vocal cord paralysis|MESH:D014826
17572393-00|107 125|cortical dysplasia|MESH:D054220
17572393-01|0 18|Cortical dysplasia|MESH:D054220
17572393-02|252 270|cortical dysplasia|MESH:D054220
17572393-06|182 200|cortical dysplasia|MESH:D054220
17828434-04|145 153|seizures|MESH:D012640
17879100-00|55 77|interstitial nephritis|MESH:D009395
17879100-01|0 35|Acute tubulo-interstitial nephritis|MESH:C564356
17879100-01|37 41|ATIN|MESH:C564356
17879100-01|68 87|acute renal failure|MESH:D058186
17879100-01|159 185|tubulo-interstitial injury|MESH:D009395
17879100-02|23 27|ATIN|MESH:C564356
17879100-03|45 64|acute renal failure|MESH:D058186
17879100-04|63 68|fever|MESH:D005334
17879100-07|63 67|ATIN|MESH:C564356
17879100-10|40 51|proteinuria|MESH:D011507
17879100-11|59 63|ATIN|MESH:C564356
17879217-00|44 62|glomerulonephritis|MESH:D005921
17879217-00|66 93|staphylococcal endocarditis|MESH:D004696
17879217-00|66 93|staphylococcal endocarditis|MESH:D013203
17879217-01|22 40|glomerulonephritis|MESH:D005921
17879217-01|133 145|tuberculosis|MESH:D014376
17879217-02|25 35|infections|MESH:D007239
17879217-02|44 66|infective endocarditis|MESH:D004696
17879217-02|68 70|IE|MESH:D004696
17879217-02|124 149|Staphylococcal infections|MESH:D013203
17879217-03|37 54|Staphylococcal IE|MESH:D004696
17879217-03|37 54|Staphylococcal IE|MESH:D013203
17879217-03|69 88|acute renal failure|MESH:D058186
17879217-03|126 144|glomerulonephritis|MESH:D005921
17954033-00|73 108|chronic hepatitis B virus infection|MESH:D019694
17954033-01|52 71|chronic hepatitis B|MESH:D019694
17954033-02|59 70|hepatitis B|MESH:D006509
17954033-02|138 157|chronic hepatitis B|MESH:D019694
17954033-03|91 110|chronic hepatitis B|MESH:D019694
17954033-04|36 55|chronic hepatitis B|MESH:D019694
17954033-12|104 123|chronic hepatitis B|MESH:D019694
17954033-12|207 226|chronic hepatitis B|MESH:D019694
18025637-00|7 29|retinal vein occlusion|MESH:D012170
18025637-01|17 39|retinal vein occlusion|MESH:D012170
18025637-01|85 97|hypertension|MESH:D006973
18025637-02|163 175|hypertension|MESH:D006973
18165598-00|118 122|pain|MESH:D010146
18165598-00|137 141|pain|MESH:D010146
18165598-01|129 141|inflammation|MESH:D007249
18165598-02|177 195|postoperative pain|MESH:D010149
18165598-06|69 73|pain|MESH:D010146
18165598-07|67 71|pain|MESH:D010146
18165598-10|91 104|tissue injury|MESH:D017695
18165598-10|158 162|pain|MESH:D010146
18189308-00|103 111|cystitis|MESH:D003556
18189308-02|126 154|urinary bladder inflammation|MESH:D003556
18189308-03|134 154|bladder inflammation|MESH:D003556
18189308-04|12 20|cystitis|MESH:D003556
18189308-05|143 151|cystitis|MESH:D003556
18189308-06|172 180|cystitis|MESH:D003556
18189308-08|86 94|cystitis|MESH:D003556
18189308-11|117 137|bladder inflammation|MESH:D003556
18340638-02|41 47|anemia|MESH:D000740
18340638-03|15 21|anemia|MESH:D000740
18340638-09|121 127|anemia|MESH:D000740
18399341-01|118 129|hypotension|MESH:D007022
18399341-08|105 116|hypotension|MESH:D007022
18399341-09|133 144|hypotension|MESH:D007022
18422462-00|66 78|HIV-infected|MESH:D015658
18422462-01|160 172|HIV-infected|MESH:D015658
18422462-01|237 249|HIV-infected|MESH:D015658
18422462-03|68 72|rash|MESH:D005076
18422462-03|108 129|peripheral neuropathy|MESH:D010523
18422462-04|23 29|anemia|MESH:D000740
18422462-04|112 121|hepatitis|MESH:D056486
18422462-04|132 140|jaundice|MESH:D007565
18422462-05|51 66|lactic acidosis|MESH:D000140
18422462-05|123 153|immune reconstitution syndrome|MESH:D054019
18422462-06|102 106|rash|MESH:D005076
18422462-06|139 160|peripheral neuropathy|MESH:D010523
18422462-07|0 6|Anemia|MESH:D000740
18422462-07|11 20|hepatitis|MESH:D056486
18422462-08|40 50|toxicities|MESH:D064420
18450790-00|16 37|sensory neurotoxicity|MESH:D010523
18450790-01|57 82|sensory axonal neuropathy|MESH:D010523
18450790-02|128 157|cutaneous lupus erythematosus|MESH:D008178
18450790-02|159 162|CLE|MESH:D008178
18450790-02|228 238|neurotoxic|MESH:D020258
18450790-03|88 91|CLE|MESH:D008178
18450790-07|28 40|paresthesias|MESH:D010292
18450790-07|49 55|cramps|MESH:D009120
18450790-10|14 24|neurotoxic|MESH:D020258
18450790-12|75 85|neurotoxic|MESH:D020258
18801087-00|19 33|pulmonary mass|MESH:D055370
18801087-00|45 74|membranous glomerulonephritis|MESH:D015433
18801087-00|93 115|valvular heart disease|MESH:D006349
18801087-01|22 32|arrhythmic|MESH:D001145
18801087-01|59 70|tachycardia|MESH:D013610
18801087-02|38 60|valvular heart disease|MESH:D006349
18801087-02|91 100|lung mass|MESH:D055370
18801087-02|126 137|proteinuria|MESH:D011507
18801087-03|4 13|lung mass|MESH:D055370
18801087-03|41 52|lung cancer|MESH:D008175
18801087-04|54 65|hemosiderin|MESH:D006486
18801087-04|151 164|hemosiderotic|MESH:D006486
18801087-06|0 19|Autoimmune diseases|MESH:D001327
18801087-06|21 36|viral hepatitis|MESH:D006525
18801087-06|48 57|neoplasms|MESH:D009369
18801087-06|105 134|membranous glomerulonephritis|MESH:D015433
18801087-07|102 118|pulmonary lesion|MESH:D055370
18801087-07|125 133|neoplasm|MESH:D009369
18801087-07|190 219|membranous glomerulonephritis|MESH:D015433
18945509-00|8 31|coronary artery disease|MESH:D003324
18945509-00|97 112|type 2 diabetes|MESH:D003924
18945509-01|57 80|coronary artery disease|MESH:D003324
18945509-01|82 85|CAD|MESH:D003324
18945509-01|124 139|type 2 diabetes|MESH:D003924
18945509-02|12 27|type 2 diabetic|MESH:D003924
18945509-02|58 61|CAD|MESH:D003324
18945509-03|20 23|CAD|MESH:D003324
18945509-03|40 48|diabetes|MESH:D003920
18945509-04|25 28|CAD|MESH:D003324
18945509-05|25 28|CAD|MESH:D003324
18945509-07|37 52|type 2 diabetes|MESH:D003924
18945509-07|122 125|CAD|MESH:D003324
18987260-00|34 45|nephropathy|MESH:D007674
18987260-00|63 75|hypertensive|MESH:D006973
18987260-01|168 181|renal disease|MESH:D007674
18987260-01|211 223|hypertensive|MESH:D006973
18987260-01|257 268|nephropathy|MESH:D007674
18987260-08|125 143|glomerulosclerosis|MESH:D005921
18987260-08|167 178|proteinuria|MESH:D011507
18987260-09|62 80|glomerulosclerosis|MESH:D005921
18987260-09|128 135|atrophy|MESH:D001284
18987260-09|140 161|interstitial fibrosis|MESH:D005355
18987260-09|185 196|proteinuria|MESH:D011507
18987260-09|201 222|chronic renal failure|MESH:D007676
18987260-10|17 24|uraemia|MESH:D014511
18987260-10|70 81|nephropathy|MESH:D007674
18987260-11|68 75|atrophy|MESH:D001284
18987260-11|107 115|fibrosis|MESH:D005355
18987260-11|123 134|nephropathy|MESH:D007674
18987260-12|68 102|focal segmental glomerulosclerosis|MESH:D005923
18987260-12|106 129|end-stage renal disease|MESH:D007676
19020118-06|53 61|seizures|MESH:D012640
19020118-08|61 74|renal failure|MESH:D051437
19020118-09|94 116|myocardial infarctions|MESH:D009203
19020118-09|121 138|renal dysfunction|MESH:D007674
19108278-00|85 104|cardiac arrhythmias|MESH:D001145
19108278-08|74 93|cardiac arrhythmias|MESH:D001145
19108278-10|12 23|arrhythmias|MESH:D001145
19108278-11|59 82|ventricular tachycardia|MESH:D017180
19139825-00|59 71|glioblastoma|MESH:D005909
19139825-01|10 33|glioblastoma multiforme|MESH:D005909
19139825-01|35 38|GBM|MESH:D005909
19139825-02|76 82|glioma|MESH:D005910
19139825-03|206 209|GBM|MESH:D005909
19139825-04|35 45|toxicities|MESH:D064420
19139825-04|82 92|toxicities|MESH:D064420
19139825-04|130 141|lymphopenia|MESH:D008231
19139825-04|146 157|neutropenia|MESH:D009503
19139825-08|172 175|GBM|MESH:D005909
19154241-00|37 56|hyperparathyroidism|MESH:D006961
19154241-02|68 81|hypercalcemia|MESH:D006934
19154241-03|12 39|Primary hyperparathyroidism|MESH:D049950
19154241-05|74 87|hypercalcemic|MESH:D006934
19178808-01|113 121|bleeding|MESH:D006470
19178808-01|327 338|hypotension|MESH:D007022
19178808-02|119 130|hypotension|MESH:D007022
19178808-03|0 10|Hemorrhage|MESH:D006470
19178808-04|20 31|hypotension|MESH:D007022
19178808-05|98 109|hypotension|MESH:D007022
19178808-05|246 257|hypotension|MESH:D007022
19184102-00|0 32|Nonalcoholic fatty liver disease|MESH:D065626
19184102-01|68 76|epilepsy|MESH:D004827
19184102-02|20 52|nonalcoholic fatty liver disease|MESH:D065626
19184102-02|54 59|NAFLD|MESH:D065626
19184102-02|94 101|obesity|MESH:D009765
19184102-03|25 41|hyperinsulinemia|MESH:D006946
19184102-03|47 65|insulin resistance|MESH:D007333
19184102-04|70 81|weight loss|MESH:D015431
19184102-05|31 38|obesity|MESH:D009765
19184102-05|40 56|hyperinsulinemia|MESH:D006946
19184102-05|58 76|insulin resistance|MESH:D007333
19184102-05|157 162|NAFLD|MESH:D065626
19263707-00|20 44|ANCA positive vasculitis|MESH:D056648
19263707-01|109 124|hyperthyroidism|MESH:D006980
19263707-03|0 65|Antineutrophil cytoplasmic antibody (ANCA)--associated vasculitis|MESH:D056648
19263707-04|25 40|Graves' disease|MESH:D006111
19263707-04|89 99|vasculitis|MESH:D014657
19263707-05|35 45|vasculitic|MESH:D014657
19263707-05|46 55|skin rash|MESH:D005076
19263707-05|84 93|arthritis|MESH:D001168
19263707-05|95 102|pyrexia|MESH:D005334
19263707-05|107 118|parotiditis|MESH:D010309
19263707-06|140 148|myositis|MESH:D009220
19263707-08|81 91|vasculitis|MESH:D014657
19293073-02|12 34|Coronary heart disease|MESH:D003327
19293073-02|39 62|cerebrovascular disease|MESH:D002561
19293073-04|135 157|coronary heart disease|MESH:D003327
19293073-05|93 115|myocardial infarctions|MESH:D009203
19293073-05|117 124|strokes|MESH:D020521
19293073-07|188 210|cardiovascular disease|MESH:D002318
19293073-07|212 215|CVD|MESH:D002318
19293073-07|311 318|strokes|MESH:D020521
19293073-07|356 362|stroke|MESH:D020521
19293073-07|411 414|CVD|MESH:D002318
19293073-08|22 47|gastrointestinal bleeding|MESH:D006471
19293073-08|51 70|hemorrhagic strokes|MESH:D020300
19293073-08|51 70|hemorrhagic strokes|MESH:D020521
19293073-10|175 178|CVD|MESH:D002318
19293073-10|212 215|CVD|MESH:D002318
19293073-11|39 61|myocardial infarctions|MESH:D009203
19293073-11|99 106|strokes|MESH:D020521
19293073-12|32 35|CVD|MESH:D002318
19293073-13|71 79|bleeding|MESH:D006470
19293073-13|98 123|gastrointestinal bleeding|MESH:D006471
19293073-14|31 50|hemorrhagic strokes|MESH:D020300
19293073-14|31 50|hemorrhagic strokes|MESH:D020521
19293073-15|54 73|hemorrhagic strokes|MESH:D020300
19293073-15|54 73|hemorrhagic strokes|MESH:D020521
19293073-16|67 70|CVD|MESH:D002318
19293073-19|41 62|myocardial infarction|MESH:D009203
19293073-19|74 81|strokes|MESH:D020521
19293073-20|43 51|bleeding|MESH:D006470
19338378-00|113 129|thrombocytopenia|MESH:D013921
19338378-01|104 114|thrombosis|MESH:D013927
19338378-01|134 150|thrombocytopenia|MESH:D013921
19338378-01|152 155|HIT|MESH:D013921
19338378-01|193 196|HIT|MESH:D013921
19338378-02|95 98|HIT|MESH:D013921
19338378-03|42 45|HIT|MESH:D013921
19338378-03|91 109|hepatic impairment|MESH:D008107
19338378-04|141 154|heart failure|MESH:D006333
19338378-04|180 197|renal dysfunction|MESH:D007674
19338378-04|233 240|obesity|MESH:D009765
19338378-07|149 156|obesity|MESH:D009765
19338378-09|6 14|bleeding|MESH:D006470
19338378-11|76 79|HIT|MESH:D013921
19338378-11|179 182|HIT|MESH:D013921
19392810-00|0 14|Rhabdomyolysis|MESH:D012206
19392810-00|25 40|ischemic stroke|MESH:D002544
19392810-01|59 71|heroin abuse|MESH:D006556
19392810-04|42 56|rhabdomyolysis|MESH:D012206
19392810-04|70 85|ischemic stroke|MESH:D002544
19392810-06|13 28|unconsciousness|MESH:D014474
19392810-08|21 35|rhabdomyolysis|MESH:D012206
19392810-08|37 56|acute renal failure|MESH:D058186
19392810-08|67 86|respiratory failure|MESH:D012131
19392810-09|45 52|aphasia|MESH:D001037
19392810-09|57 65|weakness|MESH:D018908
19392810-10|20 48|cerebral ischemic infarction|MESH:D002544
19392810-11|81 95|rhabdomyolysis|MESH:D012206
19392810-11|100 115|ischemic stroke|MESH:D002544
19392810-13|29 43|rhabdomyolysis|MESH:D012206
19392810-13|48 54|stroke|MESH:D020521
19419794-00|79 90|dyskinesias|MESH:D004409
19419794-05|69 80|dyskinesias|MESH:D004409
19419794-06|149 160|dyskinesias|MESH:D004409
19419794-07|144 155|dyskinesias|MESH:D004409
19447152-00|16 21|mania|MESH:D001714
19447152-01|151 164|bipolar mania|MESH:D001714
19447152-02|33 49|bipolar disorder|MESH:D001714
19447152-02|68 93|mitochondrial dysfunction|MESH:D028361
19447152-06|69 84|hyperlocomotion|MESH:D009069
19447152-08|31 36|mania|MESH:D001714
19447152-08|150 166|bipolar disorder|MESH:D001714
19515070-01|52 75|fulminant liver failure|MESH:D017114
19515070-02|53 72|acute kidney injury|MESH:D058186
19515070-02|74 77|AKI|MESH:D058186
19515070-03|71 94|fulminant liver failure|MESH:D017114
19515070-04|137 145|toxicity|MESH:D064420
19515070-06|68 91|fulminant liver failure|MESH:D017114
19515070-06|108 111|AKI|MESH:D058186
19515070-07|70 78|toxicity|MESH:D064420
19515070-08|94 117|fulminant liver failure|MESH:D017114
19531695-00|0 8|Delirium|MESH:D003693
19531695-01|52 60|delirium|MESH:D003693
19531695-02|97 106|confusion|MESH:D003221
19531695-02|111 119|paranoia|MESH:D010259
19531695-04|46 65|atrial fibrillation|MESH:D001281
19531695-08|4 12|delirium|MESH:D003693
19531695-09|105 113|delirium|MESH:D003693
19531695-10|223 231|delirium|MESH:D003693
19531695-11|95 103|delirium|MESH:D003693
19531695-12|73 81|delirium|MESH:D003693
19531695-13|8 16|toxicity|MESH:D064420
19549709-00|58 63|NSCLC|MESH:D002289
19549709-01|64 90|non-small-cell lung cancer|MESH:D002289
19549709-01|92 97|NSCLC|MESH:D002289
19549709-02|101 106|NSCLC|MESH:D002289
19549709-03|26 31|NSCLC|MESH:D002289
19549709-03|278 286|toxicity|MESH:D064420
19549709-05|82 87|tumor|MESH:D009369
19549709-10|33 40|fatigue|MESH:D005221
19549709-10|42 49|dyspnea|MESH:D004417
19549709-10|51 61|stomatitis|MESH:D013280
19549709-10|63 69|anemia|MESH:D000740
19549709-10|75 91|thrombocytopenia|MESH:D013921
19549709-11|0 11|Pneumonitis|MESH:D011014
19549709-13|97 102|NSCLC|MESH:D002289
19549709-14|58 63|NSCLC|MESH:D002289
19553912-00|15 21|anemia|MESH:D000740
19553912-01|15 21|anemia|MESH:D000740
19553912-03|83 89|anemia|MESH:D000740
19553912-04|118 124|anemia|MESH:D000740
19553912-05|22 28|anemia|MESH:D000740
19655282-00|110 120|chest pain|MESH:D002637
19655282-01|92 102|chest pain|MESH:D002637
19655282-01|162 185|acute coronary syndrome|MESH:D054058
19655282-03|89 99|chest pain|MESH:D002637
19655282-03|104 122|coronary vasospasm|MESH:D003329
19655282-03|151 159|ischemia|MESH:D007511
19655282-04|79 89|chest pain|MESH:D002637
19655282-05|132 142|chest pain|MESH:D002637
19655282-07|45 53|stenosis|MESH:D003251
19655282-08|52 73|myocardial infarction|MESH:D009203
19655282-09|56 66|chest pain|MESH:D002637
19655282-14|17 34|coronary stenosis|MESH:D023921
19655282-15|136 157|myocardial infarction|MESH:D009203
19655282-16|41 60|myocardial ischemia|MESH:D017202
19655282-16|137 147|chest pain|MESH:D002637
19655282-16|155 163|ischemic|MESH:D007511
19715529-00|15 59|posterior reversible encephalopathy syndrome|MESH:D054038
19715529-01|12 41|Posterior leukoencephalopathy|MESH:D054038
19715529-01|79 92|neurotoxicity|MESH:D020258
19715529-03|111 130|alcoholic cirrhosis|MESH:D008104
19715529-03|172 201|posterior leukoencephalopathy|MESH:D054038
19715529-03|205 249|posterior reversible encephalopathy syndrome|MESH:D054038
19715529-08|13 57|Posterior reversible encephalopathy syndrome|MESH:D054038
19728177-00|10 21|hypothermia|MESH:D007035
19728177-00|50 64|cerebral edema|MESH:D001929
19728177-00|69 94|intracranial hypertension|MESH:D019586
19728177-00|111 136|fulminant hepatic failure|MESH:D017114
19728177-01|72 86|cerebral edema|MESH:D001929
19728177-01|100 125|fulminant hepatic failure|MESH:D017114
19728177-01|127 130|FHF|MESH:D017114
19728177-01|174 185|hypothermia|MESH:D007035
19728177-02|131 134|FHF|MESH:D017114
19728177-02|168 182|cerebral edema|MESH:D001929
19728177-03|91 99|toxicity|MESH:D064420
19728177-05|29 32|FHF|MESH:D017114
19728177-05|56 70|cerebral edema|MESH:D001929
19728177-06|51 67|hyperventilation|MESH:D006985
19728177-06|92 101|paralysis|MESH:D010243
19728177-08|30 41|hypothermia|MESH:D007035
19728177-09|45 59|cerebral edema|MESH:D001929
19728177-09|64 89|intracranial hypertension|MESH:D019586
19728177-11|29 32|FHF|MESH:D017114
19728177-11|37 51|cerebral edema|MESH:D001929
19728177-11|71 79|overdose|MESH:D062787
19728177-11|103 114|hypothermia|MESH:D007035
19728177-12|20 31|hypothermia|MESH:D007035
19815465-00|0 28|Binasal visual field defects|MESH:D014786
19815465-01|28 42|visual defects|MESH:D014786
19815465-02|29 37|epilepsy|MESH:D004827
19815465-03|53 60|seizure|MESH:D012640
19815465-07|0 36|Bilateral visual field abnormalities|MESH:D014786
19815465-07|63 71|epilepsy|MESH:D004827
19815465-08|116 132|retinal toxicity|MESH:D012164
19841052-00|46 59|HIV infection|MESH:D015658
19841052-01|103 116|HIV infection|MESH:D015658
19841052-02|126 139|HIV infection|MESH:D015658
19841052-04|33 51|HIV seroconversion|MESH:D006679
19841052-06|23 36|HIV infection|MESH:D015658
19841052-08|69 87|HIV seroconversion|MESH:D006679
19841052-09|88 106|HIV seroconversion|MESH:D006679
19914299-00|24 39|memory deficits|MESH:D008569
19914299-01|0 6|Cancer|MESH:D009369
19920070-00|115 127|hepatomegaly|MESH:D006529
19967075-00|84 95|Nephropathy|MESH:D007674
19967075-01|126 137|nephropathy|MESH:D007674
19967075-09|19 30|nephropathy|MESH:D007674
20024739-00|45 56|HIV disease|MESH:D015658
20024739-01|56 66|depression|MESH:D003866
20024739-01|89 100|HIV disease|MESH:D015658
20024739-03|136 146|depression|MESH:D003866
20024739-03|214 224|Depression|MESH:D003866
20024739-07|48 58|depression|MESH:D003866
20024739-08|0 10|Depression|MESH:D003866
20024739-09|76 86|depression|MESH:D003866
20024739-10|10 20|depression|MESH:D003866
20024739-10|40 51|HIV disease|MESH:D015658
20034406-00|100 118|status epilepticus|MESH:D013226
20034406-01|12 29|Neuroinflammation|MESH:D007249
20034406-01|43 51|seizures|MESH:D012640
20034406-02|98 115|neuroinflammatory|MESH:D007249
20034406-03|62 80|status epilepticus|MESH:D013226
20034406-03|82 84|SE|MESH:D013226
20034406-04|9 11|SE|MESH:D013226
20034406-06|16 18|SE|MESH:D013226
20034406-09|62 64|SE|MESH:D013226
20034406-10|0 8|Seizures|MESH:D012640
20034406-11|72 74|SE|MESH:D013226
20034406-12|72 74|SE|MESH:D013226
20034406-13|35 37|SE|MESH:D013226
20034406-13|80 93|hypertrophied|MESH:D006984
20034406-15|88 90|SE|MESH:D013226
20034406-16|107 109|SE|MESH:D013226
20034406-17|0 8|Seizures|MESH:D012640
20034406-18|67 84|neuroinflammatory|MESH:D007249
20034406-18|114 122|seizures|MESH:D012640
20046642-03|103 124|cognitive dysfunction|MESH:D003072
20046642-08|64 111|deterioration of learning and short-term memory|MESH:D008569
20046642-08|64 111|deterioration of learning and short-term memory|MESH:D007859
20046642-09|42 47|tumor|MESH:D009369
20046642-09|48 56|necrosis|MESH:D009336
20046642-12|59 67|toxicity|MESH:D064420
20129423-00|28 50|fulminant eosinophilic|MESH:D004802
20129423-00|52 68|hypersensitivity|MESH:D004342
20129423-00|70 81|myocarditis|MESH:D009205
20129423-00|167 188|drug hypersensitivity|MESH:D004342
20129423-02|106 122|hypersensitivity|MESH:D004342
20129423-02|124 135|myocarditis|MESH:D009205
20129423-03|20 36|hypersensitivity|MESH:D004342
20129423-03|37 48|myocarditis|MESH:D009205
20129423-04|6 22|hypersensitivity|MESH:D004342
20129423-04|23 34|myocarditis|MESH:D009205
20129423-06|29 46|cardiogenic shock|MESH:D012770
20129423-07|80 91|myocarditis|MESH:D009205
20169779-00|57 76|Parkinson's disease|MESH:D010302
20169779-01|108 127|Parkinson's disease|MESH:D010302
20169779-01|129 131|PD|MESH:D010302
20169779-03|67 92|neuropsychiatric symptoms|MESH:D001523
20169779-03|96 98|PD|MESH:D010302
20169779-04|75 106|neuropsychiatric-like behaviors|MESH:D001523
20169779-05|134 146|parkinsonism|MESH:D010302
20169779-07|27 50|parkinsonian disability|MESH:D020734
20169779-07|52 62|dyskinesia|MESH:D004409
20169779-07|100 131|neuropsychiatric-like behaviors|MESH:D001523
20169779-08|13 43|neuropsychiatric-like behavior|MESH:D001523
20169779-09|97 107|dyskinesia|MESH:D004409
20169779-10|30 61|neuropsychiatric-like behaviors|MESH:D001523
20169779-11|35 61|neuropsychiatric disorders|MESH:D001523
20169779-11|65 67|PD|MESH:D010302
20192893-00|16 30|nephrotoxicity|MESH:D007674
20192893-01|12 29|Renal dysfunction|MESH:D007674
20192893-02|42 53|nephrotoxic|MESH:D007674
20192893-08|98 110|renal damage|MESH:D007674
20192893-09|80 88|toxicity|MESH:D064420
20408947-00|85 104|acute liver failure|MESH:D017114
20408947-01|34 48|hepatotoxicity|MESH:D056486
20408947-01|77 96|acute liver failure|MESH:D017114
20408947-01|98 101|ALF|MESH:D017114
20408947-03|245 248|ALF|MESH:D017114
20408947-03|344 347|ALF|MESH:D017114
20408947-03|375 396|chronic liver disease|MESH:D008107
20408947-03|398 401|CLD|MESH:D008107
20408947-04|31 34|ALF|MESH:D017114
20408947-05|35 38|ALF|MESH:D017114
20408947-05|120 123|ALF|MESH:D017114
20408947-05|130 133|CLD|MESH:D008107
20408947-06|175 178|ALF|MESH:D017114
20408947-06|230 233|ALF|MESH:D017114
20408947-06|244 247|CLD|MESH:D008107
20408947-07|26 29|ALF|MESH:D017114
20408947-08|139 142|ALF|MESH:D017114
20408947-08|211 214|ALF|MESH:D017114
20408947-08|234 237|CLD|MESH:D008107
20447294-00|115 131|neuropathic pain|MESH:D009437
20447294-01|206 222|neuropathic pain|MESH:D009437
20447294-02|229 233|pain|MESH:D010146
20447294-02|266 278|inflammation|MESH:D007249
20447294-02|312 331|diabetic neuropathy|MESH:D003929
20447294-04|46 58|hyperalgesia|MESH:D006930
20447294-04|176 186|neuropathy|MESH:D009422
20447294-06|183 193|neuropathy|MESH:D009422
20447294-07|146 158|hyperalgesia|MESH:D006930
20447294-07|183 194|neuropathic|MESH:D009422
20495512-00|16 32|thrombocytopenia|MESH:D013921
20495512-01|16 32|thrombocytopenia|MESH:D013921
20495512-01|34 37|HIT|MESH:D013921
20495512-03|0 10|Thrombosis|MESH:D013927
20495512-03|15 31|thrombocytopenia|MESH:D013921
20495512-03|78 81|HIT|MESH:D013921
20495512-04|18 21|HIT|MESH:D013921
20495512-05|0 3|HIT|MESH:D013921
20495512-05|58 68|thrombosis|MESH:D013927
20495512-05|92 102|thrombosis|MESH:D013927
20495512-07|17 20|HIT|MESH:D013921
20495512-08|155 158|HIT|MESH:D013921
20495512-10|113 116|HIT|MESH:D013921
20495512-11|88 91|HIT|MESH:D013921
20513036-00|9 18|paralysis|MESH:D010243
20513036-00|45 73|adductor spasmodic dysphonia|MESH:D014826
20513036-01|127 155|adductor spasmodic dysphonia|MESH:D014826
20513036-01|157 161|ADSD|MESH:D014826
20513036-02|58 69|throat pain|MESH:D010612
20513036-03|52 61|paralysis|MESH:D010243
20513036-03|93 97|ADSD|MESH:D014826
20513036-05|53 72|spasmodic dysphonia|MESH:D055154
20513036-06|14 18|ADSD|MESH:D014826
20513036-08|37 46|paralysis|MESH:D010243
20513036-08|119 128|paralysis|MESH:D010243
20513036-09|95 99|ADSD|MESH:D014826
20513036-10|66 75|paralysis|MESH:D010243
20513036-12|56 65|paralysis|MESH:D010243
20513036-12|96 105|paralysis|MESH:D010243
20513036-14|26 35|paralysis|MESH:D010243
20513036-14|62 66|ADSD|MESH:D014826
20513036-15|32 41|paralysis|MESH:D010243
20513036-15|89 93|ADSD|MESH:D014826
20513036-16|24 33|paralysis|MESH:D010243
20513036-17|4 13|paralysis|MESH:D010243
20566328-00|0 24|Mitochondrial impairment|MESH:D028361
20566328-00|56 75|cardiac dysfunction|MESH:D006331
20566328-01|123 142|cardiac dysfunction|MESH:D006331
20566328-02|21 34|cocaine abuse|MESH:D019970
20566328-02|101 129|left ventricular dysfunction|MESH:D018487
20566328-06|131 158|mitochondrial abnormalities|MESH:D028361
20566328-07|83 110|mitochondrial abnormalities|MESH:D028361
20566328-07|122 141|cardiac dysfunction|MESH:D006331
20566328-07|166 187|diastolic dysfunction|UNKNOWN_Disease
20566328-08|91 110|cardiac dysfunction|MESH:D006331
20566328-08|127 147|mitochondrial defect|MESH:D028361
20589632-00|28 44|hemolytic anemia|MESH:D000743
20589632-01|24 38|acute leukemia|MESH:D015470
20589632-01|72 78|anemia|MESH:D000740
20589632-02|42 56|hemoglobinuria|MESH:D006456
20589632-04|20 36|hemolytic anemia|MESH:D000743
20589632-07|16 22|anemia|MESH:D000740
20589632-07|81 87|anemia|MESH:D000740
20589632-08|13 22|hemolysis|MESH:D006461
20682692-00|123 143|diabetic nephropathy|MESH:D003928
20682692-01|119 134|type 1 diabetes|MESH:D003922
20682692-01|190 201|nephropathy|MESH:D007674
20682692-01|280 300|diabetic nephropathy|MESH:D003928
20682692-01|302 322|diabetic nephropathy|MESH:D003928
20682692-02|140 148|fibrosis|MESH:D005355
20682692-02|225 233|diabetes|MESH:D003920
20682692-03|92 112|diabetic nephropathy|MESH:D003928
20682692-06|130 150|diabetic nephropathy|MESH:D003928
20682692-08|131 151|diabetic nephropathy|MESH:D003928
20682692-09|101 109|fibrosis|MESH:D005355
20682692-09|139 150|nephropathy|MESH:D007674
20682692-10|71 91|diabetic nephropathy|MESH:D003928
20682692-11|83 103|diabetic nephropathy|MESH:D003928
20682692-11|114 136|diabetes complications|MESH:D048909
20828385-00|69 89|mantle cell lymphoma|MESH:D020522
20828385-01|0 20|Mantle cell lymphoma|MESH:D020522
20828385-01|22 25|MCL|MESH:D020522
20828385-01|60 89|B-cell non-Hodgkin's lymphoma|MESH:D008228
20828385-03|71 74|MCL|MESH:D020522
20828385-03|177 180|MCL|MESH:D020522
20828385-03|189 194|tumor|MESH:D009369
20828385-05|66 71|tumor|MESH:D009369
20828385-05|175 180|tumor|MESH:D009369
20828385-06|94 99|tumor|MESH:D009369
20828385-07|77 85|necrotic|MESH:D009336
20828385-08|27 32|tumor|MESH:D009369
20828385-08|134 139|tumor|MESH:D009369
20828385-08|214 217|MCL|MESH:D020522
20859899-00|0 7|Syncope|MESH:D013575
20859899-00|18 30|hyperkalemia|MESH:D006947
20859899-01|80 101|myocardial infarction|MESH:D009203
20859899-01|145 166|loss of consciousness|MESH:D014474
20859899-01|181 192|bradycardia|MESH:D001919
20859899-01|203 215|hyperkalemia|MESH:D006947
20859899-03|13 25|hyperkalemia|MESH:D006947
20859899-05|49 61|hyperkalemia|MESH:D006947
20859899-05|171 188|renal disturbance|MESH:D007674
20927253-00|17 21|pain|MESH:D010146
20927253-01|12 24|Osteoporosis|MESH:D010024
20927253-02|84 96|osteoporosis|MESH:D010024
20927253-04|0 20|Musculoskeletal pain|MESH:D059352
20927253-05|80 84|pain|MESH:D010146
20927253-06|43 55|osteoporosis|MESH:D010024
20927253-06|67 71|pain|MESH:D010146
20927253-06|100 104|pain|MESH:D010146
20927253-06|166 178|osteoporosis|MESH:D010024
20959502-00|91 101|meningitis|MESH:D008581
20959502-01|82 92|bacteremia|MESH:D016470
20959502-01|113 123|meningitis|MESH:D008581
20959502-02|88 96|weakness|MESH:D018908
20959502-02|133 142|pneumonia|MESH:D011014
20959502-06|32 51|acute renal failure|MESH:D058186
20959502-07|140 154|cardiac arrest|MESH:D006323
20959502-08|39 49|bacteremia|MESH:D016470
20959502-08|120 129|infection|MESH:D007239
20959502-09|84 94|meningitis|MESH:D008581
20959502-13|98 120|interstitial nephritis|MESH:D009395
20959502-13|135 145|bacteremia|MESH:D016470
20959502-15|72 82|bacteremia|MESH:D016470
20959502-16|55 65|meningitis|MESH:D008581
21195121-00|28 39|convulsions|MESH:D012640
21195121-02|10 21|convulsions|MESH:D012640
21195121-03|207 215|epilepsy|MESH:D004827
21195121-04|125 133|epilepsy|MESH:D004827
21195121-05|114 124|convulsion|MESH:D012640
21195121-05|184 194|convulsion|MESH:D012640
21195121-06|83 93|convulsion|MESH:D012640
21195121-06|147 157|convulsion|MESH:D012640
21195121-06|185 195|convulsive|MESH:D012640
21195121-08|107 115|seizures|MESH:D012640
24055495-00|44 62|cognitive deficits|MESH:D003072
24055495-01|50 58|dementia|MESH:D003704
24055495-01|71 90|Alzheimer's disease|MESH:D000544
24055495-03|60 80|memory deterioration|MESH:D008569
24055495-04|97 115|cognitive deficits|MESH:D003072
24055495-05|152 170|cognitive deficits|MESH:D003072
24055495-09|137 155|cognitive deficits|MESH:D003072
24055495-09|172 194|glucose hypometabolism|MESH:D018149
24055495-09|198 200|AD|MESH:D000544
